






















































Systemic+ sclerosis+ (SSc)+ is+ a+ complex+ autoimmune+ disease+with+ unknown+
aetiology.+While+ the+ presence+ of+ autoAantibodies+ classifies+ this+ disease+ as+
autoimmune,+ the+ issues+ concerning+ this+ disease+ extend+much+ further+ with+
particular+respect+to+inflammation+and+the+gradually+progressing+internal+and+
external+organ+fibrosis.+If+not+lethal,+at+the+very+least,+the+symptoms+of+SSc+are+
lifeAaltering.+ Many+ potential+ driving+ forces+ are+ hypothesised+ to+ exacerbate+
pathology,+ one+ of+ which+ is+ the+microenvironment+ in+ lesional+ skin,+ in+ which+
resident+ mesenchymal+ stem+ cells+ (MSCs),+ are+ exposed+ to+ aberrantly+
expressed+ growth+ factors+ and+ cytokines,+ and+ excessively+ stiffened+ and+
abundant+ extracellular+matrix.+ + In+ this+ thesis,+ it+ is+ hypothesised+ that+MSCs+
adopt+ a+ proAfibrotic,+ chronic,+ wound+ healing+ phenotype+ in+ response+ to+ the+
disease+microenvironment.+
+
Different+ representations+ of+ the+ disease+microenvironment+ were+ assessed,+
including+patient+blister+fluid,+and+some+of+its+individual+components,+IL31+and+
lactate,+ in+addition+ to+ the+physical+stiffness+of+ the+microenvironment.+MSCs+
cultured+ in+ these+ conditions+ were+ assayed+ for+ migration,+ induced+ gel+
contraction,+proAfibrotic+gene+expression+and+differentiation.+The+presence+of+
activated+ MSCs+ in+ patients’+ skin+ was+ also+ assessed+ and+ compared+ with+
healthy+ skin.+ Patient+ blister+ fluid+ induced+ MSC+ migration,+ collagen+ gel+
contraction+and+proAfibrotic+gene+expression+more+ than+healthy+blister+ fluid.+
Additionally,+ individual+components+of+ the+SSc+blister+ fluid+accounted+ for+at+
least+ some+ of+ these+ responses.+ Osteogenic+ differentiation+ of+ MSCs+ was+
enhanced+ by+ SSc+microenvironments,+ both+ soluble+ and+ physical,+ whereas+













being+ the+ current+ efforts+ to+ explain+ and+ understand+ systemic+ sclerosis+ and+









at+ least+ partially+ responsible+ for+ many+ systemic+ sclerosis+ pathologies+ is+
demonstrated+in+this+thesis.+Systemic+sclerosis+is+a+relatively+rare+disease,+and+





method+ for+ visualising+ mesenchymal+ stem+ cells+ in+ dermal+ tissue,+ that+
maintains+structural+integrity+of+the+cells+and+extracellular+matrix,+is+presented.+
This+alone+will+impact+the+way+not+only+mesenchymal+stem+cells+are+visually+






On+the+other+hand,+ the+research+also+ impacts+ fields+outside+academia.+The+
strongest+ being+ the+ evidence+ against+ using+ mesenchymal+ stem+ cells+
indiscriminately+ as+ therapeutic+ agents+ in+ systemic+ sclerosis,+ as+ is+ currently+
being+trialled.+The+studies+also+give+insight+into+how+lactate+concentrations+can+
be+used+as+part+of+a+minimally+invasive+technique+to+aid+in+systemic+sclerosis+











in+ diagnosis.+ Nevertheless,+ other+ aspects+ of+ the+ research+ will+ impact+ the+
broader+field+of+research+by+filling+in+critical+gaps+in+knowledge.++
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of+ mesenchymal+ origin,+ namely+ osteoblasts,+ adipocytes+ and+ chondrocytes.++
They+ were+ originally+ identified+ and+ isolated+ from+ bovine+ bone+ marrow+ by+
Friedenstein+ in+ the+ 1970s+ (Friedenstein+ et+ al.+ 1974).+ Cells+ with+ these+
properties+can+be+derived+from+bone+marrow,+fat+and+umbilical+cord+and+it+has+





cells.+ Two+ main+ theories+ existi+ one+ is+ that+ they+ are+ a+ subset+ of+ specific+




These+ cells+ are+ pleiotropic+ and+ have+ functions+ other+ than+ differentiation.+
Simultaneously,+ they+are+ thought+ to+be+myogenic+ in+ their+pluripotency.+This+






(Sacchetti+et+al.+2007).)There+ is+one+explanation+ for+ the+diverging+ theories.+
Caplan+has)suggested+that+there+is+a+group+of+CD146+positive+cells+that+have+
both+ skeletogenic+ and+ myogenic+ differentiation+ potential+ and+ fit+ the+ more+
blurred+definition+of+MSCs+(Caplan+2008).+Others+claim+that+that+while+there+
indeed+is+a+cell+type+that+is+CD146Apositive+and+myogenic,+they+differ+from+the+







like+ cells+ of+ mesenchymal+ origin,+ shown+ to+ be+ multipotent+ and+ capable+ of+
differentiating+down+adipogenic,+osteogenic+and+chondrogenic+cell+lineages.+
MSCs+do+not+have+specific+surface+markers+and+therefore,+are+characterised+
through+ combinations+ and+ elimination+ of+markers,+ as+well+ as+ differentiation+
capacity.+ In' vivo,+MSCs+express+ variable+markers+dependent+on+ the+ tissue+
they+ reside+ in+ and+ factors+ present+ in+ the+ surrounding+ environment.+ Then,+
following+ isolation+ and+ culture+ in' vitro,+ the+ markers+ may+ vary+ even+ more+
depending+on+the+method+of+isolation,+together+with+culture+material+and+cryoA
preservation+ (Chamberlain+ et+ al.+ 2007).+ As+ such+ translating+ MSC+ surface+
expression+findings+in'vitro+to+in'vivo'models+holds+some+difficulty.+To+remove+
some+of+the+confusion+and+variation,+MSCs+have+been+categorised+as+being+












The+ multipotency,+ differentiation+ potential,+ selfArenewal+ capacity,+ lack+ of+
teratoma+ formation+ and+ immune+ interaction+ makes+ MSCs+ of+ interest+ as+








several+ effector+ functions+ (Uccelli+ et+ al,+ 2008).+ Generally,+ they+ have+ a+




antiAproliferative+ to+ antiAinflammatory+ (Glenn+ and+ Whartenby+ 2014).+
Furthermore,+ the+microenvironment+ of+ the+MSCs+can+dictate+ their+ plasticity+
and+likely+causes+the+switch+from+an+immuneAinhibitory+state+to+an+immuneA
stimulatory+one.+The+antiAinflammatory+effects+of+MSCs+are+directed+at+many+
immune+ cells.+ They+ can+ inhibit+ the+ respiratory+ burst+ of+ neutrophils+ after+
detection+of+a+pathogen+keeping+the+pathogen+associated+molecules+hidden+
from+the+immune+system.+They+can+also+inhibit+monocyte+differentiation+into+
dendritic+ cells.+ + Dendritic+ cells+ are+ antigenApresenting+ cells+ that+ engulf+ the+
pathogen+and+present+the+antigen+on+their+cell+surface+to+TAcells+to+provoke+an+
inflammatory+ response.+ MSC+ inhibition+ of+ dendritic+ cell+ responses+ thereby+
stops+the+crossover+from+innate+to+adaptive+immune+systems.+MSCs+also+have+
an+effect+on+macrophage+phenotypes+and+encourage+M2+antiAinflammatory+
polarisation+ as+ opposed+ to+ the+ M1+ proAinflammatory+ phenotype+ through+
indoleamine+2,+3Adioxygenase+and+prostaglandin+E2+(Uccelli+et+al.+2008).+In+




There+ are+ a+ few+ major+ reservations+ regarding+ MSC+ usage+ as+ treatment+
therapies.+The+plasticity+of+MSCs+means+that+their+phenotype+and+activity+can+
be+ readily+altered+ex'vivo.'Considering+ that+before+MSC+administration+ into+
patients,+MSCs+need+ to+be+cultured+ for+a+minimum+of+10+weeks+ in+order+ to+










means+ of+ administration+ needs+ to+ be+ developed+ if+ they+ are+ to+ be+ used+






that+ the+ short+ survival+ time+ cannot+ accommodate+ the+ lengthy+ process+ of+
differentiation+and,+as+such,+the+paracrine+secretions+of+MSCs+in+the+target+site+
are+responsible+for+the+results+seen+after+infusion.+In+addition+to+mediating+their+
immune+ effects+ through+ direct+ cellAcell+ contact,+MSCs+ act+ on+ neighbouring+




cellular+ degradation.+ Such+ factors+ include+ microARNA+ (miRNA)+ molecules,+
proteins+and+ lipids+ that+are+ released+ in+exosomes+and+act+extracellularly+ to+
carry+out+MSC+function.+MSCs+promote+angiogenesis+and+neoAvascularisationi+




In+ order+ for+MSCs+ to+ differentiate+ they+ need+ to+ be+ subject+ to+ very+ specific+
microenvironmental+cues+that+span+further+than+matrix+stiffness+and+cytokine+
concentration.+ Adipogenic+ and+ osteogenic+ differentiation+ of+ MSCs+ are+










downstream+ transcription+ factors+ involved+ are+ thought+ to+ determine+ the+
direction+of+ differentiation.+For+ example,+ adipogenic+ differentiation+ relies+ on++
CCAATAenhancerAbinding+ proteins+ (C/EBP)+ and+ peroxisome+ proliferatorA
activated+ receptors+ (PPAR)+ transcription+ factors,+ whereas+ osteogenic+
differentiation+involves+RuntArelated+transcription+factor+1+(RUNX)+and+OSX+to+
induce+ expression+ of+ osteogenic+ genes+ (Bellido+ et+ al.+ 1997iFritzius+ and+
Moelling+2008).++
+









during+ adipogenic+ differentiation+ and+ decreased+ during+ osteogenic+
differentiation+ (Li+ et+ al.+ 2013).)Furthermore,+ when+ these+miRNA+molecules+
were+ overexpressed,+ differentiation+ was+ able+ to+ be+ steered+ towards+
adipogenic+lineages,+whereas+inhibiting+them+significantly+reduced+adipogenic+

























in' the' nucleus' and' after' association' with' modification' complexes' (DROSHA),' the' miRNA'
molecules'are'processed'to'adopt'a'hairpin'loop'structure'denoted'prePmiRNA.'PrePmiRNA'
molecules' are' transported' into' the' cytoplasm' for' further' processing' into' single' stranded'
miRNA'molecules.'Together'with'protein'complexes'(RISC),'the'miRNA'molecules'interfere'
with'translation'in'one'of'two'ways.'They'either'have'perfect'complementary'base'pairing'with'












the+ primary+ manifestations+ (Gabrielli+ et+ al.+ 2009).+ Prevalence+ varies+
considerably+across+the+world,+but+generally+affects+between+150A300+people+
per+million+(Barnes+and+Mayes+2012).+ It+can+be+categorised+ into+ two+ types,+
diffuse+ and+ limited,+ defined+ by+ the+ pattern+ of+ skin+ involvement.+ In+ limited+
21"
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gastroAintestinal+ tract+ and+ kidney+ involvement,+ whereas+ in+ lcSSc,+ lung+ and+
kidney+ involvement+ are+ less+ frequent,+ but+ vascular+manifestations+ such+ as+









failure+ and+ the+ most+ common+ cause+ of+ death+ in+ SSc+ patients,+ pulmonary+
arterial+hypertension+(PAH)+(Barnes+and+Mayes+2012).+
+
One+ of+ the+ most+ common+ and+ ubiquitous+ symptoms+ of+ SSc+ is+ Raynaud’s+
phenomenon,+a+syndrome+that+presents+itself+throughout+the+SSc+pathology+
timeline+ and+ is+ essentially+ the+ constriction+ of+ blood+ flow+ to+ acral+ regions,+
particularly+digits.+It+can+be+described+as+the+result+of+an+imbalance+between+
vasodilation+and+vasoconstriction+and+in+more+severe+cases,+like+those+seen+
in+ SSc,+ digital+ ulcers+ and+ eventual+ amputation+ are+ common+ results+ of+ this+





more+ severe.+ Blood+ perfusion+ can+ be+ detected+ by+ laser+ speckle+ contrast+





as+blue,+ indicating+very+ little+blood+perfusion,+and+this+ is+exaggerated+ in+ the+
fingers+(Figure+1.2).+The+Raynaud’s+phenomenon+in+SSc+patients+essentially+
stops+normal+blood+circulation+resulting+in+the+white+appearance+of+the+fingers+
which+ then+ turn+blue+and+eventually+ red+after+ reperfusion.+While+Raynaud’s+
phenomenon+ can+ occur+ in+ otherwise+ healthy+ people,+ known+ as+ primary+
Raynaud’s,+secondary+Raynaud’s+is+associated+with+underlying+autoimmune+













and' SSc' patient' (right).' SSc' patients' show' considerably' less' cutaneous' blood' perfusion'
(Ruaro'et'al.'2015).'
+











Figure' 1.3'Nailfold' capillaries' of' healthy' and'SSc' individuals.'Capillaroscopic' images'
(200x' magnification)' of' healthy' normal' nailfold' capillary' beds,' and' SSc' patients' with'











The+ route+ of+ pathology+ of+ SSc+ can+ be+ simplified+ down+ to+ microvascular+
damage+followed+by+an+uncontrolled+inflammatory+response+that+gives+rise+to+
fibrosis.+ Effective+ treatments+ are+ + available+ for+ vascular+ complications+





been+ shown+ to+ benefit+ (Denton+ 2015).+ Fibrotic+ lesions+ are+ caused+ by+ a+
continuous+aberrant+tissue+repair+process+and+extracellular+matrix+deposition.+
The+matrix+stiffness,+caused+by+extracellular+matrix+deposition+and+the+excess+
collagen,+ is+ enough+ to+ induce+ myofibroblast+ differentiation+ and+ activation++
(Shiwen+et+al.+2015).+Myofibroblasts+are+the+major+producers+of+collagen+and+




redundant.+ For+ example,+ myofibroblasts+ are+ removed,+ avoiding+
inappropriately+prolonged+tissue+repair+(Juric+et+al.+2009iShiwen+et+al.+2015).+
Anoikis+ depends+on+ cell+ detachment+ from+ the+ extracellular+matrix,+ blocking+










direct+ analysis+ of+ the+ microenvironment+ in+ fibrotic+ lesions,+ rather+ than+ the+
global+ analysis+ serum+ would+ achieve+ (Sondergaard+ et+ al.+ 1998).+ The+ SSc+




cells+ infiltrating+ the+ lesions.+ Together,+ these+ factors+ all+ contribute+ to+ the+
pathogenesis.+ +The+combination+of+ soluble+ factors+present+ in+ the+ lesions+ is+















fibroblasts,+ and+ also+ stimulates+ their+ production+ of+ CTGF+ and+ the+
vasoconstrictor,+ endothelinA1.+ The+ CTGF+ induced+ by+ TGFβ+ can+ promote+
fibroblast+proliferation+and+migration+ to+sites+of+ inflammation.+Excess+PDGF+
signalling+in+the+microenvironment+caused+by+upregulation+of+the+receptor+and+





tissue+ inhibitors+ of+ metalloproteanases+ (TIMPs),+ enzymes+ involved+ in+ the+
breakdown+of+extracellular+matrix+proteins+(Eckes+et+al.+2014).++
+
Furthermore,+ fibroblasts+ respond+ to+ the+ excess+ TGFβ+ in+ SSc+
microenvironment,+resulting+in+PDGF+Receptor+(PDGFR)+upregulation+which+
in+ turn+ causes+a+ stronger+ reaction+ to+PDGF,+ known+ to+ be+ increased+ in+ the+
microenvironment,+ creating+ a+ chronic+ feedforward+ cycle+ (Ball+ et+ al.+ 2010).+











TGFβ+ increases+ αAsmooth+ muscle+ actin+ (αASMA)+ expression+ indicating+
myofibroblast+ presence+ and+ activation.+ The+ canonical+ Wnt+ pathway+ is+
proposed+ to+ be+ one+ of+ the+ ways+ in+ which+ TGFβ+ causes+ myofibroblast+
differentiation.+ Nuclear+ accumulation+ of+ βAcatenin+ confirms+ Wnt+ pathway+
activation+in+the+SSc+microenvironment+(Bergmann+and+Distler+2016).++
+
Wnt+ treatment+ of+ dermal+ fibroblasts+ resulted+ in+ a+ similar+ αASMA+ response,+
indicating+its+role+downstream+of+TGFβ+in+addition+to+nuclear+accumulation+of+
βAcatenin.+Inhibiting+TGFβ+pathway+activation+with+a+TGFβ+receptor+inhibitor+
SDA208+ and+ inhibiting+ the+ Wnt+ pathway+ with+ DickkopfA1(Dkk1)+ leads+ to+ a+





some+ SSc+ patients+ and+ can+ explain+ the+ chronic+ overAstimulation+ of+ this+
pathway+and+the+resulting+collagen+and+αASMA+expression+in+SSc+(Gabrielli+et+
al.+2009).+As+such,+targeting+these+activating+antibodies+was+thought+to+be+a+
potential+ therapy+ for+ SSc.+ Imatinib+ mesylate+ inhibits+ the+ activating+
autoantibodies,+via+ its+effect+on+ the+PDGF+receptor+ tyrosine+kinase.+ In'vitro'
mouse+studies+of+imatinib++mesylate+showed+promising+results+by+alleviating+
skin+ fibrosis+ in+ an+ SSc+ mouse+ model+ through+ PDGF+ signalling+ inhibition+
(Akhmetshina+et+al.+2009).+Translation+of+ this+ into+SSc+patients+has+proved+
less+ than+ successful.+ In+ a+ Phase+ 2+ trial,+ the+ adverse+ effects+ of+ imatinib+
mesylate+meant+that+only+12/20+SSc+patients+completed+the+trial.+Furthermore,+














SSc.+ In+ mice+ with+ bleomycin+ induced+ fibrosis,+ TAcell+ depletion+ alleviates+





















induce+ collagen+ expression+ in+ SSc.+ In+ confirmation+ of+ this,+ even+ though+
typically+ fibroblasts+ are+ not+ found+ to+ express+ IL6+ receptor,+ in+ SSc,+ dermal+
fibroblasts+can+be+activated+to+produce+collagen+by+the+addition+of+IL6+(Khan+
et+al.+2012aiHugle+et+al.+2013).+In+fact,+many+cells+lacking+the+IL6+receptor+on+
their+ cell+ membrane+ can+ respond+ to+ IL6.+ This+ is+ due+ to+ the+ fact+ that+ IL6+
signalling+occurs+via+one+of+two+waysi+classic+signalling+where+by+IL6+binds+to+




















including'hepatocytes'and' leukocytes' respond' to' IL6'by' classic' signalling.' IL6'binds' to' its'
receptor'and'gp130'on'the'cell'membrane'inducing'ERK'and'STAT3'signalling'pathways'and'
activation' (a).' Many' cells' do' not' express' IL6' receptor' and' thereby' respond' to' IL6' via'
transsignalling.'This'occurs'when' IL6'binds' to'a'soluble' form'of' its' receptor'which' in' turn,'
dimerises'with'membranePbound'gp130'(b)'(O'Reilly'et'al.'2013).''
+
In' vivo+ studies+ on+ different+ SSc+mouse+models+ showed+ that+ IL6+ knockout+
resulted+ in+ a+ reduction+ of+ the+ fibrosis+ and+ the+ aggravated+ autoimmune+
response.++While+these+findings+implicate+the+elevated+IL6+in+SSc+as+being+at+
least+partially+responsible+for+the+fibrotic+response,+controversially,+there+may+
be+ inherent+ differences+ in+ the+ SSc+ derived+ cells+ themselves.+ Fibroblasts+
derived+ from+ pulmonary+ fibrosis+ lesions+ respond+ to+ IL6+ treatment+ by+
proliferation+ and+ activation+ of+ collagen+ expression,+ whereas+ the+ same+
























readily+ (Bilsborough+et+al.+2006). In+addition+ to+keratinocytes,+macrophages+
respond+to+IL31+by+expressing+a+relatively+high+amount+of+ IL31RA+and+also+




















The+ vascular+ damage+ and+ ischaemia+ predicted+ to+ be+ one+ of+ the+ earliest+
symptoms+of+SSc,+are+likely+to+result+in+a+change+in+the+biochemical+balance+
of+ the+ ischaemic+area.+The+chronic+ tissue+hypoxia+may+result+ in+a+switch+to+
anaerobic+ metabolism+ by+ resident+ cells,+ a+ phenomenon+ observed+ in+ the+
hypoxic+microenvironment+of+tumours+(Warburg+effect)+(Pavlides+et+al.+2010).+
The+resulting+accumulation+of+intracellular+pyruvate+leads+to+increased+lactate+
production+ and+ release,+ and+ the+ lactate+ is+ believed+ to+ be+ a+ critical+ soluble+
metabolite+acting+within+ tumour+microenvironments.+ + +Furthermore,+ low+pH,+
increased+ protons,+ hypoxia+ and+ elevated+ extracellular+ purines+ such+ as+
adenosine+ triphosphate+ (ATP),+ are+ all+ characteristic+ of+ ischaemic+ disease+
microenvironments,+which+could+contribute+to+biomechanisms+of+disease.+
++
Lactate+ itself+ has+ been+ implicated+ in+ SSc+ as+ a+ novel+marker+ of+ secondary+




was+developed+where+ lactate+ levels+were+measured+ in+ this+way+before+and+
after+a+cold+stimulus,+such+as+ immersion+of+hands+ in+10°C+water.+Typically,+
following+ a+ cold+ stimulus+ and+ resulting+ vasoconstriction,+ effective+ perfusion+
occurs+to+wash+away+the+lactate+that+accumulated+in+the+ischaemic+tissue+as+
a+result+of+the+anaerobiosis+that+occurs+in+the+cold.+However,+it+was+shown+that+
this+ perfusion+was+ absent+ in+ SSc+ patients+ with+ Raynaud’s,+ and+ those+with+
secondary+Raynaud’s+Phenomenon) (Pucinelli+ et+ al.+ 2002).+Rather+ than+ the+












study+ suggest+ that+ SSc+ patients+ with+ PAH+ have+ distinct+ metabolic+
abnormalities+that+differ+from+SSc+patients+without+PAH+(Deidda+et+al.+2017).)
Therefore,+ lactate+ merits+ further+ study+ as+ a+ soluble+ metabolite+ in+ the+ SSc+
microenvironment,+which+may+be+altering+or+activating+cells.++Furthermore,+the+
increased+ mechanical+ stress+ within+ SSc+ fibrotic+ lesions+ merits+ study+ as+ a+





the+ similarities+ between+MSCs+and+ fibroblasts,+ these+proAfibrotic+ processes+
may+ apply+ to+MSCs.+ Therefore,+ proteins+ in+ the+ form+ of+ growth+ factors+ and+
cytokines,+ metabolites+ including+ lactate,+ and+ mechanical+ stress+ responses+
may+all+be+acting+on+cells+within+the+SSc+microenvironment.++Because+of+their+
wide+ distribution+ and+ perivascular+ location+ in+ skin+ and+ internal+ organs,+ it+ is+

































and' induce' an' inflammatory' response.' They' may' also' respond' to' the' characteristic'
autoantibodies.'Endothelial'cells'and'MSCs'have'a'feed'forward'relationship,'which'may'be'










and+endothelial+cells+ interact+ to+maintain+ the+vasculature+ through+reparative+
































between+endothelial+ cells+ and+pericyte+progenitor+ cells+ has+been+ identified.+
These+ progenitor+ cells+ are+ thought+ to+ be+ of+ mesenchymal+ origin+ and+
differentiate+ into+pericytes+under+ the+ influence+of+TGFβ1+(Ding+et+al.+2004).+
There+is+evidence+to+suggest+that+pericyte+differentiation+into+myofibroblasts+is+
occurring+ in+ SSc+ and,+ since+MSCs+ reside+ in+ the+ perivascular+ niche,+ these+
pericytes+may+actually+be+MSCs,+supporting+the+idea+that+MSC+activation+has+
a+role+in+promoting+fibrosis+in+SSc+(Rajkumar+et+al.+1999).)On+the+other+hand,+
MSCs+ physiologically+ can+ have+ a+ proAangiogenic+ and+ proAneovasculogenic+
role.+ They+ can+ directly+ differentiate+ into+ cells+ that+ maintain+ vasculature+
homeostasis,+but+more+ than+ that,+ the+MSC+secretome+contains+ factors+ that+
have+ been+ found+ to+ induce+ the+ migration,+ proliferation+ and+ activation+ of+
endothelial+cells,+while+inhibiting+their+apoptosis.+Such+proAangiogenic+factors+





Typically,+ endothelial+ cells+ inhibit+MSCAmyofibroblast+ differentiation.+ In+ SSc+
however,+it+has+been+suggested+that+the+damaged+endothelial+cells+induce+a+
pathogenic+ pathway+ in+ which+ they+ cause+MSCs+ to+ switch+ from+ supporting+




when+ cultured+ with+ MSCs.+ This+ result,+ together+ with+ SScAendothelial+ cell+















implicated+ in+ the+ loss+ of+ blood+ vessel+ stabilization,+ possibly+ causing+




ability+ to+ differentiate+ into+ progenitor+ endothelial+ cells+ and+ partake+ in+
vasculogenesis+(Capelli+et+al.+2017).)This+may+be+significant+since+failure+of+





integrity,+ particularly+ of+ vertebrae+ (Valenzuela+ et+ al.+ 2016).+ Conversely,+
calcinosis+is+also+a+feature+of+SSc+where+bone+mineral+is+aberrantly+deposited,+
particularly+in+the+digits.+Considering+that+MSCs+differentiate+into+osteoblasts,+
there+ is+conflicting+evidence+over+how+ this+differentiation+ is+ involved+ in+SSc+


















while+ PPARγ+ and+ lipoprotein+ lipase+ (LPL),' increased.+ Healthy+ MSC+




overexpression+ of+ miRA151A5p+ itself+ in+ tightAskin+ mice,+ without+ MSC+
transplantation+reduced+the+IL4/IL4R+expression+of+bone+marrow+MSCs+and+
also+ improved+ their+ osteogenic+ differentiation+ potential.+ These+ results+were+
reflected+ in+humans.+SSc+patients+have+significantly+ reduced+ levels+of+miRA
151A5p+in+their+serum+and+supporting+the+hypothesis,+bone+marrow+MSCs+of+
these+ patients+ showed+ increase+ IL4/IL4R+ mTOR+ signalling+ (Chen+ et+ al.++
2017b).+
++
The+ loss+ of+ subcutaneous+ fat+ in+ SSc+ patients+ is+ an+ early+ phenomenon+
suggesting+that+rather+than++being+merely+a+secondary+symptom,+it+may+be+an+
initial+ event+ increasing+ the+ differentiation+ of+ myofibroblasts,+ and+ thereby+






























inclined+ to+ adopt+ a+ proAfibrotic+ phenotype.+ It+ was+ demonstrated+ that+ TGFβ+










opposite+ is+ seen+ in+ healthy+ MSCs.+ It+ may+ be+ possible+ that+ the+ negative+
feedback+ loop+ that+ describes+ the+ healthy+ MSC+ reaction+ to+ TGFβ+ is+
dysregulated+in+SSc+MSCs+(Hegner+et+al.+2016).+
+
Of+ importance+ to+ note,+ no+ differences+ in+ clonegenic+ potential+ of+








fibres+ and+ a+myofibroblastAlike+ cell+morphology.+ + On+ the+ other+ hand,+ while+
phenotypic+similarities+are+detected+between+healthy+and+SSc+derived+MSCs,+
they+ have+ been+ found+ to+ respond+ differently+ to+ SSc+ microenvironment+
components+with+respect+to+expression+of+contractile+proteins.+PDGFABB+and+
FGF+ reduced+ αASMA+ and+ myosin+ light+ chain+ kinase+ (MLCK)+ expression,+
however+this+reduction+was+more+prominent+in+healthy+MSCs+significantly+with+
regards+ to+ αASMA+ expression+ under+ PDGFABB+ treatment+ conditions.+
Furthermore,+TGFβ+increased+αASMA+expression+of+SSc+MSCs+significantly+
more+than+their+healthy+counterparts,+indicating+SSc+MSCs+being+more+readily+
differentiated+ into+myofibroblast+ cells.+TGFβ+also+was+ found+ to+ inhibit+MSC+
differentiation+ into+ vascular+ smooth+ muscle+ cells+ while+ CTGF+ and+ bAFGF+
induced+vascular+smooth+muscle+cell+differentiation+of+healthy+MSCs+only.+SSc+
MSCs+ were+ also+ found+ to+ respond+ to+ TGFβ+ by+ producing+ collagen+ type+ I,+
significantly+implicated+in+SSc,+whereas+healthy+MSCs+produced+collagen+type+
III.+Together,+with+downregulation+of+the+collagen+degrading+enzyme+MMP9,+



















healthy'MSCs.' SSc'MSCs' show' reduced' propensity' to' differentiate' into' vascular' smooth'
muscle'cells'than'healthy'MSCs.'Healthy'MSCs'show'reduced'αPSMA'expression'in'response'
































tissue,+ possibly+ adipose+ tissue,+ to+ a+ site+ of+ inflammation+ where+ they+
differentiate+into+the+cells+needed+for+tissue+repair,+for+example+keratinocytes+




wounds.+ MSCs+ can+ secrete+ antiAfibrotic+ factors+ together+ with+ angiogenic+
factors+ which+ induce+ wound+ healing+ and+ acting+ together+ with+ the+ antiA
inflammatory+ effects+ of+ MSCs,+ resolve+ the+ inflammation+ surrounding+ the+
wound.+ These+ roles+ of+ MSCs+ work+ in+ syncytium+ resulting+ in+ the+ overall+
reduction+ of+ fibrosis+ and+ scar+ tissue.+ Perhaps+ in+ SSc,+ rather+ than+ MSCs+
themselves+ being+ inherently+ dysfunctional,+ it+ could+ be+ that+ their+ inability+ to+
resolve+ the+ tissue+ damage+ results+ from+ changes+ induced+ in+ the+ disease+
microenvironment.+ There+ is+ now+ interest+ in+ using+ MSC+ secretome+
transplantation+as+ therapy+ rather+ than+ the+ cells+ themselves.+This+ has+been+
conducted+ by+ culturing+ MSCs+ in+ serum+ free+ media+ and+ exposing+ them+ to+
hypoxic+ conditions+ to+ preAcondition+ them+ to+ becoming+more+migratory+ and+
stimulate+their+expression+of+growth+factors)(Zhou+et+al.+2013).+Hypoxic+preA
conditioning+also+maintains+stem+cell+pluripotency+and+ their+undifferentiated+
phenotype,+ important+ factors+when+considering+ the+use+of+MSCs+ in+ therapy)
(Hawkins+et+al.+2013).+The+MSCs+secrete+soluble+factors+into+the+media+which+
is+then+used+as+a+representation+of+the+secretome.+This+conditioned+media+was+
applied+ topically+ onto+ induced+ wounds+ of+ otherwise+ healthy+ individuals+ to+
assess+wound+healing.+It+was+found+that+application+of+the+MSC+conditioned+
media+ to+wounds,+ reduced+erythema+and+ redness+of+ the+wound+as+well+as+
pigmentation,+ consistent+ with+ resolution+ of+ inflammation.+ The+ reduction+ of+
hyperpigmentation+was+attributed+to+the+inhibition+of+the+melanogenic+enzymes+
expressed+ by+ the+ melanophages,+ induced+ to+ phagocytose+ the+ damaged+




transepidermal+ water+ loss.+ Treatment+ with+ MSC+ conditioned+ media+
significantly+ reduced+ the+ amount+ of+ transepidermal+ water+ loss+ indicating+
quicker+and+more+effective+wound+healing.+The+reduction+in+the+transepidermal+
water+ loss+could+also+be+an+explanation+ for+ the+ reduced+hyperpigmentation+
observed+(Zhou+et+al.+2013).+Physical+changes+in+skin+elasticity+and+collagen+
content+ was+ not+ observed+ in+ this+ study.+ The+ presence+ of+ MSCs+ may+ be+
responsible+ for+ these+ recovery+ mechanisms,+ possibly+ through+ cell+
differentiation+ or+ direct+ cellAcell+ contact+ rather+ than+ paracrine+ signalling.+
Myofibroblasts+are+cells+ known+ to+be+ involved+ in+skin+contractility+ in+wound+
healing,+ differentiating+ from+ fibroblasts+ in+ subepithelial+ skin+ layers.+ They+
express+αASMA+which+induces+skin+contraction+in+order+to+close+the+wound,+by+
pulling+on+ the+neighbouring+healthy+skin+ in+a+mechanism+ that+ leads+ to+scar+
formation.+Uysal+et+al,+found+that+following+injection+into+wounds+in+rats,+MSCs+
played+an+immunoregulatory+role+and+reduced+αASMA+and+TGFβ+expression+
thus,+ reducing+wound+contraction.+This+ is+ in+conflict+with+ the+proposed+ idea+
that+ MSCs+ promote+ wound+ healing.+ Perhaps+ there+ is+ a+ fine+ line+ between+
wound+healing+and+scar+formation+whereby+MSCs+induce+healing+of+the+wound+
via+ transdifferentation+ and+ tissue+ regeneration+ but,+ revert+ the+ exaggerated+
response+ of+ skin+ contraction+ and+ scarring+ following+ more+ severe+ wounds+)
(Uysal+et+al.+2014).+TGFβ+ is+ the+growth+ factor+ found+ to+be+at+ least+partially+
responsible+for+fibroblast+to+myofibroblast+differentiation+during+wound+healing.+
Addition+ of+ TGFβ+ to+ fibroblasts+ induces+ a+ significant+ increase+ in+ αASMA+
expression+indicating+myofibroblast+differentiation+together+with+upregulation+
of+ fibronectin+ and+ vitronectin+ receptors.+ Inhibition+ of+ these+ receptors+ with+





cell+ contraction+ indicating+ cell+ migration.+ In+ this+ case,+ the+ contraction+ was+
proposed+to+be+due+to+cell+matrix+collagen+reorganisation+by+myofibroblasts+
which+ by+ inhibiting+ fibronectin+ and+ vitronectin,+ reversed+ this+ matrix+
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The+ combination,+ presence+ and+ concentration+ of+ the+ growth+ factors+ and+
cytokines+ present+ in+ the+ SSc+microenvironment+ not+ only+ depends+ on+ their+
production+and+degradation,+but+also+on+the+physical+environment+they+act+in.+
The+ SSc+ extracellular+ matrix+ is+ a+ product+ of+ the+ aberrant+ wound+ healing+
process.+The+ chronic+ tissue+ repair+ is+ not+ resolved+and+ results+ in+ excessive+
collagen+deposition,+dermal+thickening,+scarring+and+eventually+fibrosis.+The+
accumulation+of+ collagen+ is+due+ to+both+excessive+production+and+ inhibited+
degradation.+ Collagen+ type+ I,+ the+ main+ constituent+ of+ human+ extracellular+
matrix,+ is+ more+ readily+ expressed+ in+ SSc+ since+ the+ CCAAT+ binding+
transcription+factor+(CBF)+responsible+for+its+expression+has+a+higher+binding+
affinity+for+the+collagen+promoter+region+in+SSc+fibroblasts.+Binding+of+CBF+to+
the+COL1A1+ promoter+ was+ found+ to+ be+ 3A5+ times+ stronger+ in+ SSc+ dermal+





Myofibroblasts+ are+ the+ cells+ responsible+ for+ tissue+ remodelling+ and+
extracellular+ matrix+ deposition+ in+ fibrosis.+ Continuous+ extracellular+ matrix+
deposition+ promotes+ further+ myofibroblast+ differentiation+ from+ fibroblasts+




that+ induces+ signal+ transduction+ to+ the+ MSC+ nucleus,+ instructing+ the+
appropriate+ cell+ response.+ Such+ transducers+ possibly+ include+ myocardin+
related+ transcription+ factorAA+ (MRTFA)+ and+ nonAmuscle+ myosin+ isoforms,+
which+ act+ on+ cellular+ transcription+ and+ gene+ expression+ to+ alter+ the+ actin+
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cytoskeleton+ and+ focal+ adhesions+ in+ order+ to+ “feel”+ the+ extent+ of+ possible+
deformity+of+ the+matrix,+ and+ thereby+gauge+ its+potential+ phenotypic+ change+
(Engler+ et+ al.+ 2006).+ MRFTA+ is+ a+ cytoplasmic+ transcription+ factor+ found+ in+
dermal+fibroblasts,+keratinocytes,+endothelial+cells+and+MSCs,+that+is+induced+
to+ translocate+ to+ the+ nucleus+ under+ conditions+ of+ mechanical+ stress.+
Cytoplasmic+to+nuclear+translocation+occurs+by+actin+cytoskeleton+remodelling+
and+polymerisation+mediated+by+Rho+GTPases.+Once+in+the+nucleus,+MRTFA+
is+ involved+ in+ the+ transcription+ of+ genes+ involved+ in+ further+ cytoskeleton+
remodelling.+In+SSc,+MRFTA+is+implicated+as+the+mechanosensing+mechanism+
by+which+SSc+myofibroblasts+are+activated+and+synthesise+collagen+type+I+in+
response+ to+stiff+surroundings+and+ interestingly,+ is+ itself+ further+activated+by+










to+deform+ the+ substrate+ it+ is+ attached+ to.+A+ stiff+ substrate,+ like+SSc+skin,+ is+
typically+ considered+ to+ be+ between+ 50A80+ kPa+ while+ healthy+ skin,+ or+ soft+
matrices,+range+from+4A12+kPa+(Sackson+et+al.+2013).++
+




(Engler+ et+ al.+ 2006).+ The+ effect+ of+ the+ matrix+ microenvironment+ on+ the+
differentiation+potential+of+MSCs+seems+to+be+stronger+and+more+longAlasting+
than+that+of+conditioned+media.+MSCs+differentiated+via+matrix+stiffness+initially+
are+passive+ in+ their+ responses+and+do+not+ take+an+aggressive+differentiated+
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committed+ profile+ automatically.+ Rather+ they+ seem+ to+ hover+ between+ their+
former+‘stemness’+state+and+their+new+commitment.+Perhaps+at+this+stage+the+
soluble+ factors+ of+ the+ microenvironment+ play+ the+ more+ important+ role+ in+
cementing+their+new+phenotype+(Engler+et+al.+2006).+++
)
Although+ the+majority+of+ the+myofibroblasts+are+believed+ to+be+derived+ from+
tissue+resident+ fibroblasts,+ this+ is+not+proven,+and+MSCs+may+play+a+ role+ in+
adding+to+the+myofibroblast+population.+The+relationship+between+MSCs+and+
myofibroblasts+ is+of+considerable+ interest+ in+SSc.+ It+has+been+hypothesised+
that+ MSCs+ expressing+αASMA+ are+ somewhat+ lineage+ committed+ and+ have+
restricted+selfArenewal+capacity+while+those+lacking+αASMA+retain+pluripotency.+
These+ different+ phenotypes+ can+ be+ controlled+ by+ matrix+ stiffness.+





3.1%+ expression+ on+ stiff+ and+ soft+ substrates+ respectively).+αASMA+ positive+






(smooth+ muscle+ cell+ markers)+ as+ well+ as+ collagen+ type+ II+ and+ LDL+
(chondrogenic+and+adipogenic+markers),+in+response+to+matrix+stiffness.+Stiff+
matrices+induced+MSC+αAactin+and+calponinA1+expression,+while+soft+collagen+
gel+ matrices+ did+ not+ induce+ expression+ of+ smooth+ muscle+ cell+ markers.+









by+ the+ “roughness”+ of+ the+ surface+ it+ resides+ on.+ Since+ one+ of+ the+ major+
limitations+ of+ MSC+ clinical+ trials+ is+ the+ extremely+ low+ proportion+ of+ MSCs+
reaching+the+target+site+in+order+to+perform+therapeutic+functions,+enhancing+
MSC+ inherent+ability+ to+migrate+ is+one+potential+way+of+ resolving+ this+ issue.+
The+positive+ results+ from+MSC+clinical+ trials+ can+be+explained+by+ the+quick+
migration+ to+ the+ target+ site+ rather+ than+ a+ high+ proportion+ of+ viable+ MSCs+
targeting+ the+ site.+While+ preAconditioning+MSCs+ in' vitro+ can+ be+ done+ using+
specific+cytokine+exposure,+such+as+IL6+treatment,+there+are+several+limitations+
to+ this.+Cytokine+signalling+ is+usually+shortAlived+but+more+concerning+ is+ the+
potential+effect+of+the+cytokines+or+growth+factor+molecules+on+MSC+phenotype+
and+ lineage+ commitment.+ Since+ MSC+ therapeutic+ strategies+ depend+ on+
pluripotency+potential,+it+is+important+that+MSCs+injected+retain+the+phenotype+




MSC+ motility+ (Jingjing+ Han+ et+ al.+ 2014).+ A+ study+ was+ conducted+ culturing+
adipose+derived+human+MSCs+on+substrates+of+different+“roughness”+labelled+
R0,+ R1+ and+ R2+ ranging+ from+ completely+ flat+ to+ increasing+ roughness+
respectively,+and+observing+cell+migration+and+ focal+adhesion+kinase+ (FAK)+
and+mitogen+activated+protein+kinase+(MAPK)+expression+(Li+et+al.+2017).+The+
roughness+ of+ the+ substrates+ also+ corresponded+ to+ increasing+ Young’s+
Modulus,+with+ rougher+substrates+also+being+calculated+as+stiffer.+FAK+ is+a+
molecule+ that+ when+ phosphorylated+ is+ activated+ and+ is+ involved+ in+ focal+
adhesion+turnover,+creating+focal+adhesions+at+the+leading+edge+of+the+cell+and+
detachment+of+them+at+the+rear+end,+thereby+creating+tension+from+the+leading+
end+ pulling+ the+ cell+ forward+ (Li+ et+ al.+ 2017).+ FAK+ is+ also+ involved+ in+ the+
activation+of+MAPK+which+when+phosphorylated+in+turn+phosphorylates+myosin+
light+ chain,+ further+ enhancing+ cell+ motility.+ Cells+ were+ cultured+ on+ these+
different+substrates+before+detaching+and+seeding+onto+a+24+well+plastic+plate+
for+a+scratch+wound+assay.+Cells+preAconditioned+on+ the+completely+ flat+R0+
substrate+ were+ significantly+ slower+ at+ migrating+ across+ the+ scratch+ in+
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R0+ surfaces.+ FAK+ expression+ and+ MAPK+ phosphorylation+ were+ also+
significantly+higher+in+cells+cultured+on+R1+substrates+and+were+maintained+for+
14+ days+ after+ reseeding.+ This+ underlines+ the+ controversial+ issue+ of+ MSC+
memory,+ a+ concept+ that+ states+ that+ MSCs+ can+ remember+ mechanical+
signalling+ even+ after+ the+ signal+ is+ removed+ depending+ on+ the+ length+ and+
exposure+of+the+signal.+Yang+et+al,+assign+this+to+the+effects+of+the+YAP/TAZ+















they+ do+ not+ induce+ immune+ responses+ upon+ intravenous+ administration,+
through+ lack+of+major+histocompatibility+complex+ (MHC)+expression,+and+as+











120+ days+ post+ injury.+ Cells+ injected+ 4+ hours+ after+ injury+ were+ able+ to+
differentiate+ into+ functional+ epithelial+ and+endothelial+ lung+ cells,+ highlighting+
MSC+pluripotency+and+the+fact+that+their+regenerative+potential+can+indeed+be+
exploited+therapeutically.+However,+MSCs+injected+at+the+later+time+points+were+
found+ to+ have+ myofibroblastAlike+ properties+ due+ to+ the+ TGFβ+ mediated+
inhibition+ of+ differentiation.+ The+ difference+ in+ lung+microenvironment+ at+ the+
different+ time+ points+ emphasises+ how+ the+ microenvironment,+ in+ particular+
TGFβ+concentration+and+matrix+stiffness,+determines+MSC+function+(Yan+et+al.+
2007).+Clinical+ trials+ investigating+ the+potential+of+MSC+transplantation+have+
been+ of+ particular+ interest+ with+ regards+ to+ autoimmune+ diseases,+ where+
rejection+and+histocompatibility+are+of+major+concern.+The+ability+of+MSCs+to+
evade+ the+ host+ immune+ system+ grants+ much+ more+ liberty+ in+ the+ case+ of+




MSC+ administration+ (Theofilopoulos+ and+ Dixon+ 1985iYoud+ et+ al.+ 2010).+
Likewise+in+rheumatoid+arthritis+mouse+models,+MSC+treatment+was+found+to+
both+alleviate+arthritic+symptoms+and+tissue+damage+yet+also+exacerbate+TA
cell+ proliferation+ and+ autoimmunity+ (Schurgers+ et+ al.+ 2010).)Often+ in+ these+
studies,+the+encouraging+in'vitro+studies+were+not+reflected+in'vivo,+and+as+such+
it+can+be+hypothesised+that+the+MSC+activity+is+being+altered+in'vivo,+possibly+




not+ accounted+ for+ in+ the+ timeAlimited+ in' vitro+ preliminary+ studies.+ Injecting+
MSCs+into+rheumatoid+arthritis+mouse+models+after+inflammation+was+induced+
showed+ opposite+ and+ ineffective+ results+ when+ compared+ with+ MSC+
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In+humans,+MSCs+ injected+directly+ into+ the+heart+of+patients+with+ ischaemic+
cardiomyopathy+showed+regenerative+improvement+and+an+overall+benefit+in+
myocardial+contractility+and+remodelling+(Behfar+et+al.+2014).+In+autoimmune+
diseases+ like+ systemic+ lupus+ erythematosus,+ intravenous+ administration+ of+
















engrafted+cells+however,+were+not+ found+ to+differentiate+ into+hepatocytes+ in+
order+ to+ replace+ damaged+ tissue,+ rather+ there+ was+ evidence+ of+ their+
differentiation+into+myofibroblastAlike+cells,+thereby+exacerbating+the+injury+and+















at+ least+ temporarily+ improved+and+necrosis+was+ reduced+ in+3+of+5+patients.+
However,+ within+ 12+ months+ post+ MSC+ transplantation,+ ulcers+ recurred+
(Keyszer+ et+ al.+ 2011iTodorovic+ et+ al.+ 2005).+ A+ clinical+ trial+ using+ adipose+
derived+MSC+transplantation+in+SSc+was+conducted+on+12+patients+diagnosed+
with+limited+cutaneous+SSc+(Granel+et+al.+2015).+Autologous+MSCs+were+used,+
obtained+ by+ extracting+ adipose+ tissue+ from+ the+ patients+ and+ isolating+ and+
















healthy+ counterparts,+ autologous+ transplantation+ may+ not+ actually+ be+
beneficial+in+the+long+term.+To+date+the+most+successful+MSC+clinical+trials+in+
SSc+ have+ been+ based+ on+ localised+ injections+ into+ hands,+ fingers+ and+














occurs+ after+ division+ via+ a+ double+ stranded+ pangenomic+ RNA/DNA+
intermediate+that+separates+and+becomes+2+double+stranded+DNA+replicates.+
Divisions+are+determined+by+a+large,+hollow,+bell+shaped+nuclear+morphology,+
with+ a+ dense+ chromatin+ ring+ at+ the+ ‘open’+ end+ (Figure+ 1.6).+ Such+ nuclear+
division+ is+ observed+ in+ adenomatous+ tumours+ and+ in+ early+ embryogenesis+
where+ they+ represent+ the+ presence+ of+ stem+ cells+ during+ growth+ and+
differentiation+(Thilly+et+al.+2014).+Further,+metakaryotic+stem+cells+have+been+
observed+ to+ be+ recruited+ to+wounds+within+ 24+hours+ of+ trauma.+Due+ to+ the+
physiological+wound+ repair+ function+of+MSCs,+ this+ finding+was+of+significant+
interest+(Gostjeva+et+al.+2009).)In+this+thesis+the+property+of+metakaryotic+cell+















1.9) Conclusion:) possible) role) of) MSCs) activated) within) the) disease)
microenvironment)in)SSc)
MSCs+are+undoubtedly+an+important+cell+type+of+relevance+to+SSc,+and+their+
almost+ubiquitous+presence+ in+ the+human+body+ is+a+highly+attractive+quality+
when+considering+their+therapeutic+use+and+potential.+They+are+a+highly+plastic+





cells,+ altering+ the+ microenvironment+ they+ reside+ in,+ which+ in+ turn+ may+ act+
through+both+positive+and+negative+feedback+to+the+MSCs+themselves.++
+
This+ heterogeneity+ in+ their+ characteristics,+ together+ with+ the+ wide+ range+ of+
derivations+ and+ expression+ profiles+ is+ also+ reflected+ in+ the+ controversy+
surrounding+their+definition.+In+this+thesis,+MSCs+will+be+defined+as+fibroblastA
like+ cells+ that+ can+ be+ derived+ from+ adipose+ tissue,+ bone+ marrow+ and+ the+
umbilical+cord,+with+the+ability+to+differentiate+into+osteoblasts,+adipocytes+and+




wide+ range+ of+ symptoms,+ but+ ultimately+ systemic+ fibrosis+ is+ the+ undoubted+
main+ characteristic+ (Gabrielli+ et+ al.+ 2009).+ Understanding+ of+ the+
pathophysiology+of+ this+disease+ is+still+very+much+ incomplete,+with+potential+
mechanisms+ of+ its+ cause+ ranging+ from+ genetic+ susceptibility+ and+
environmental+ exposure+ to+ inherent+ vascular+ dysfunction+ and+ abnormal+
microenvironment+constituents+ (Eckes+et+al.+2014).+As+such+ treatments+are+
merely+ to+ alleviate+ symptoms,+ particularly+ those+ regarding+ Raynaud’s+
phenomenon+ and+ the+ resulting+ digital+ ulcers.+ To+ date,+ in+ regards+ to+ this+
disease,+MSCs+have+been+ largely+been+proposed+ to+be+a+benefit+with+ their+
exploitation+ as+ therapies+ being+ investigated.+ This+ thesis+ investigates+ the+
opposite,+ suggesting+ a+ more+ pathological+ role+ for+ these+ cells.+ Just+ as+ the+
different+ roles+ of+ MSCs+ can+ be+ used+ as+ advantageous,+ explaining+ and+
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supporting+ their+ therapeutic+ use,+ this+ thesis+ aims+ to+ place+MSCs+ as+major+
players+ in+ the+SSc+pathogenesis,+synergising+with+ the+proAfibrotic+ factors+of+





Osteoblast+ presence+ and+ atypical+ deposition+ of+ calcium+ minerals+ is+
responsible+ for+ the+ calcinosis+ seen+ in+ approximately+ 22%+ of+ SSc+ patients+
(Valenzuela+et+al.+2013).+Calcinosis+is+a+painful+symptom+of+SSc+and+results+
in+ inflammation+and+ loss+of+dexterity+particularly+ in+ the+ fingers.+Conversely,+
SSc+patients+often+present+with+osteopenia,+a+ loss+of+overall+ bone+density,+





symptom+ of+ SSc,+ such+ that+ mouse+ models+ often+ mimic+ this+ symptom+ in+




increase+ in+ one+ lineage+ induction+ coincides+ with+ a+ reduction+ in+ the+ other+
(Nuttall+ &+ Gimble+ 2000).+ Perhaps,+ an+ imbalance+ between+ the+ two+ lineage+
routes+is+of+importance+of+SSc+and+is+in+turn,+a+result+of+SSc+microenvironment+
constituents,+ namely,+ TGFβ,+ and+members+ of+ the+ canonical+Wnt+ pathway,+




and+differentiate+ into+ cells+ involved+ in+ vasculature+homeostasis+ (Ding+et+ al.+
2004).+With+Raynaud’s+and+microvascular+dysfunction+being+such+a+universal+







progression+ and+ symptoms.+ In+ addition+ to+ the+ direct+ involvement+ of+MSCs+
themselves,+is+the+issue+of+their+interaction+with+the+unique+composition+of+the+
SSc+microenvironment.+Principally,+MSCs+both+ secrete+ and+ respond+ to+ the+
proAfibrotic+ growth+ factor+ TGFβ.+ This+ alone+ is+ supportive+ for+ some+ form+ of+
MSCAcaused+exacerbation+of+SSc.+Furthermore,+and+as+ investigated+ in+ this+
thesis,+ MSCs+ may+ have+ distinct+ responses+ to+ SSc+ related+ cytokines+ and+
metabolites+such+as+IL31+and+lactate.+The+potential+importance+of+IL31+in+SSc+
is+ relatively+ new+and+ its+ relationship+with+MSCs+ is+ uninvestigated.+Notably,+
many+SSc+mouse+models+available+do+not+take+into+account+the+pruritus+and+







by+ elucidating+ their+ role+ in+ wound+ healing+ responses,+ adipogenic+ and+
osteogenic+ differentiation+ in+ SSc,+ together+ with+ measuring+ SSc+
microenvironment+ induced+RNA+expression+and+protein+synthesis.+Different+
representations+ of+ the+ SSc+ microenvironment+ were+ used+ in+ an+ attempt+ at+
identifying+key+factors+which+may+be+promoting+MSCs+in+SSc.+Blister+fluid+was+
considered+ to+ the+ be+ the+ fullest+ available+ representation+ of+ the+ SSc+













































































MSCs+ were+ cultured+ in+ osteogenic+ (OIM)+ or+ adipogenic+ induction+ media+








contaminating+ epithelial+ cells+ were+ detached+ by+ Trypsin/EDTA.+ Fibroblasts+
were+ cultured+ further+ and+ then+ subcultured+ in+ T75+ tissue+ culture+ flasks.++
Passaged+cells+were+cultured+further+in+DMEM+supplemented+with+10%+FCS+















nonAadherent+ cells+ were+ aspirated+ before+ washing+ cells+ with+ DPBS.+
Trypsin/EDTA+was+added+to+the+flask+before+incubation+at+37°C+5%+CO2.+10%+
serum+ DMEM+ was+ added+ to+ neutralise+ the+ Trypsin/EDTA+ activity+ and+ the+
detached+ cells,+ thought+ to+ be+ MSCs,+ were+ centrifuged+ at+ 1250RPM+ for+ 5+
minutes+before+subAculturing.+These+primary+cultures+were+used+only+to+test++






collagen+ hydrogel+ coated+ plates+ (Cell+ Guidance+ Systems+ SW12ACOLA50,+
SW12ACOLA4).+ These+ 12+ wells+ are+ collagen+ coated+ hydrogels+ at+ specific+













Blood+ from+ SSc+ and+ healthy+ individuals+ was+ taken+ by+ a+ phlebotomist.+ For+
plasma+ analysis,+ purple+ topped+ blood+ tubes+ were+ used+ containing+ EDTA+











SSc+ patients+ with+ dcSSc+ were+ selected+ for+ blister+ fluid+ donation.+ Using+ a+
dermal+ suction+ apparatus+ (Ventipress,+ Upsalla,+ Sweden)+ and+ a+ technique+
originally+devised+by+Sondergaard+et+al,+an+8mm+blister+was+ formed+on+ the+
anterior+ forearm+ of+ patients+ and+ healthy+ controls+ under+ negative+ pressure+
(280A310+mmHg)+over+3+hours+(Sondergaard+et+al.1998).+The+interstitial+fluid+
in+ the+blister+was+aspirated+using+a+23Agauge+needle.+100A250+µl+of+ fluid+ is+
collected+ per+ blister+ and+ stored+ in+ 1.5+ ml+ Eppendorf+ tubes+ following+












healthy+ control+ individuals+ were+ assayed.+ The+ Luminex+ bead+ panel+ was+
washed+with+wash+buffer+ (200+µl/+well)+before+ the+addition+of+25+µl+Human+
Cytokine+Standards+(10,000+pg/ml)+or+SSc+and+healthy+blister+fluid+samples+













systems)+was+used+ to+assay+ the+amount+of+ IL31+ in+43+SSc+and+21+healthy+
control+blister+fluid+samples+as+well+as+23+SSc+and+27+healthy+control+plasma+
samples.+A+96+well+ELISA+plate+coated+with+100+µl+capture+antibody+per+well+
diluted+ in+ reagent+ diluent+ (0.8+ µg/ml)+ was+ incubated+ at+ room+ temperature+
overnight+before+blocking+with+300+µl+reagent+diluent+for+1+hour+(1%+BSA+in+
PBS,+0.2+µm+filtered).+A+serial+dilution+of+standards+was+prepared+ranging+from+
the+8000+ to+0+pg/ml.+ 100+µl+ of+ standard+or+blister+ fluid/plasma+sample+was+









































specific+ and+ staining+ intensity+ is+ proportional+ to+ DNA+ concentration.+ After+
hydrolysis,+sections+were+rinsed+in+distilled+H2O+and+placed+into+a+Petri+dish+at+













counting+ the+ number+ of+ bellAshaped+ nuclei+ in+ 10+ randomly+ selected+ 20x+





Adipose+ derived+ MSCs+ were+ cultured+ in+ a+ T75+ flask+ until+ ~70%+ confluent+
before+being+seeding+ in+12+well+plates,+with+either+soft+or+stiff+matrices+at+a+
seeding+density+of+50000+cells+per+well.+They+were+cultured+in+10%+serum+for+













































isopropanol+ from+ each+ well+ was+ pipetted+ into+ a+ 96+ well+ plate+ using+ fresh+
isopropanol+ as+ blank+ standards+ and+ absorbance+ was+measured+ at+ 490nm+
using+a+plate+reader.+Absorbance+was+corrected+for+controls+and+standards.+
Absorbances+ which+ are+ greater+ than+ 3+ times+ standards+ and+ controls+ were+





























well+ and+ scraped+ using+ a+ cell+ scraper+ before+ aspirating+ lysates+ into+ 1.5ml+





500+ µl+ of+ Buffer+RPE+was+ added+ to+ the+ spin+ column+ for+ each+ sample+ and+

























in+ the+ studies+ were+ Tata+ Binding+ Protein+ (TBP)+ Forward+ sequence+
AGTGACCCAGCATCACTGTTT,+ reverse+ sequence+
GGCAAACCAGAAACCCTTGC,+ IL31+ Receptor+ pair+ 2,+ forward+ sequence+
TGTGCGGTCAAGGAGTCAAA,+ reverse+ sequence+








plus+ two+MSC+cell+ lines+was+extracted+using+ the+RNeasy+extraction+ kit.+ To+
assay+ IL31+ receptor+mRNA+ concentration,+ qPCR+was+ performed+ using+ the+
Qiagen+QuantiFAST+SYBR+Green+kit+and+protocol.+Two+primer+mixes+were+
prepared,+ IL31+receptor+ (IL31R2)+and+ the+housekeeping+gene+primer+TATA+
binding+ protein+ (TBP).+ Forward+ and+ reverse+ primers+ for+ each+ primer,+ were+






for+10+seconds,+60ºC+ for+10+seconds+and+60ºC+ for+20+seconds,+melt,+ ramp+
from+74ºC+ to+ 95ºC,+ rising+ by+ 0.5,+wait+ for+ 90+ seconds,+wait+ for+ 5+ seconds,+





calculating+ 2AΔCT+ and+ plotting+ the+ average+ for+ replicates+ of+ each+ sample.+
Graphpad+Prism+7.0+was+used+to+conduct+a+twoAway+ANOVA+with+Tukey’s+post+
hoc+ test+ to+ correct+ for+ multiple+ comparisons+ and+ determine+ statistical+
significance.+ IL31RA+ expression+was+ also+measured+ on+ one+MSC+ cell+ line+





cultured+ in+ 10%+ serum+ DMEM+ until+ full+ confluency+ before+ serum+ starving+
overnight+and+ treating+ for+16+hours+as+ follows:+serum+free+DMEM,+TGFβ+ (4+
ng/ml),+SSc/healthy+control+blister+fluid+(1:50),+SSc/healthy+control+blister+fluid+
(1:50)+++TGFβ+inhibitor+1D11+(10+µg/ml),+SSc/healthy+control+blister+fluid+(1:50)+
++Wortmannin+ (100+nM),+SSc/healthy+control+blister+ fluid+ (1:50)+++U0126+ (5+








to+ make+ the+ primer+ mixes.+ Samples+ were+ loaded+ in+ duplicates+ into+ the+
Rotorgene+6000+and+the+PCR+run+was+set+to+the+same+template+used+for+the+
























primers+ of+ two+ proAfibrotic+ genes,+ αASMA+ and+ CTGF+ in+ addition+ to+ the+






cells+ were+ treated+ with+ SSc+ or+ control+ blister+ fluid+ at+ the+ following+ dilution+
factors:+ 1:5,+ 1:10,+1:20,+1:50,+and+1:125.+All+ concentrations+were+using+ the+









hours:+ 0.2%+ serum,+ TGFβ+ (4+ ng/ml)+ and+ CCGA1423+ (10+ µM)+ (Cayman+
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Chemicali+ Michigan,+ USA).)Treatments+ were+ added+ to+ 0.2%+ serum+with+ 4+







10%+ serum,+ +SSc+ or+ control+ blister+ fluid+ (1:125),+ IL31+ (50+ ng/ml),+ TGFβ+ (4+
ng/ml).+ 50+ ng/ml+ IL31+ was+ used+ as+ the+ optimum+ concentration+ for+ all+
experiments+ in+ this+ thesis+ following+experiments+conducted+by+others+ in+ the+
lab+ whereby+ a+ Western+ blot+ of+ proAfibrotic+ proteins+ in+ response+ to+ IL31+
concentrations+of+1,+2.5,+5,+10,+50+and+100+ng/ml+showed+that+expression+did+
not+increase+when+treated+with+IL31+concentrations+above+50+ng/ml,+and+was+
less+ than+ optimal+ at+ lower+ concentrations.+ Blister+ fluid,+ IL31+ and+ TGFβ+





per+well+ (1+ tablet+complete+mini,+100+µl+Phosphatase+ inhibitor+2+and+100+µl+
Phosphatase+inhibitor+3+in+9.8+ml+RIPA+buffer,+SigmaAAldrichi+Missouri,+USA).+
The+ lysed+ cells+ were+ scraped+ off+ using+ a+ cell+ scraper.+ The+ protein+
concentrations+of+ each+sample+was+determined+with+ the+Bicinchoninic+Acid+
Assay+Kit+and+protocol+(BCA)+(Life+Technologiesi+Paisley,+UK).++10+µl+of+Bovine+
Serum+ Albumin+ (BSA)+ standards+ found+ in+ the+ kit,+ of+ known+ protein+
concentrations+were+added+to+the+96+well+plate+as+a+standard+curve.+The+lysed+
cell+samples+were+also+pipetted+into+the+remaining+wells+of+the+96+well+plate.+
200+µl+ of+ colour+ change+Working+Reagent+was+added+ to+each+sample+and+
incubated+ while+ covered+ for+ 30+ minutes+ at+ 37°C+ 5%+ CO2.+ Protein+
concentrations+were+measured+using+a+Mitras+LB940+Multimode+Microplate+
Reader+ (Berthold+ Technologies,+ Bad+ Wildbad,+ Germany)+ at+ 570+ nm.+
67"
"














run+ for+1.5+hours+at+200V.)The+gels+were+ removed+ from+ the+cassettes+and+
immersed+ in+ Transfer+ Buffer+ (50+ ml+ NuPAGE+ Transfer+ Buffer+ 20X+ (Life+
Technologiesi+ Paisley,+ UK)+ in+ 200+ ml+ 70%+ Methanol+ and+ 750+ ml+ distilled+
water).+While+immersed+in+the+buffer,+gels+were+placed+over+chromatography+
paper+ and+ sponges.+ A+ membrane+ was+ placed+ over+ the+ gel,+ followed+ by+
chromatography+paper+and+more+sponges.+Any+bubbles+between+layers+were+
carefully+ rolled+ out+ before+ placing+ the+ whole+ gel/membranes/sponge+
‘sandwich’+in+a+transfer+cassette+and+running+it+for+2+hours+at+35+V.+The+proteins+
now+transferred+to+the+membrane+were+stained+using+Ponceau+Red+S+Solution+













3000)+ (Merck+ Millipore).+ Membranes+ were+ left+ rolling+ in+ diluted+ primary+
antibodies+at+4°C+overnight.+Membranes+were+washed+with+PBSATween+(10%+
PBS,+ 0.05%+ tween)+ for+ 10+ minutes+ three+ times+ before+ probing+ with+ antiA

































added+ to+ the+ culture+ dish+ to+ prevent+ dehydration+ of+ the+ cells+ on+ the+ chip.+
Culture+ dishes+ were+ incubated+ for+ 2.5+ hours+ to+ allow+ for+ cell+ adhesion.+
Following+incubation,+the+entire+chips+were+immersed+by+flooding+the+well+with+
serum+ free+ media,+ IL31+ (50+ ng/ml)+ in+ serum+ free+ media,+ SSc+ blister+ fluid+
(1:125)+in+serum+free+media+or+10%+serum.+Chips+were+incubated+and+imaged+
at+ 0,+ 24+ and+ 48+ hours+ at+ 2.5x+ magnification+ using+ phase+ contrast+ Zeiss+
Axiocam+to+observe+cell+migration.+The+area+the+cell+population+inhabited+was+











































































control+ blister+ fluid+ (1:125),+ or+ IL31+ (50+ ng/ml).+ Blister+ fluid+ and+ IL31+ were+
added+to+0.2%+serum+conditions.+A+different+sample+of+blister+fluid+was+used+
for+each+replicate+for+both+cell+lines.+Cells+were+treated+for+16+hours+and+lysed+
for+ RNA+ extraction+ using+ Qiagen+ RNeasy+ extraction+ kit+ and+ protocol.+ In+




sample+ was+ analysed+ using+ principal+ components+ analysis.+ PAvalues+ were+
determined+with+Wald’s+statistic+test.+Transcriptome+analysis+was+conducted+
using+ paired+ end+ reads+ and+ were+ mapped+ to+ the+ Ensembl+ human+
transcriptome+ reference+ sequence+ (latest+ version+ available+ during+ analysis:+
GRCh38+ (84)).+Mapping+and+generation+of+ read+ counts+per+ transcript+were+
done+ using+ Kallisto+ (Bray+ et+ al.+ 2016),+ based+ on+ the+ novel+ idea+ of+
















a+ quality+ control+ assessment.+ Functional+ classification+ of+ genes’+ list+ was+
performed+ using+ Ingenuity+ Pathway+ analysis+ (IPA,+
https://www.qiagenbioinformatics.com/).+ The+ “core+ analysis”+ function+ was+
used+to+interpret+the+data+in+the+context+of+biological+processes,+pathways+and+





















surrounding+ the+ role+ of+ MSCs+ in+ SSc.+ The+majority+ of+ the+ published+ work+
attempts+to+evaluate+their+beneficial+uses+in+potential+transplant+therapies+in+
many+autoimmune+diseases,+including+SSc.+However,+even+less+data+exists+
on+ the+ role+ of+ the+ endogenous+ tissue+ resident+ MSCs+ in+ these+ diseases,+
particularly+ SSc+ and+ how+ MSCs+ function+ in+ these+ pathological+
microenvironments.+MSCs+are+proposed+to+partake+in+metakaryotic+stem+cell+
division,+ which+ is+ an+ amitotic+ process+ giving+ rise+ to+ both+ symmetrical+ and+
asymmetrical+ division.+ This+ potentially+ is+what+ allows+ for+ the+MSCs+ to+ selfA
renew+and+differentiate+simultaneously.+BellAshaped+nuclei+are+proposed+to+be+
indicative+ of+ metakaryotic+ stem+ cells.+ Their+ behaviour+ with+ regards+ to+ cell+


















patient+ biopsies+ were+ taken+ and+ after+ fixing+ them+ in+ Carnoys+ fixative+ and+
storing+ in+70%+ethanol,+biopsies+were+stained+ for+metakaryotic+cell+division.+
Such+nuclear+divisions+are+not+reported+to+be+seen+in+healthy+tissues+but+are+
present+ in+ tumour+ and+ during+ embryogenesis,+ and+ may+ represent+ MSCs+
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undergoing+ activation+ and+ division.+ The+ histology+ was+ conducted+ in+
collaboration+with+Dr+Elena+Gostjeva,+Boston,+MIT,+a+cytopathologist+who+first+
described+this+form+of+cell+division+(Gostjeva+et+al.+2009).+Four+healthy+and+four+
SSc+ biopsies+ were+ treated+ as+ described+ in+ the+methods+ to+ investigate+ the+
presence+of+such+nuclei.+Feulgen+staining+methods+of+acid+hydrolysis+followed+
by+Schiff+ reagent+ treatment,+ allowing+ for+ semiAquantitative+measurement+ of+
DNA+ content+ by+ measuring+ the+ amount+ of+ aldehydes+ released+ upon+ DNA+
hydrolysis,+were+used+previously+by+Dr+Gostjeva’s+group+ in+developing+ this+
technique.+Staining+intensity+of+the+aldehydes+released+from+DNA+is+directly+












section+ could+ be+ spread+ individually+ onto+ slides+ to+ assess+ differences+ in+
metakaryotic+cell+division+at+the+different+skin+levels.++
 
Section 1 (~ 1mm, skin surface) 
Section 2 (~ 2 mm depth from the surface) 













shaped+ nucleus+ was+ observed+ in+ the+ uppermost+ section.+ Also,+ in+ healthy+































Feulgen’s+ staining+ stains+ DNA+ content+ and+ thereby+ allows+ identification+ of+
mitotically+dividing+cells.+Figure+3.5+shows+a+mitotically+dividing+epithelial+cell+






















on+ the+ basis+ of+ their+ nuclear+ morphology+ (Figure+ 3.5).+ Many+ biAnucleated+
cellular+nuclei+can+be+observed+in+the+SSc+biopsies,+indicating+the+presence+of+
osteoclast+ cells.+ The+ presence+ of+ these+ cells+ was+ particularly+ seen+ on+ the+
pigmented+skin+surface+of+section+1,+responsible+for+the+darker+background+of+
this+slide.+Osteoclasts+are+not+generally+seen+in+the+skin+and+were+not+found+in+
the+ healthy+ control+ sections+ examined.+ They+ derive+ from+ differentiation+ of+
peripheral+blood+mononuclear+cells+and+monocytes+in+response+to+RANKL+and+
macrophage+colonyAstimulating+factor+which+are+induced+by+proAinflammatory+
cytokines+ involved+ in+SSc+ including,+ IL33,+ IL17+and+TNFα+ (Raimondo+et+al.+
2017).++Some+SSc+patients+suffer+from+acroosteolysis,+bone+resorption+of+the+
digits.+ It+ was+ found+ that+ this+ bone+ resorption+ is+ a+ result+ of+ increased+






in'SSc' skin'biopsy' sections'only.'Healthy' skin' biopsy' sections' showed' no' evidence' of'
calcified'bone'material'not'black'stained'calcinotic'lesions.'
+
Strikingly,+ bone+ material+ was+ identified+ in+ a+ top+ section+ of+ an+ SSc+ biopsy,+
together+with+calcinosis+present+in+three+out+of+the+four+SSc+sections+(Figure+
3.6).+The+presence+of+calcinosis+was+determined+by+the+amount+of+blackened+







































































Conversely,+ in+ all+ the+ healthy+ control+ biopsies,+ regardless+ of+ the+ layer,+
metakaryotic+divisions+were+not+seen+and+the+collagen+fibres+were+much+less+













































in+ the+ skin.+ The+ metakaryotic+ nuclei+ in+ this+ section+ do+ not+ appear+ to+ be+
undergoing+apoptosis.++
+
Figure+ 3.12+ seems+ to+ show+ an+ individual+ cell+ with+ a+metakaryotic+ nucleus+


























dividing,+ however,+ in+ the+ SSc+ skin+ biopsy,+ amitotic+ cell+ divisions+ of+ these+
metakaryotic+nuclei+was+observed+in+the+third+section+where+the+new+nucleus+

















Figure' 3.13' Metakaryotic' stem' cell' dividing' amitotically.'Magnification' of' symmetrical'
































































contain+ such+ cells+ (Figure+ 3.17).+ This+ possibly+ illustrates+ the+ abnormal+











































Quantification+ of+ the+ number+ of+ metakaryotic+ nuclei+ in+ each+ section+ was+
conducted+by+counting+them+in+ten+randomly+chosen+20x+magnification+field+





























While+physiologically,+MSCs+are+not+ thought+ to+be+dividing+until+ induced+ to+












2015i+ Friedenstein+ et+ al.+ 1974).+ Furthermore,+ their+ increased+ presence+ is+
associated+with+much+thicker+collagen+bundles,+possibly+ indicating+that+they+
are+either+producing+the+collagen+itself,+or+acting+on+collagenAsecreting+cells+to+
induce+ collagen+ expression+ (Schurgers+ et+ al.+ 2010).+ Both+ of+ these+








an+ important+symptom+of+SSc+and+also+ the+ impression+that+MSCs+could+be+
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responsible+ for+ this+deregulation.+This+ is+supported+by+ literature+stating+ that+




































Chapter)4):) Profiling) systemic) sclerosis) tissue) fluid) to) determine) the)
factors)present)in)the)disease)microenvironment)
 
4.1) Introduction:) examining) the) growth) factor) and) cytokine)
microenvironment)in)SSc)
The+ SSc+ microenvironment+ is+ multiAfactorial,+ and+ this+ is+ perhaps+ an+
explanation+ for+ the+ heterogeneous+ nature+ of+ SSc+ and+ the+ large+ amount+ of+
theories+and+hypotheses+surrounding+its+pathology.+Many+factors+are+thought+
to+play+a+role,+yet+how+significant+that+role+is,+together+with+how+they+interact+
with+ other+ known+ factors+ is+ still+ unknown+ to+ some+ extent.+ The+ SSc+
microenvironment+consists+of+many+cell+ types.+These+ include+ immune+cells+
such+ as+ Th2+ cells,+ which+ exacerbate+ fibrosis,+ BAcells+ producing+ the+
autoantibodies,+ and+macrophages+ and+monocytes+ involved+ in+ inflammation+
and+ chemotaxis+ (Fuschiotti+ 2017i+ Raker+ et+ al.+ 2017).+ Arguably+ the+ most+
important+cell+type+in+SSc+pathology+is+the+fibroblast.+These+are+thought+to+be+
activated+by+LAP+bound+TGFβ+and+induced+to+differentiate+into+myofibroblasts,+
the+ cells+ ultimately+ responsible+ for+ the+ collagen+ deposition+ and+ persistently+
unregulated+fibrosis+and+scarring.+The+substrate+these+cells+attach+to+is+also+of+
importance+since+the+stiff+nature+of+SSc+extracellular+matrix,+~50+kPa+on+the+
Young’s+ Modulus+ Scale,+ can+ influence+ cellular+ function,+ namely+ fibroblast+




portion+ of+ the+microenvironment.+Notably+ the+most+wellAknown+ and+ studied+
growth+factor+implicated+in+SSc+is+TGFβ,+and+together+with+other+growth+factors+








One+ way+ of+ representing+ SSc+ microenvironment+ is+ by+ using+ blister+ fluid+
aspirated+from+suction+blisters+made+ in+SSc+and+healthy+ individuals’+normal+

















4.2) Specific) analysis) of) IL31) as) a) candidate) factor) in) the) SSc)
microenvironment))
After+finding+that+MSCs+were+present+in+SSc+skin,+but+before+investigating+their+
role+ in+ this+ microenvironment,+ the+ constituents+ of+ the+ microenvironment+
needed+to+be+elucidated+in+the+hope+that+factors+could+be+identified+as+specific+
to+ MSC+ activation.+ As+ such,+ several+ representations+ of+ the+ SSc+
microenvironment+were+used+in+this+thesis.+Blister+fluid+from+SSc+and+healthy+









important+ driver+ of+ SSc,+ IL31+ should+ be+ investigated+ in+ this+ disease.+ + This+











Lactate+ presence+ is+ an+ indication+ of+ anaerobic+ respiration,+ one+ of+ the+







multiple+ lines+ of+ evidence+ indicate+ that+ raised+ levels+ of+ lactate+might+ exert+
important+ biologic+ effects+ on+ target+ cells+ within+ the+ lesions+ including+








the+ lesional+ skin+ of+ SSc+ patients+ will+ identify+ key+ factors+ involved+ in+ MSC+
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of+ 41+ growth+ factors+ and+ cytokines.+ + This+ assay+ revealed+ proteins+ with+
significantly+elevated+concentrations+in+SSc+blister+fluid+compared+to+controls.+
PDGFAAA+is+one+such+protein,+likely+to+be+involved+in+fibroblast+recruitment+to+
fibrotic+ lesions+ (10.38pg/ml+ versus+ 6.94pg/ml+ p=0.03).+ Monocyte+
chemoattractant+ protein+ (MCPA1)+ is+ another+ chemoattractant,+ implicated+ in+
SSc+mouse+models.+ Its+ levels+ in+ SSc+ blister+ fluid+ negatively+ correlate+ with+
disease+duration.+By+contrast+in+plasma,+a+different+pattern+was+observed.+Th2+
cytokines,+IL1a,+IL2,+IL10+and+VEGF+were+all+found+to+be+increased+more+than+
1.5+ fold+ in+ SSc+ plasma+ compared+ to+ controls.+ Other+ cytokines+ significantly+
elevated+ include+ IL6+ (38.78pg/ml+ versus+ 5.51pg/ml+ p=0.01)+ and+ IL15+
(6.27pg/ml+ versus+ 4.38pg/ml+ p=0.03).+ Interestingly,+ IL17+was+ only+ found+ in+
SSc+ blister+ fluid+ from+ diffuse+ patients+ and+ not+ in+ healthy+ control+ or+ limited+
patient+blister+fluid+(Clark+et+al.+2015a).+The+data+is+summarised+in+Table+4.1.+
Furthermore,+an+ELISA+assay+was+used+in+a+preliminary+screen+of+28+SSc+and+
15+ healthy+ control+ blister+ fluid+ samples+ showing+ a+ significant+ difference+
















like' tyrosine' kinased' GCSF,' granulocyte' colonyPstimulating' factord' GMCSF,' granulocyte–
macrophage'colonyPstimulating'factord'GRO,'growth'regulated'oncogened'IFN,'interferond'IL,'
interleukind'ILP1RA,'interleukinP1'receptor'antagonistd'IPP10,'Interferon'gamma'induced'protein'








































(top)' is' increased' compared' to' healthy' control' samples' (p=0.0003).' Plasma' IL31' levels'


























other+hand,+ the+significantly+higher+ IL31+concentration+found+ in+SSc+plasma+








































Figure' 4.2' ELISA' assay' of' IL31' in' blister' fluid' and' plasma.'Blister' fluid' from' anterior'
forearm' dermal' lesions' and' corresponding' plasma' samples' taken' from' SSc' and' healthy'
control' (HC)' individuals' were' assayed' for' IL31.' Blister' fluid' (top)' showed' no' significant'
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Conducting+ a+ spearman’s+ rank+ correlation+ showed+ a+ significant+ positive+



























Also,+a+group+of+SSc+patients+were+ found+ to+have+blister+ fluid+ level+of+ IL31+
greater+ than+1000pg/ml.+ +The+characteristics+of+ these+patients+are+shown+in+
Table+ 4.2.+ Interestingly+ these+ patients+ were+ from+ both+ limited+ and+ diffuse+
disease+ subset+ and+ from+ both+ early+ and+ late+ stage+ disease.+ + However,+ all+
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59" Female" Diffuse" Scl70,"RF" 2010" 18" 122" 188" 20"
44" Female" Limited" ANA,"
ACA"
2006" 16" 122" 279" 11"
65"" Male" Diffuse" RNA"Pol"
III"
2011" 23" 130" 276" 21"
66" Female" Diffuse" RNA"Pol"
III"
2014" 23" 102" 319" 10"
60" Male" Limited" ACA" 2010" 24" 130" 172" 4"
+
Table' 4.2'Characteristics'of' patients'with'high' IL31' levels' correlating'with'high' itch'







lactate+dehydrogenase,+generating+a+colour+change+ in+ the+probe+ interacting+
with+ the+ enzyme+ product,+measured+ at+ 450+ nm.+ The+ optical+ density+ of+ the+
colour+ change+ is+ proportional+ to+ the+ lactate+ concentration.+ Average+ lactate+
concentration+of+SSc+blister+fluid+was+higher+than+that+of+healthy+control+blister+
fluid,+although+the+difference+between+the+SSc+and+healthy+blister+fluid+was+not+
significant+ (p=0.1001)+ (Figure+ 4.4).+ Also,+ the+ standard+ error+ of+ SSc+ data+ is+
larger+ than+ healthy+ controls,+ reflecting+ the+ heterogeneity+ of+ the+ disease+




























the+ disease+and+ yet,+ to+ date,+ very+ little+ data+ exists+ on+ profiling+ the+ specific+








increased+ in+ SSc+ blister+ fluid.+ When+ the+ sample+ size+ was+ made+ larger,+







levels+ of+ pruritus,+ consistent+ with+ the+ known+ prurigenic+ properties+ of+ this+
cytokine.+Although+not+significant,+results+seemed+to+suggest+there+was+more+
propensity+ for+SSc+patients+with+higher+ IL31+ levels+ to+have+been+diagnosed+
with+dcSSc+rather+than+be+part+of+the+limited+subset.++
+
These+ findings+ warrant+ IL31+ being+ used+ as+ one+ of+ the+ ways+ SSc+
microenvironment+is+modelled+in+tissue+culture+in+this+thesis,+with+effects+of+
IL31+ treatment+ giving+ rise+ to+ conclusions+ regarding+ MSC+ response+ to+




contained+more+ lactate+ than+healthy+ control+ blister+ fluid+as+measured+by+a+
lactate+colorimetric+assay.+While+ the+difference+ is+not+significant,+ the+mean+








lactate,+ representing+potentially+ important+metabolites.+Not+ only+were+ these+
microenvironments+ studied+ as+models+ of+SSc+ in+ this+ thesis,+ identifying+ key+
factors+ of+ SSc+ blister+ fluid+ meant+ that+ they+ could,+ in+ turn,+ be+ individually+
inhibited+ to+ robustly+ elucidate+ the+ extent+ of+ their+ role+ in+ blister+ fluid.+ This+



























































than+ innocent+ bystanders+ of+ the+ SSc+ disease+ process,+ despite+ often+ being+
overlooked+ as+ pathological.+ From+ their+ potential+ role+ in+ vasculature+
deregulation,+ through+ their+ part+ in+ the+ osteogenicAadipogenic+ imbalance,+ to+
their+ differentiation+ into+ myofibroblastAlike+ cells+ directly+ exacerbating+ the+
collagen+ deposition+ and+ fibrosis,+ it+ is+ possible+ that+ their+ heterogeneic+






It+ has+ been+ shown+ that+ MSCs+ express+ αASMA+ in+ response+ to+ proAfibrotic+
microenvironments+(Talele+et+al.+2015).+MSCs+expressing+αASMA+were+found+




SMA+ show+ significantly+ reduced+ clonogenicity+ and+ expression+ of+ stem+ cell+
specific+RNA+molecules, octamerAbinding+ transcription+ factor+ 4+ (OCT4)+and+




regards+ to+ wound+ healing.+ Wound+ healing+ is+ a+ process+ in+ which+ skin+
contraction+ is+ induced+by+αASMAApositive+contractile+bundles,+pulling+on+the+
neighbouring+healthy+cells+in+an+attempt+to+close+the+wound.+This+excessive+
pulling+makes+ the+ surrounding+ skin+ tight+ and+ thicker+ and+ thereby+ results+ in+
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scars.+ This+ process+ is+ further+ affected+ by+ the+ cytokine,+ growth+ factor+ and+




MSC+ expression+ of+ αASMA+ increases+ not+ only+ whole+ cell+ contractility+ and+
migration,+but+also+ the+contractility+of+ the+cytoskeleton+ in+ the+cytoplasm.+αA
SMA+ polymerisation+ to+ stress+ fibres+ in+ the+ cytoplasm+was+ found+ to+ be+ the+
primary+ mechanism+ of+ αASMA+ mediated+ contractility+ (Talele+ et+ al.+ 2015).)
YAP/TAZ+ are+ transcription+ factors+ predominantly+ found+ in+ the+ cytoplasm,+
which+ are+ shuttled+ to+ the+ nucleus+ where+ they+ regulate+ the+ transcription+ of+
genes+highly+associated+with+stem+cell+differentiation,+fate+and+phenotype.+This+
nuclear+ localisation+was+ found+ to+be+mediated+by+αASMA+polymerisation+ to+
contractile+fibres,+as+αASMA+knockdown+reduced+nuclear+localisation+of+YAP.+























With+ αASMA+ being+ not+ only+ one+ of+ the+ most+ important+ SSc+ markers+ of+
pathology,+ but+ also+ expressed+ by+ MSCs+ under+ proAfibrotic+ conditions,+ this+









together+ are+ expressed+ by+myofibroblasts,+ and+ as+ such,+ in+ these+Western+
blots,+their+protein+expression+levels+will+be+used+as+possible+markers+of+MSC+
to+ myofibroblast+ differentiation.+ Furthermore,+ a+ characteristic+ of+ SSc+
myofibroblasts+ is+ their+ability+ to+contract+collagen+gels+ in'vitro.+ +MSCs+were+
cultured+in+collagen+gels+and+treated+with+SSc+or+healthy+control+blister+fluid,+




Given+ the+above+background,+ the+overall+ hypothesis+of+ this+Chapter+ is+ that+
treatment+of+MSCs+with+SSc+blister+fluid,+or+with+key+constituents,+will+induce+












Initially+ the+ microenvironmentAMSC+ cross+ talk+ was+ modelled+ using+ MSCs+
cultured+ in+a+monolayer+and+ treated+with+SSc+blister+ fluid,+diluted+ in+culture+
media.+Figure+5.1+shows+the+first+Western+blot+attempted+on+MSCs+treated+for+




were+ used+ as+ an+ internal+ control+ sample+ for+ collagen+ type+ I+ and+ CTGF+




Relative+ density+ of+ the+ bands+ was+ calculated+ with+ Image+ J+ Software+
Densitometer+and+was+plotted+ for+each+ treatment+and+each+protein+ readout+
(Figure+5.1B).+Expression+of+all+three+proAfibrotic+proteins+was+most+affected+
























loading+ per+ channel+ was+ reduced+ to+ 4+ µg+ per+ well,+ resulting+ in+ technically+
improved+blots.+Readouts+ for+ this+attempt+were+αASMA+and+collagen+ type+ I+
(Figure+5.2).+Again,+IL31+was+not+found+to+affect+expression+of+the+proAfibrotic+
factors+more+than+serum+controls+and+as+such+its+elevation+in+SSc+blister+fluid+
cannot+ account+ for+ the+ full+ effects+ of+ blister+ fluid+ on+ proAfibrotic+ protein+
expression.+αAsma+ expression+ was+ induced+ by+ SSc+ blister+ fluid+more+ than+
collagen+type+I,+yet+both+were+more+highly+expressed+in+response+to+SSc+blister+
fluid+ than+ to+ healthy+ control+ blister+ fluid,+ further+ confirming+ a+ differential+
response+of+MSCs+to+the+SSc+microenvironment,+and+supporting+the+idea+that+




























































































5.3)+ to+ compare+ the+ different+ effects+ of+ different+ blister+ fluid+ samples+ on+ its+
expression.+While+there+was+some+variation+between+the+two+assays,+the+trend+
was+expectedly+the+same+and+both+assays+resulted+in+the+conclusion+that+SSc+
blister+ fluid+ contains+ some+ factor(s)+ responsible+ for+ the+ increase+ in+ αASMA+
expression+ compared+ with+ healthy+ control+ blister+ fluid.+ Moreover,+ this+
difference+cannot+be+fully+accounted+for+by+the+increased+IL31+in+SSc+blister+
fluid+samples,+since+high+dose+IL31+treatment+alone+did+not+result+in+increased+




and+ SSc+ blister+ fluid+ treated+ MSCs+ (p=0.0511)+ however,+ no+ significant+
difference+was+detected+between+the+two+blister+fluids.+There+is+more+αASMA+
induced+by+SSc+blister+ fluid+ than+healthy+control+blister+ fluid+and+since+ IL31+
treatment+does+not+elicit+any+comparable+responses,+it+stands+to+reason+that+
other+constituents+of+SSc+blister+ fluid,+not+present+or+ lesser+ in+control+blister+
















(SScBF)' induced'more'αPSMA' than'0.2%'serum' (p=0.0511).'No'significant'difference'was'
found'between'SScBF'and'control'blister'fluid'(cBF)'(p=0.0956).'*p<0.05.'
+
The+Western+ blot+ protein+ assays,+ most+ importantly+ illustrated+ that+ there+ is+
potentially+a+difference+between+SSc+and+healthy+control+blister+fluid+and+their+
propensity+ to+ activate+MSCs+ to+ express+ proAfibrotic+ proteins,+ particularly+αA
SMA,+associated+with+SSc.+From+this,+it+can+be+concluded+that+SSc+blister+fluid+
constituents+not+present+in+healthy+control+blister+fluid,+or+at+least+at+a+much+
lower+ concentration,+are+ responsible+ for+ the+differential+ induction+effects+on+
MSCs.+MSCs+in+low+serum+conditions+express+little+αASMA,+collagen+type+I+and+





























Interestingly,+ it+ does+ not+ seem+ the+ simple+ case+ of+ higher+ blister+ fluid+

















The+ collagen+ fibres+ in+ SSc+ skin+ is+ proposed+ to+ be+ aligned+ in+ nature+ in+
comparison+ to+ the+woven+collagen+configuration+of+healthy+skin+ (Figure+2.4+
and+ Figure+ 3.4).+ This+ difference+ was+ proposed+ to+ reflect+ the+ migratory+
capabilities+ of+ cells+ in+ SSc+ skin,+ possibly+ making+ migration+ to+ sites+ of+
inflammation,+wound+healing+and+fibrosis+easier+along+aligned+collagen.++
+
Glass+ slides+ preAcoated+ with+ bovine+ collagen+ in+ woven+ or+ aligned+
configurations+were+used+in+these+preliminary+experiments+with+human+dermal+
fibroblasts+ cultured+on+ the+ slides,+ as+ a+ prelude+ to+ using+MSCs.+They+allow+
close+representation+of+cell+migration+through+healthy+or+SSc+tissue.+Different+
treatments+such+as+the+SSc+blister+fluid+or+its+constituents+were+added+to+the+








Dermal+ fibroblast+were+seeded+onto+ the+slides+ in+3+µl+ foci,+being+allowed+to+
adhere+ before+ flooding+ the+ slide+ with+ condition+ media.+ However,+ major+
technical+ problems+ were+ encountered+ with+ this+ assay,+ mainly+ the+ lack+ of+
adherence+of+ the+cells+ to+ the+slides+and+ their+ resultant+death.+Furthermore,+
when+ assaying+ the+ few+ foci+ that+ attached,+ very+ poor+ reproducibility+ was+
achieved+ regarding+ cell+ number+ per+ focus+ since+ the+ large+ amount+ of+ cell+
detachment+ resulted+ in+ unclear+ foci+ boundaries.+ Reducing+ the+ cell+ number+
from+12,000+ to+4500+per+ focus,+ in+an+attempt+ to+eliminate+ the+possibility+of+
contact+inhibition+was+not+successful,+and+the+majority+of+cells+detached+from+
the+ collagen+ glass+ slides.+ Likewise,+ cells+ in+ complete+ serum+ free+ media+

















readily+ available+ in+ our+ lab,+ to+ optimise+ the+ protocol+ and+ determine+

























EGF,+ the+ fact+ that+ IL31+ is+ just+as+potent,+ if+not+more,+as+serum+at+ inducing+
migration,+illustrates+its+possible+role+in+cell+migration+in+SSc+wounds.+The+high+










plates' in'DMEM'with'0.2%'serum' (negative'control),'10%'serum' (positive'control),'or'with'








The+ dose+ response+ previously+ conducted+ by+ colleagues+ testing+ increasing+








































In+addition+ to+ IL31+ treatments,+ the+cells+were+also+ treated+with+ two+different+
















By+ 6+ hours+ post+ treatment,+ IL31+was+ shown+ to+ be+ clearly+ an+ effective+ cell+
migratory+ inducer,+with+migration+ being+ significantly+ induced+ by+ IL31+ (0.2%+
serumi+2.07+mm2i+ IL31+1.38+mm2i+p=0.001)+and+ inhibited+by+both+ inhibitors+
(IL31i+1.38+mm2+i+Wortmannin/U0126i+2.24/1.89+mm2+i+p=0.001).+Interestingly,+
at+ this+ point+ Wortmannin+ was+ a+ significantly+ more+ potent+ inhibitor+ of+ IL31+
induced+cell+migration+than+U0126+across+all+cell+lines+(Wortmannini+2.24+mm2,+




By+24+hours,+ IL31+significantly+enhanced+migration+compared+ to+ the+serum+
negative+control+(0.2%+serumi+0.92+mm2i+IL31i+0.28+mm2i+p<0.05),+an+effect+
blocked+by+both+of+the+inhibitors.+Both+inhibitors+seemed+to+reverse+migration+
to+ the+ same+ extent+ by+ this+ time+ although+ the+ area+ of+ the+ scratch+ under+





stands+ to+ reason+ that+ upon+ IL31+ stimulation,+ the+ two+ pathways+ do+ not+
converge.+However,+they+both+completely+reverse+the+migratory+effect+of+IL31+
to+ a+ similar+ extent.+By+ 24+ hours,+ the+SScF2+ cells+ had+ completely+migrated+


































































































































































































































Having+established+ the+ above+protocol+with+ fibroblasts,+ further+ experiments+
were+performed+with+MSCs+in+order+to+model+SSc+environment+interaction+with+
MSCs+undergoing+migration.+After+50+ng/ml+was+chosen+as+the+optimum+IL31+
concentration,+ a+ scratch+ wound+ assay+ was+ conducted+ on+ adiposeAderived,+
commercially+ obtained+MSCs.+ This+ assay+measured+ the+ effect+ of+ two+ SSc+
microenvironment+ representations,+blister+ fluid,+or+else+ IL31,+with+or+without+
Wortmannin+inhibition,+using+MSC+migration+as+the+readout.+In'situ,+MSCs+are+
thought+to+be+activated+to+migrate+to+sites+of+wounds+to+carry+out+their+wound+





When+ considering+ MSCs+ as+ quiescent+ homeostatic+ cells,+ it+ was+ thought+
possible+that+conditioned+media+may+not+be+enough+to+induce+their+migration.+
However,+with+MSCs+being+fibroblastAlike+in+shape+and+substrate+attachment,+
it+ was+ not+ implausible+ that+ they+ would+ respond+ to+ SSc+ microenvironment+
conditions+in+a+similar+way+to+dermal+fibroblast.++
+
MSCs+ were+ treated+ with+ serum+ controls,+ IL31+ at+ 50+ ng/ml+ with+ or+ without+
Wortmannin+(100+nM),+and+SSc+or+healthy+control+blister+fluid+diluted+1:125.+In+
each+of+three+replicates,+a+different+blister+fluid+sample+was+used+to+account+
for+ differences+ in+ blister+ fluid+ constitution+ between+ patients+ or+ healthy+
individuals.+Since+both+signalling+pathway+inhibitors+worked+to+a+similar+extent+










conditions+ migrated+ similar+ amounts,+ resulting+ in+ similar+ scratch+ areas.+
Furthermore,+although+no+statistical+significance+was+reached,+the+blister+fluid+
treated+cells+did+seem+to+have+migrated+across+the+scratch+slightly+more+than+










on+ fibroblasts,+ IL31+ induced+ migration+ was+ completely+ reversed+ by+ PI3K+
inhibition+by+Wortmannin+(p=0.027)+to+an+extent+that+the+area+of+the+scratch+by+
24+hours+was+larger+than+the+scratches+in+wells+treated+with+0.2%+serum+alone.+



















































































































































Figure' 5.8' Microscope' images' of' MSC' migration' in' response' to' SSc'
microenvironments.'MSCs'treated'with'0.2%'serum'(negative'control),'10%'serum'(positive'
control),'IL31'(50'ng/ml),'with'or'without'wortmannin'(100'nM)'in'0.2%'serum,'SSc'or'control'
blister' fluid' in'0.2%'serum' (1:125).'Wells'were' imaged'at'0,'8'and'24'hours'using'at'2.5x'
magnification.'ImageJ'software'was'used'to'outline'the'scratch'in'red'and'measure'the'area'














the+ use+ of+ IL31+ as+ a+ model+ of+ SSc+ microenvironment+ however,+ when+
comparing+the+ induction+capability+of+ IL31+on+MSC+migration+ to+ that+of+SSc+
blister+fluid,+it+is+clear+that+the+latter+contains+a+factor(s)+that+is+not+taken+into+
account+with+the+use+of+IL31+alone.+The+effect+of+IL31+alone+on+MSC+migration+
was+more+akin+ to+ that+of+healthy+control+blister+ fluid+ rather+ than+SSc+blister+
fluid,+not+reflecting+the+elevated+IL31+concentration+in+SSc+blister+fluid.+On+the+












the+ effect+ of+ SSc+ blister+ fluid+ on+ MSCs,+ it+ was+ considered+ not+ adequately+
representative+of+what+occurs+ in'vivo.+In+order+to+remove+the+effect+the+hard+


















the+gel+and+contraction+of+ the+gel.+Gel+contraction+ is+ thought+ to+be+brought+
about+by+polymerisation+of+αASMA+positive+contractile+fibres+that+span+the+cells+
and+ affect+ the+ formation+ and+ maturation+ of+ focal+ adhesions+ which+ in+ turn+
influence+ cellular+ attachment+ to+ the+ substrate.+ Focal+ adhesion+ turnover+






on+cellular+contraction+of+ the+matrix.+This+results+ in+closing+of+ the+wound+by+
stretching+ the+ surrounding+ skin.+ The+ second+ and+ later+ stage+ involves+
maintenance+ of+ tension+ in+ the+ cytoskeleton+ and+ this+ process+ results+ in+ the+
formation+of+scar+tissue+(Grinnell+1994).+The+in'vitro+collagen+lattice+model+can+
be+used+to+represent+both+stages.+Floating+gels+are+detached+from+the+plastic+




cells+ can+ form+ attachments+ between+ the+ gels,+ themselves+ and+ the+ plastic,+


















physical+ change+ in+diameter+of+ each+gel.+This+was+because+when+ the+gels+




SSc+ blister+ fluid+ promoted+ contraction+ of+ MSC+ collagen+ gel+ matrices+

































populated'gels'were' treated'with' serum' free'media,' 10%'serum,'SSc'blister' fluid' (SScBF'
1:125),'control'blister' fluid'(cBF'1:125)'or' IL31'(50'ng/ml)'with'or'without'Wortmannin'(100'
nM).'Wortmannin' was' added' 1' hour' prior' to' IL31' and' other' treatments.' SSc' blister' fluid'

























on+MSCs+ suspended+ in+ a+ collagen+ gel+ lattice,+ as+ does+ IL31.+ Potentially+ a+








addition+of+ treated+media.+The+positive+control+ in+ this+assay+was+TGFβ.+Not+
only+is+this+growth+factor+undoubtedly+associated+with+and+highly+involved+in+
SSc+pathology,+ it+ is+known+ to+effectively+ induce+cell+populated+collagen+gel+
contraction.+ The+media+ added+ to+ the+ gels+were+ treated+with+ TGFβ,+ SSc+ or+
healthy+ control+ blister+ fluid,+with+or+without+ the+ following+ inhibitors,+ 1D11,+a+
TGFβ+neutralising+antibody,+Wortmannin,+a+PI3K+inhibitor+or+U0126,+a+MAPK+
inhibitor.+Inhibitors+were+added+to+the+gels+one+hour+before+stimulating+ligands.+










contraction+ enough+ to+mimic+ serum+ free+ conditions.+ This+may+ suggest+ that+
there+is+no+one+individual+pathway+involved+in+MSC+migration+in+response+to+
SSc+ microenvironment+ conditions.+ While+ all+ three+ inhibitors,+ 1D11,+
Wortmannin+and+U0126,+caused+some+slight+but+noticeable+ inhibition+of+gel+
contraction,+none+significantly+inhibited+the+loss+of+gel+weight+caused+by+blister+
fluid.+ In+addition,+ no+one+ inhibitor+ seemed+ to+be+more+potent+ than+another.+
Serum+free+media,+as+the+negative+control+in+this+assay,+resulted+in+the+least+
contraction,+as+expected.+This+alone+shows+that+any+reduction+in+gel+weight+
was+a+direct+result+of+MSC+interaction+with+ factors+ in+ the+media.+When+SSc+
blister+fluid+was+inhibited+with+Wortmannin,+there+was+no+significant+inhibitory+
effect,+ however+ the+complete+opposite+was+ found+when+ inhibiting+ IL31+with+










Such+ results+ seem+ to+ hint+ at+ the+ possibility+ of+ multiple+ pathways+ working+
together+ synergistically+ such+ that+ inhibiting+ one+ makes+ no+ significant+

























































plus+ all+ three+ inhibitors+ together.+αASMA+RNA+expression+was+used+as+ the+







PI3K+ or+ MAPK+ pathways+ but+ does+ not+ account+ for+ migration+ stimulated+
irrespective+ of+ αASMA.+ This+ assay+ illustrates+ the+ extent+ of+ MSC+ to+
myofibroblast+ differentiation+promoted+by+SSc+blister+ fluid+ via+ the+ individual+
pathways.+
+
Illustrated+ in+ Figure+ 5.11,+ of+ all+ the+ treatments,+ the+ TGFβ+ positive+ control+
induced+the+most+(2+fold+increase)+αASMA+expression+(TGFβi+32.7i+serum+free+
controli+ 16.84i+ p<0.004),+ closely+ followed+ by+ SSc+ blister+ fluid+ (serum+ free+















gels+ shown+ in+ Figure+ 5.10.+ + Possible+ explanations+ include+ failure+ of+ the+












































were' treated'with' serum' free'media,'TGFβ' (4'ng/ml),'SSc'and'healthy' control' blister' fluid'






























































































































Considering+ the+ increased+IL31+ in+SSc+microenvironment,+ in+addition+ to+ the+
quicker+ response+of+SSc+ fibroblasts+ to+ IL31+ treatment+ in+ the+scratch+wound+
assay+in+Chapter+5.5.2,+the+amount+of+IL31RA+expression+was+assessed+on+




in+ IL31+ signal+ transduction,+ are+ receptive+ to+ the+ higher+ IL31+ levels+ in+ SSc.+
While+ oncostatin+ M+ is+ also+ a+ ligand+ for+ the+ IL31RAAoncostatin+ M+ receptor+
dimer,+ the+ binding+ affinity+ of+ IL31+ to+ the+ receptor+ is+ not+ dependent+ on+ its+
presence+and+as+such+oncostatin+M+was+not+assessed+in+these+studies.+qPCR+







media.+ Healthy+ control+ dermal+ and+ lung+ fibroblast+ IL31RA+ expression+ was+
significantly+ lower+ than+ their+ SSc+ counterparts+ (p=0.0148+ and+ p=0.0163+
respectively).+Both+SSc+ lung+and+dermal+ fibroblasts+expressed+ IL31RA+to+a+
similarly+ high+ level.+ Untreated+ healthy+ adiposeAderived+ MSCs+ expressed+
IL31RA+similar+to+SSc+fibroblasts.+Treating+these+MSCs+with+SSc+blister+fluid+
for+ 16+ hours+ induced+more+ IL31RA+ expression+ than+ untreated+MSCs,+ and+




in+ the+vicinity+of+ this+ increased+ IL31+would+express+higher+ levels+of+ IL31RA+
subunits+ on+ their+ cell+ membrane+ through+ a+ possible+ positive+ feedback+
response.+While+ macrophages+ and+ keratinocytes+ typically+ express+ IL31RA+


































The+ results+ from+ SSc+ dermal+ and+ lung+ fibroblasts+ compared+ to+ healthy+
fibroblasts+could+indicate+that+since+SSc+fibroblasts+were+previously+exposed+
to+SSc+microenvironment+conditions,+they+may+be+primed+to+express+IL31RA,+





to+ that+ of+SSc+ fibroblasts.+Exposing+MSCs+ to+SSc+or+ control+ blister+ fluid+ in+
culture+ did+ not+ affect+ IL31RA+expression+ significantly+ but+ did+ hint+ at+ higher+
expression+levels+in+response+to+SSc+blister+and+interestingly,+lower+levels+than+


































be+ involved+ in+ SSc+ blister+ fluid+ stimulated+ gel+ contraction,+ inhibition+ of+ its+
transport+into+MSCs+by+αCHCA+only+partially+reversed+the+contraction.+Like+in+
previous+ collagen+ gel+ contraction+ assays,+ SSc+ blister+ fluid+ samples+ were+
significantly+better+at+causing+MSC+migration+and+gel+contraction+than+healthy+
control+blister+fluid+(SSc+blister+fluidi+0.08+g,+healthy+control+blister+fluidi+0.16+











Tukey’s' Post' Hoc' test' was' conducted' to' find' statistical' significance' between' multiple'
















MSCs+ cultured+ as+monolayers+ in+ 24+ well+ plates+ were+ analysed+ for+αASMA+
expression+by+a+qPCR+assay.+After+16+hours+of+treatment,+RNA+was+extracted+
and+αASMA+RNA+in+the+lysates+was+compared+to+TBP+expression.+A+higher+αA
SMA+ expression+ level+ was+ used+ as+ a+ readout+ of+ MSC+ fibrogenic+ activity.+
Kottmann+et+al,+found+that+lactate+dehydrogenase,+the+enzyme+responsible+for+
pyruvate+to+lactate+metabolism,+is+an+important+mediator+in+activation+of+latent+
TGFβ.+ In+ turn,+ the+ anaerobic+ conditions+ of+ SSc,+ can+ explain+ the+ increased+
lactate+ concentration+ in+ SSc+ microenvironment.+ Increased+ lactate+ is+
responsible+for+a+general+decrease+in+pH+levels+and+acidosis.+It+has+been+found+
that+ TGFβ+ is+ activated+ from+ its+ latent+ form+ under+ acidic+ conditions+ and+ as+
hypothesised,+ the+ TGFβ+ is+ a+ major+ inducer+ of+ MSC+ differentiation+ into+
myofibroblasts.+Since+myofibroblasts+are+predominant+expressers+of+αASMA,+
it+ stands+ to+ reason+ that+ increased+ lactate+ concentration+ can+ increase+
differentiation+ and+ thereby+αASMA.+Adding+ to+ this,+ inhibition+ of+ the+ enzyme+
lactate+ dehydrogenase,+ by+ stopping+ pyruvate+ metabolism+ and+ lactate+
formation,+has+been+shown+to+inhibit+production+of+TGFβ+mediated+collagen+
type+I,+II+and+III+expression+as+well+as+αASMA+expression.+This+result+suggests+
using+Gossypol,+ the+ lactate+ dehydrogenase+ inhibitor,+ as+ a+ pharmacological+
therapy+for+fibrosis+(Kottmann+et+al.+2015).)This+experiment+attempted+to+see+






treatment+ (Figure+ 5.14).+ MSCs+ treated+ with+ 10%+ serum+ media+ expressed+
higher+ levels+of+αASMA+than+any+other+treatment.+Both+SSc+blister+ fluid+and+
lactate+ treatment+ resulted+ in+very+similar+ levels+of+αASMA+(p=0.9999)+which+
was+ significantly+ inhibited+ to+ levels+ below+ baseline+ by+ the+ addition+ of+ the+
lactateAprotein+ coAtransporter+ inhibitor+ αCHCA+ (p=0.0148+ and+ 0.0078+






















fluid' (SScBF,' cBF' 1:50)' with' or' without' αCHCA.' αCHCA' significantly' inhibits' αPSMA'
expression'in'response'to'lactate'(p=0.0079)'and'SSc'blister'fluid'(p=0.0148).'Healthy'control'
blister' fluid' did' not' affect'αPSMA' ' (p=0.9999).' All' lactate' and' blister' fluid' treatments'were'






















blister+ fluid+ treatment+of+MSCs,+but+ like+ IL31,+does+not+seem+to+be+ the+only+
factor.+ While+ inhibiting+ lactate+ transport+ significantly+ affected+ αASMA+
expression,+in+monolayer+cultures+of+MSCs,+it+did+not+fully+inhibit+the+MSC+gel+









form+of+MSC+activation,+migration+ or+ collagen+gel+ contraction,+ and+ both,+ to+
some+extent+resulted+ in+ increased+αASMA+expression.+For+ this+reason,+ their+


























OnePway' ANOVA' with' Tukey’s' post' hoc' measured' significance' of' p<0.05.' The' only'








































cytokines+ present+ in+ blister+ fluid+ at+ picogram/ml+ concentrations,+ such+ high+
dilution+ factors,+ like+ 1:125+ (used+ in+ the+ majority+ of+ experiments),+ make+ it+
unlikely+that+the+culprit+responsible+for+the+differing+actions+of+SSc+and+healthy+
control+blister+fluid+is+a+simple+protein+factor+present+at+slightly+higher+levels+in+














by+ their+ preAexposure+ to+ increased+ IL31+ in' situ.' More+ interesting+ is+ the+
increased+receptor+expression+on+healthy+adiposeAderived+MSCs+that+have+not+
been+ exposed+ to+ SSc+ microenvironments.+ This+ indicates+ that+ MSCs+
themselves+ are+ ready+ to+ respond+ to+ increases+ in+ IL31+ and+ explains+ their+
migration+across+a+scratch+when+treated+with+IL31.+Furthermore,+encouraging+




not+wholly+ responsible+ for+ fibroblast+ and+MSC+migration,+ its+ role+ cannot+ be+
overlooked.+This+particularly+resonates+since+MSC+migration+across+a+scratch+





migrate+ in+collagen+gels+and+with+ them,+pull+collagen+ fibres,+ resulting+ in+gel+
contraction.+Reflective+ of+ the+models+ of+ interaction+ explained+ thus+ far,+ SSc+
blister+fluid+was+responsible+for+the+highest+degree+of+gel+contraction+observed,+
measured+by+loss+of+gel+weight.+Again,+although+IL31+has+some+effect,+this+is+
more+akin+ to+ that+of+healthy+control+blister+ fluid+and,+ therefore,+ it+ cannot+be+
deemed+as+ the+defining+ factor+differing+ the+ functions+of+ the+ two+blister+ fluid+
derivations,+ even+ though,+ treatment+with+ the+PI3K+ inhibitor+Wortmannin+did+
reduce+gel+contraction.+Since+TGFβ+is+known+to+influence+fibroblast+ability+to+
contract+ collagen+ gels,+ this+ was+ used+ as+ a+ positive+ control+ on+ MSC+ gel+
contraction.+TGFβ+did+ indeed+result+ in+high+levels+of+gel+contraction,+closely+




to+ TGFβ,+ likewise,+ inhibiting+ PI3K+ and+ MAPK+ by+Wortmannin+ and+ U0126,+
respectively,+ had+ only+ modest+ effects+ on+ inhibition+ of+ IL31+ induced+ gel+
contraction.+As+such,+it+can+be+concluded+that+either+these+three+pathways+play+





was+ used+ as+ the+ measure+ of+ MSC+ activation+ in+ this+ assay.+ Like+ with+ gel+
contraction,+ blister+ fluid+ mediated+ MSC+ αASMA+ expression+ was+ not+ highly+
inhibited+by+the+use+of+the+inhibitors,+either+alone+or+simultaneously.+From+this,+










by+ anaerobic+ glycolysis.+ The+ increase+ in+ lactate+ found+ in+ SSc+ blister+ fluid+
indicates+a+higher+rate+of+production+than+removal+in+SSc+patients.+This+could+
be+ due+ to+ the+ reduced+ oxidative+ capacity+ of+ the+ cells+ in+ these+ ischaemic+
regions.+ Lactate+ is+ reported+ to+ affect+ cell+migration+ and+ invasion+ in+ cancer+
(Valvona+ et+ al.+ 2016).+ The+ increased+ lactate+ and+ decreased+ pH+ of+ the+
microenvironment+ activate+ metalloproteinases,+ which+ in+ turn+ affect+
extracellular+ matrix+ turnover+ and+ degradation.+ This+ remodelling+ of+ the+





SSc+ microenvironment+ is+ known+ to+ be+ hypoxic,+ and+ therefore,+ it+ is+ not+
surprising+ that+ SSc+ blister+ fluid+ contains+ more+ lactate+ than+ healthy+ control+
blister+ fluid.+Lactate+alone+however,+ like+IL31,+does+not+ fully+account+ for+ the+
MSCs+ responses+ to+ SSc+ blister+ fluid+ since+ gel+ contraction+ in+ response+ to+
lactate+was+ less+ than+ that+of+SSc+blister+ fluid.+On+ the+other+hand,+ inhibiting+
lactate+transport+in+MSCs+using+αCHCA+significantly+reversed+gel+contraction+
and+αASMA+expression+as+a+ result+of+SSc+blister+ fluid.+This+ inhibitor+blocks+
lactate+transport+both+into+and+out+of+cells.+Since+the+inhibitor+seems+to+have+
the+highest+effect+on+SSc+blister+ fluid+ treated+cells+ it+can+be+concluded+ that+
lactate+ in+blister+ fluid+ + is+partially+ responsible+ for+both+migration+and+αASMA+
expression+of+MSCs+to+a+some+extent,+similar+to+that+of+IL31.+Following+on+from+
this,+ it+ was+ thought+ that+ IL31+ and+ lactate+ could+ be+ working+ together+ in+ an+

































the+ conclusion+ that+ under+ these+ SSc+ mimicking+ conditions,+ MSCs+ fully+







is+considerably+ faster+ than+ the+use+of+microarrays+and+allows+more+precise+
quantification+of+RNA+expression.+RNAseq+can+elucidate+both+coding+and+nonA
coding+regions+of+RNA+and+takes+into+consideration+splicing+and+some+postA
transcriptional+ modifications.+ But,+ the+ main+ benefit+ RNAseq+ has+ over+
microarrays+is+that+there+is+no+need+to+have+a+preAconceived+notion+of+potential+







single+ stranded+ and+ the+molecules+ are+ then+ aligned+ to+ a+ reference+ human+








This+ Chapter+ hypothesises+ that+ SSc+ blister+ fluid+ will+ have+ a+ differential+
expression+effect+on+MSCs+and+fibroblasts+compared+to+healthy+control+blister+





2)+ To+ use+ Ingenuity+ Pathway+ Analysis+ (IPA)+ to+ contextualise+ and+
biologically+ predict+ functions+ and+ pathways+ causing+ the+ differential+
expression.++





base+pair+ paired+end+strands+measuring+15+million+ reads+per+ sample.+The+
study+ was+ separated+ into+ two+ groups,+ one+ using+ healthy+ control+ dermal+
fibroblasts,+and+ the+other,+adiposeAderived+MSCs,+ in+order+ to+ compare+ the+
patterns+of+gene+expression+in+SSc+environment+activated+MSCs+with+those+
induced+ in+ fibroblasts.+ Both+ groups+were+ treated+ identically+with+ the+ same+
number+of+replicates+as+followsi+0.2%+serum+as+control,+SSc+or+healthy+control+
blister+fluid+diluted+1:125,+or+IL31+(50+ng/ml).+As+with+other+blister+fluid+assays,+
a+ different+ blister+ fluid+ sample+was+ used+ for+ each+ of+ the+ four+ replicates+ to+
account+for+the+inherent+range+in+blister+fluid+constituents.+The+RNAseq+was+
conducted+in+collaboration+with+UCL+Genomics.+Both+fibroblasts+and+MSCs+
were+ used+ to+ attempt+ to+ determine+ how+ much+ an+ effect+ was+ due+ to+ the+
microenvironment,+ and+ how+ much+ due+ to+ intrinsic+ nature+ of+ the+ cells+












αPSMA),' activated+ leukocyte+ cell+ adhesion+ molecule' (ALCAM),+ alkaline+
phosphatase' (ALPL),' cell+ migration+ inducing+ hyalaronan+ protein' (CEMIP),'
collagen+ type+ I+α1' (COL1A1),'collagen+ type+ IIIα1' (COL3A1),'collagen+ type+
IVα1' (COL4A1),' connective+ tissue+ growth+ factor' (CTGF),' endoglin' (ENG),'
fibronectin+1' (FN1),'glioma+associated+oncogene' (GLI1),' insulinAlike+growth+
factor+ binding+ protein+ 5' (IGFBP5),' interleukin+ 31' (IL31),' interleukin+ 31+
Receptor+ A' (IL31RA),' interleukin+ 6' (IL6),' 5’+ nucleotidaseAecto' (NT5E,' or'
CD73),' runt+ related+ transcription+ factor+ 2' (RUNX2),' signal+ transducer+ and+
activator+ of+ transcription+ 4' (STAT4),+ transforming+ growth+ factor+β' (TGFβ1),'
transforming+growth+factor+β+Receptor+1'(TGFβR1)''and''thymus+cell+antigen+
1'(THY1).'In+fact,+surprisingly,+when+constructing+a+heatmap+without+actively+











from+blue+ through+yellow+ to+ red,+with+dark+blue+being+ the+ least+differentially+
expressed,+ getting+ lighter+ into+ yellow,+ through+ increased+ expression+
151"
"
represented+ by+ orange,+ gradually+ getting+ darker+ to+ red,+ indicating+ positive+
upregulation.++
+









within+ the+MSC+ samples,+ for+ the+most+ part,+ the+ differently+ treated+ samples+
cluster+ together,+ such+ that+ all+ SSc+ blister+ fluid+ treated+ MSC+ samples+ are+
clustered+ beside+ each+other,+ and+most+ of+ the+ IL31+ treated+ samples+ cluster+
































or+CTGF.+NT5E' is+a+gene+relating+ to+ the+pluripotency+of+MSCs.+SSc+blister+
fluid+ treated+ MSCs+ express+ less+ of+ this+ gene+ than+ the+ other+ treatments,+
possibly+ indicating+ SSc+ blister+ fluid+ induced+ differentiation+ of+ MSCs+ into+
myofibroblasts,+considering+increased+αASMA+expression.+ALCAM+is+a+gene+
involved+in+cellular+adhesion,+particularly+during+migration.+Under+blister+fluid+
conditions,+ expression+ of+ this+ gene+ is+ upregulated+ compared+ with+ control+
media+and+IL31+treatments.+This+also+is+reflective+of+the+scratch+wound+assays+
described+ in+ Chapter+ 5.5.3.+ + IL31RA' gene' expression+ was+ only+ slightly+
increased+ in+ response+ to+ IL31+ treatment,+ most+ likely+ through+ a+ positive+
feedback+mechanism,+ and+ unlike+ in+ the+ qPCR+assay+ for+ IL31RA,+ (Chapter+
5.6.3),+blister+fluid+had+no+noticeable+effect+on'IL31RA'expression.+There+was+
no+ noticeable+ difference+ between+ all+ treatments+ on+TGFβ' or+TGFβR+ gene+
expression.+'A+reduction+in+THY1+expression+has+been+shown+to+be+indicative+
of+ MSC+ differentiation,+ in+ this+ assay+ however,+ this+ was+ not+ the+ case,+ and+
expression+of+this+gene+was+not+different+across+all+treatments+(Moraes+et+al.+
2016).+ Likewise,+ fibronectin+was+ not+ upregulated+ by+ any+ of+ the+ treatments,+
since+ fibronectin+ is+ involved+ in+ cell+migration,+ it+ can+ be+ concluded+ that+ the+
migration+observed+under+blister+fluid+conditions+in+the+scratch+wound+assays+
is+not+due+to+an+ increase+ in+ fibronectin+expression.+Although+the+JAK/STAT+













































and' dermal' fibroblasts' treated' with' SSc'







fluid% and% IL31% was% diluted% in% 0.2%% serum%media.% Candidate%
gene% (right)% expression% analysed% for% each% sample.% Samples%
clustered%hierarchically%by%similarity%candidate%genes%were%The%
genes% chosen% were% aggrecan% (ACAN),% actin% α72% (ACTA2,%
otherwise%known%as%α7SMA),%activated%leukocyte%cell%adhesion%
molecule% (ALCAM),% alkaline% phosphatase% (ALPL),% cell%
migration%inducing%hyalaronan%protein%(CEMIP),%collagen%type%
Iα1% (COL1A1),% collagen% type% IIIα1% (COL3A1),% collagen% type%
IVα1% (COL4A1),% connective% tissue% growth% factor% (CTGF),%
endoglin% (ENG),% fibronectin% 1% (FN1),% glioma% associated%
oncogene% (GLI1),% insulin7like% growth% factor% binding% protein% 5%
(IGFBP5),% interleukin% 31% (IL31),% interleukin% 31% Receptor% A%
(IL31RA),% interleukin% 6% (IL6),% 5’% nucleotidase7ecto% (NT5E,% or%
CD73),% runt% related% transcription% factor% 2% (RUNX2),% signal%
transducer% and% activator% of% transcription% 4% (STAT4),%


















from& the& heatmap& (Figure& 6.1),& dermal& fibroblasts& cannot& be& considered&
unresponsive&to&SSc&blister&fluid.&Genes&upregulated&by&SSc&blister&fluid&are&
summarised&in&Figure&6.2.&Although&dermal&fibroblasts&express&some&αMSMA,&
their& levels& are& thought& to& be& lower& than& myofibroblast& expression& levels.&
Bearing&this&in&mind,&treating&fibroblasts&with&blister&fluid&increased&expression&
of& the& ACTA2& gene& encoding& αMSMA.& Since& fibroblasts& are& terminally&










this& is& reflective& in& the& countplot& of& this& gene.& SSc& blister& fluid& induces&
























fluid& is& not& due& to& its& elevated& IL31& levels.&This& is& further& confirmed&by& the&
similar&expression&of&IL6&in&response&to&healthy&control&blister&fluid,&which&was&






















p=0.0169,+ respectively).+ CEMIP+ expression+ is+ increased+ by+ SSc+ blister+ fluid+ (p=0.0014)+
compared+ to+ control+ media+ and+ IL31+ (p=0.0018).+ No+ difference+ between+ expression+ in+
response+ to+control+ blister+ fluid+ compared+with+control+media+but+p=0.0012+ compared+with+
IL31+treatment.+FBN2+expression+increased+in+response+to+SSc+blister+fluid+(p=0.0001).+IL6+









































(Chapter& 5.2),& fibroblasts& are& only& minimally& induced& to& express& CTGF& or&
collagen& type& I& in& response& to&SSc&blister& fluid.&Since& the&same& results&are&
seen& in&both& cell& types,& it& can&be&concluded& that&SSc&blister& fluid&does&not&
contain&appropriate&stimuli& for& these&proteins& to&be&expressed&regardless&of&





is+not+affect+by+any+ treatment.+ collagen+ type+ I+ (COL1A1)+expression+ is+ reduced+by+ IL31+ in+
comparison+ to+ SSc+ blister+ fluid+ (SScBF+ p=0.0254)+ and+ healthy+ control+ blister+ fluid+ (cBF+












which& is& an& inflammatory& cytokine& produced& by& CD8Mpostive& TMcells,&
associated&with&SSc&fibrosis.&Moreover,&it&has&been&documented&that&the&level&
of&serum&IL13&correlates&positively&with&degree&of&fibrosis&severity&(Fuschiotti&
et& al.& 2013).& IL31& treatment& of& dermal& fibroblasts& increased& expressed& of&
IL13RA2&significantly&higher&than&control&media&or&blister&fluid&treatments.&As&






led& to& an& increase& in& IL6& production& indicating& that& ANXA1& inhibits& IL6&
production& (Jia& et& al.& 2013).& IL31& treatment&was& found& to& increase&ANXA1&
expression&(Figure&6.5).&This&expression&may&explain&the&reduced&IL6&levels&
found&in&response&to&IL31&illustrated&in&Figure&6.5.&ANXA1&is&also&involved&in&








2008).! Similarly,& to& CXCL5,& IL33& expression& was& only& induced& by& IL31&
treatment.&Neither&SSc&nor&healthy&control&blister&fluid&had&any&effect&on&IL33&
expression&in&comparison&to&each&or&to&control&media.&IL33&has&been&found&to&
be& expressed& in& both& dermal& and& lung& fibroblasts& in& SSc& and& has& been&
hypothesised& to&be& involved& in&early&endothelial&cell&activation&and&damage&
161#
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expression+ was+ only+ increased+ by+ IL31,+ significantly+ more+ than+ levels+ found+ after+ DMEM+
(p=0.0284)+ SScBF+ (0.0001)+ and+ cBF+ (3.48x10R5)+ treatments.+ CXCL5+ expression+ was+









Together& these& results& show& how& specific& SSc& microenvironments& affect&
dermal&fibroblast&expression.&The&main&finding&from&this&assay&was&the&lack&of&
significance&found&in&the&different&expression&between&SSc&and&healthy&control&
blister& fluid.&While&αRSMA& and&CEMIP& expression&hinted&at&being&higher& in&





fibroblasts& is& through& the& collective& effect& of& soluble& factors& together& with&




with&SSc& blister& fluid.& As& observed& in& the& heatmap,&MSCs& respond& to&SSc&




























































Figure' 6.6' SSc' blister' fluid' increases' expression' of' ACTA2,' CEMIP,' CSRP2,' CTGF,'




and+ IL31+ (p=2.23x10R89+ and+ p=0.02203).+ SScBF+ induces+ more+ CSRP2+ than+ DMEM+
(p=1.97x10R34),+cBF+(p=0.00324)+and+IL31+(p=7.39x10R34).+SSc+blister+fluid+is+responsible+for+
increased+expression+of+CTGF+compared+with+DMEM+(p=4.07x10R9)+and+IL31+(p=0.002604).+
cBF+ also+ induced+ CTGF+ expression+ higher+ than+ baseline+ (p=0.000188).+ No+ significant+
difference+was+seen+in+CTGF+expression+between+SScBF+and+cBF+(p=0.385).+cBF+induced+
ALCAM+ more+ than+ DMEM+ (p=5.08x10R8),+ SScBF+ (p=0.000595)+ and+ IL31+ (p=4.08x10R23).+
SScBF+stimulates+ALCAM+expression+more+than+DMEM+(p=5.08x10R8)+and+IL31+(p=4.46x10R
7).+Collagen+ type+1a1+ (COL1a1),+ is+stimulated+by+SScBF+only+ (p=0.0302).+Il6+expression+ is+


















As& seen& in& dermal& fibroblasts,& SSc& blister& induced& expression& of& CEMIP+
(Figure&6.6),& the&protein& involved& in&cell&migration,&however,&contrary& to& the&
effects&on&fibroblasts,&healthy&control&blister&fluid&also&induced&a&very&similar&
amount.&As&such,&it&is&difficult&to&conclude&an&SSc&blister&fluid&specific&protein&
responsible& for& this.&One& explanation& is& a& common& factor& in& both&SSc& and&




As& with& dermal& fibroblasts,& MSCs& responded& to& blister& fluid& by& stimulating&
expression&of&IL6.&Intriguingly&in&MSCs,&healthy&control&blister&fluid&had&more&
of&an&effect&on& IL6&expression.&With& inflammation&and& fibrosis&being&almost&
oppositely& occurring& phenomena,& one& theory& is& that& SSc& blister& fluid& could&
contain&factors&more&conducive&to&inducing&fibrogenic&responses&whereas&the&
act&of&taking&blister&fluid&from&healthy&individuals&itself&is&causation&of&a&wound&


















also& shown& in& the& RNA& sequencing& data& with& SSc& blister& fluid& inducing&
expression&of&CTGF&more&than&any&other&treatments&and&significantly&higher&
than&control&media&and&IL31&(p=4.47x10M9&and&p=0.0076&respectively)&(Figure&
6.6).& Since& CTGF& can& be& induced& by& PDGF& and& considering& PDGF& is&









ALCAM& is&a&cell&adhesion&gene&expressed&on&stromal&pluripotent&cells.& It& is&
also&known&as&CD166&(Kim&et&al.&2017).&The&pattern&of&differential&expression&
of&ALCAM& is&strange.&While&control&media&and& IL31& treated&MSCs&express&
similar& low& levels&of&ALCAM,&blister& fluid& treatment&significantly&upregulated&
the&expression,&particularly&healthy&control&blister&fluid&which&is&a&better&inducer&
of&ALCAM&than&SSc&blister&fluid&(p=0.000595)&(Figure&6.6).&ALCAM&positive&
cells& have& been& found& to& have& a& lower& proliferative& capacity& than& ALCAM&
negative&cells,&and&are&also&more&committed& to& the&myofibroblastic& lineage.&
This& finding&goes&against& the& theory& that&SSc&blister& fluid&primes&MSCs& for&
myofibroblast&commitment&more&than&healthy&control&blister&fluid.&Furthermore,&
ALCAM&positive&stromal&cells&are& less&able& to& function&as&epithelial&support&
cells& than& ALCAM& negative& cells.& In& the& case& of& SSc& this& could& be&MSCs&








increased&COL1A1&expression& in& response& to&SSc&blister& fluid& (Figure&6.6).&
This&was& significantly& higher& than&baseline&expression&under& control&media&
conditions&(p=0.0302),&but&was&not&supportive&of&MSCs&being&the&sole&or&main&








IL31& than&SSc&blister& fluid,&was&better&at& inducing& IL6&expression&of&MSCs.&
Whilst& in& fibroblasts,& both& derivations& of& blister& fluid& are& equally& good& at&

























TGFβ& is& typically& found& associated& with& LAP& on& its& CMterminus,& making& it&





fluid.& Other& studies& in& this& thesis& (Chapter& 5.6.2)& have& shown& that& TGFβ&
treatment& significantly& affects& MSC& migration,& contraction& and& αMSMA&
expression.&However,& in& future&studies& it&would&be&useful& to&assay& free&and&
total&TGFβ&in&the&blister&fluid&samples.!
!
NT5E& is& a& marker& of& MSCs& and& is& also& known& as& CD73.& MSCs& are& not&
considered&to&be&MSCs&without&surface&expression&of&this&marker.&As&such,&
theoretically,&inhibition&of&this&protein&is&indicative&of&MSCs&losing&their&MSCM
like& phenotype,& and& possibly& differentiating.& Interestingly,& polymorphisms&













discourages& renewal& of& vasculature.& Further,& this& is& not& affected& by& IL31,&
indicating&that&while&IL31&is&an&important&part&of&the&SSc&microenvironment,&it&
is& by& no& means& the& sole& culprit& of& SSc& microenvironment& pathogenicity.&
169#
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Calcinosis& is& prevalent& in& SSc& and& is& a& result& of& increased& osteogenic&
differentiation.& Contradictory& to& this& finding,& VEGFC& induces& MSC&
differentiation&into&osteoblasts&(Murakami&et&al.&2017).&This&can&be&explained&
by&the&possibility&that&MSCs&have&to&commit&to&either&a&proMosteogenic&or&proM














Pathway& analysis& was& performed& using& Ingenuity& Pathway& Analysis& (IPA)&
software& to& highlight& predicted& pathways& involved,& in& the& context& of& their&
physiological& significance.& This& software& uses& the& differentially& expressed&
genes& from& the& RNAseq& data,& inputted& as& FASTQ& files,& and& with& its& own&




predictions& are& based& on& existing& literature& and& experimental& data.& For& the&




comparisons& were& chosen& to& elucidate& the& specific& effects& of& IL31& on&
fibroblasts,&and&compare&it&to&the&effects&of&SSc&blister&fluid&on&MSCs.&Then&to&





how& well& the& RNAseq& data& fits& into& said& pathways.& Both& upregulated& and&
downregulated& pathways& can& be& detected& as& well& as& the& percentage& of&
overlap,& depicting& how& many& differentially& expressed& genes& overlap& with&
known& genes& of& the& canonical& pathway.& Significance& is& calculated& by& the&
software&as&–Log&(pMvalue),&and&as&such,&all&values&above&1.3&are&significant,&
indicating&p<0.05.&ZMscores&are&computed&by& the&software& representing& the&
























































Supportive$ of$ MSC$ differentiation$ in$ SSc$ microenvironments,$ the$ NANOG$
pathway$ is$ both$ significantly$ involved,$ and$ significantly$ deactivated$ (Figure$
6.9).$ NANOG$ is$ associated$with$ pluripotency$ of$mammalian$ cells,$ thus,$ its$






and$ in# vitro$ adipogenic$ differentiation$ assays$ suggest$ inhibition$ of$




















as& nodes,& linked& together& based& on& biological& connectivity.& A& score& is&
algorithmically& computed& for& each&network&based&on& the&number&of& nodes,&




fluid.&The& intensity&of& the&colour&of&each&node& is&a& representation&of& the&ZD
score,& i.e.& the& directionality& of& the& connection,& and& how& significant& it& is.&
Uncoloured,& grey& nodes& are& of& molecules& that& were& not& found& to& be&
differentially&expressed&in&the&original&RNAseq&dataset&and&have&been&filled&in&
by&the&software&to&complete&the&network.&The&shapes&of&the&nodes&represent&




comparing& expression& of& 0.2%& serum& and& SSc& blister& fluid& treated& MSCs.&
Figure&6.10A&is&a&network&predicted&to&be&involved&in&connective&tissue&and&
organismal&injury,&and&cell&morphology,&with&a&high&score&of&37,&consisting&of&
33& focus& nodes.& It& is& centralised& around& the& growth& factor& ERBB2.& Other&
factors&of&relevance&to&the&finding&of&SSc&blister&fluid&induced&cell&migration&are&
Rho& GTPases,& also& highlighted& in& this& network.& Furthermore,& osteogenic&
differentiation& associated& genes& fit& into& this& network& such& as&TWIST2.'The&

















































IPA& has& the& useful& ability& to& predict& upstream& regulators& that& explain& the&











TGFβ& was& measured& to& be& an& upstream& regulator& of& over& 100& of& the&
differentially& expressed& genes& analysed.& These& include& ACTA2,' ACAN,&
collagen&genes,&Rho&GTPases,&TWIST&genes,&NT5E,'IL6&and&TGFβ&receptors&
where&p=8.62x10D30&and&Z=D0.372.&The&negative&ZDscore&indicates&activation&








PPARG' was& found& to& be& a& statistically& significant& upstream& regulator& of&
ACTA2&and&COL1A1'(p=0.00000105&and&Z=1.269)&with&the&directionality&of&
this& regulation&predicted& to&be& inhibitory.&PPARG& is&a&gene& that&encodes&a&


















than&SSc&blister& fluid& treatment& (See&Figure&6.1,&6.6&and&6.11),&SSc&blister&
fluid&does& induce& IL6&but&not&as&much&as&healthy&control& blister& fluid.&This&
pathway& is& thought& to&be& responsible& for& the& shift& from&acute& inflammation&























































Fitting& these& pathways& into& biological& significance& shows& that& most& of& the&
involved& functions& that& differ& between& the& two& conditions& relate& to&




SSc& blister& fluid& include& differentiation& and& proliferation& of& multilineage&
progenitor&cells,& fibrosis&and&wound&healing.&All& three&functions&support& the&
hypothesis&of&this&thesis,&that&SSc&blister&fluid&induces&MSCs&to&differentiate&
into&proGfibrotic&wound&healing&cells.&Furthermore,&the&functions&found&to&be&
deactivated&by&SSc&blister& fluid& included&proliferation&of&endothelial&cells.& If&






when& comparing& the& effects& of& SSc& blister& fluid& with& 0.2%& serum,& the&
oestrogen&receptor&was&measured&to&be&a&significant&upstream&regulator&of&
SSc&blister& fluid& induced&pathways.&With&a&high&ZGscore&of&2.534& indicating&


















Categories Diseases&or&Functions&Annotation p5Value Z5score #&Molecules
Cellular'Development differentiation'of'cells 5.89E913 3.169 81
Cellular'Growth'and'Proliferation,'Organismal'Development proliferation'of'multilineage'progenitor'cells 1.28E907 0.838 9
Organismal'Injury'and'Abnormalities,'Tissue'Morphology healing'of'wound 2.22E907 1.254 13
Organismal'Injury'and'Abnormalities Fibrosis 1.03E908 0.092 29
Cell'Death'and'Survival necrosis 5.62E914 0.57 93
Cellular'Growth'and'Proliferation cell'proliferation'of'vascular'endothelial'cells 6.74E907 90.633 11
Embryonic'Development,'Organismal'Development development'of'body'axis 7.16E907 90.373 40
Organismal'Development formation'of'vessel 7.25E907 90.786 11
Cell9To9Cell'Signaling'and'Interaction,'Hematological'System activation'of'blood'cells 7.27E907 92.047 27
Hematological'System'Development'and'Function,'Tissue'Morphology quantity'of'blood'cells 7.54E907 91.756 39
Cardiovascular'System'Development'and'Function,'Organismal'Development angiogenesis 1.53E916 92.465 52
Cardiovascular'System'Development'and'Function,'Organismal'Development vasculogenesis 1.88E915 92.615 45
Cardiovascular'System'Development'and'Function development'of'vasculature 1.83E914 92.464 53
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In# order# to# draw# comparisons# with# the# effects# induced# in# MSCs# by# SSc#
microenvironment# factors,# and# test# the# theory# that#MSCs# differentiate# into#
fibroblast;like#cells,#an#IPA#analysis#was#conducted#comparing#the#differential#
expression# effects# of# 0.2%# serum# and# IL31# on# healthy# dermal# fibroblasts#
(Figure#6.12).#The#most#significantly#activated#pathways#in#response#to#IL31#
are# integrin,# PI3K# and# IL8# pathways.# These# are# pathways# commonly#
associated#with# inflammation.# Interestingly# the#PTEN# pathway# is# inhibited,#
since#PTEN#itself# is#an# inhibitor#of#PI3K#pathway,# the#upregulation#of#PI3K#
stimulation# in# response# to# IL31#may#be# through# inhibition#of# its# inhibitor.# In#
addition# to# these# inflammatory# processes,# IL31# also# seems# to# trigger# pro;
fibrotic#processes#through#TGFβ#signalling#and#cell#migration#through#RhoA#
signalling.# The# regulation# of# actin# based# motility# by# RhoA# explains# the#





































Analysing) disease) and) function) of) the) differential) pathways) highlighted) the)
effect)of) lactic)acid)production)(Table)6.3).) IL31) induces)production)of) lactic)
acid,)a)molecule)increased)in)SSc)due)to)hypoxic)conditions.)IL31)was)also)
responsible) for) inducing) pathways) in) dermal) fibroblasts) predicted) to) be)




in) only) SSc) skin) biopsies.) On) the) other) hand,) reflective) of) the) loss) of)










Networks) created) from) the) differentially) expressed) gene) profile) of) dermal)
fibroblasts) highlighted) two) main) genetic) networks,) inflammatory) response,)
cellItoIcell) signaling) and) interaction,) and) cell) movement) in) cellular)
development,) shown) in) Figure) 6.13.) Genes) involved) in) the) inflammation)
network)(Figure)6.13A))revolve)around)IL6)as)a)central)node.)IL31)is)part)of)
the) IL6) family)and,) therefore,)would)be)expected) to)activate) related)genes.)
Genes) involved) in)cell)movement) (Figure)6.13B))on) the)other)hand) include)
ANXA,)CXCL1)and)dynein)related)genes.)These)centre)around)ERK1/2,)one)
of)the)targets)of)U0126)inhibition)used)in)the)scratch)wound)assays.)Both)of)
these) networks) confirm) the) IL6Ilike) and) migratory) inductions) of) IL31)
Categories Diseases+or+Functions+Annotation p2Value Z2score #molecules
Carbohydrate+Metabolism,+Small+Molecule+Biochemistry production+of+lactic+acid 0.00368 >2.021 5
Cellular+Growth+and+Proliferation proliferation+of+cells 4.50E>13 >1.589 200
Cell+Morphology mineralization+of+connective+tissue+cells 0.000473 >1.358 5
Cell+Death+and+Survival apoptosis+of+fibroblast+cell+lines 0.000175 >1.219 23
Cell+Death+and+Survival,+Organismal+Injury+and+Abnormalities cell+death+of+endothelial+cells 0.00612 >0.904 11
Cellular+Development,+Connective+Tissue+Development+ differentiation+of+fibroblast+cell+lines 0.00419 >0.73 12
Cell+Death+and+Survival apoptosis+of+fibroblasts 0.000117 >0.694 17
Cardiovascular+System+Development+and+Function, angiogenesis 6.71E>05 0.085 52
Cardiovascular+System+Development+and+Function development+of+vasculature 6.12E>06 0.106 62

































focus) molecules) (A).) Genes) involved) in) cellular) movement,) score) of) 33) with) 26) focus)
molecules)(B).)Nodes)in)green)are)activated)by)IL31.)Red)nodes)are)of)genes)deactivated)by)























6.5" Investigating" adipogenic" differentiation" in" response" to" SSc"
microenvironments"
In) SSc,) a) common) feature) observed) is) the) loss) of) subcutaneous) fat)
(Bogatkevich) 2015).) It) can) be) stipulated) that) the) MSCs) that) reside) in)
subcutaneous) adipose) tissue,) instead) of) being) recruited) for) adipocyte)
regeneration) and) renewal,) are) otherwise) occupied) in) wound) healing) and)





insulin,) indomethacin) and) IBMX) (inhibitor) of) cyclic) nucleotide)
phosphodiesterases))levels.)As)a)control,)MSCs)were)also)cultured)in)DMEM)
supplemented) with) 10%) serum.) Adipogenic) induction) media) was)
supplemented)with)either)SSc)blister) fluid)or)healthy)control)blister) fluid.)To)
account)for)differences)between)individuals,)a)different)sample)of)blister)fluid)








clear) that) even) from) as) early) as) day) 4,) there) are) some) phenotypic)
morphological) changes) seen) as) a) result) of) culturing) in) adipogenic) media,)
whereas,) the) cells) cultured) in) 10%) serum) remained) fibroblastIlike) in)
morphology.)MSCs)in)adipogenic)media)became)more)rounded)in)shape)with)
fewer)elongated)projections)(Figure)6.14).)By)day)10)the)differences)between)
DMEM) treated) and) adipogenic) induction) media) treated) MSCs) was) stark)

























































only) adipocytes) absorb) the) stain) where) measurement) of) the) amount) of)
absorbed)stain)is)a)measure)of)adipocyte)presence.)The)stain)is)itself)red)and,)









SSc) blister) fluid) partially) inhibited) the) adipogenic) differentiation) induced) by)














































The) most) striking) result) from) the) RNAseq) assay) was) the) difference) in)
expression) profile) between) fibroblasts) and) MSCs) treated) identically.)
Expanding)this,)MSCs)had)more)distinct)responses)to)SSc)blister) fluid)than)
dermal)fibroblasts.)This)alone)suggests)that)factors)of)SSc)blister)fluid)act)on)














on) fibroblasts.)On) the)contrary,) in)MSCs,)SSc)blister) fluid) induced)CSPR1,)










and) differentiate.) Furthermore,) physiologically,) MSCs) express) VEGF)
molecules) as) part) of) their) role) in) endothelial) and) vascular) homeostasis.)
Expression) of) VEGFC) is) significantly) decreased) by) SSc) blister) fluid)
highlighting) the) importance) of) MSCs) in) the) early) SSc) event) of) vascular)
damage.)IPA)pathway)analysis)illustrated)the)complexity)of)gene)expression)
in)response)to)SSc)microenvironments)and)generated)both)existing)and)novel)











Aside) from) the) role) of) MSCs) in) migration) and) protein/RNA) expression) as)
explained) in) this)Chapter,) the)main) role) of)MSCs)as)pluripotent) stem)cells)










































further)stiffness,) leading)to)a)continuing)cycle.) In)order) for) this)cycle) to)ring)
true,)the)MSCs)must)have)a)way)of)sensing)the)stiffness)of)their)surroundings)
in) order) to) be) induced) to) differentiate.) This) sensing) is) thought) to) occur) by)
MRTFA.)As)described)in)Chapter)1,)MRTFA)is)a)transcription)factor,)usually)
sequestered) in) the)cytoplasm,)where)upon) integrin)mediated)adhesion)and)
downstream) Rho) signalling) in) response) to) extracellular) matrix) stiffness,) it)











MRTFA) expression) has) been) investigated) in) the) context) of) SSc) and) is) a)
mediator)of)TGFβIinduced)myofibroblast)differentiation.)MRTFA)expression)in)
myofibroblasts)resulted)in)increased)αISMA)expression)even)in)the)absence)
of) TGFβ) and) when) knocking) down)MRTFA,) TGFβ) mediated)myofibroblast)
function) was) decreased,) measured) by) a) decrease) in) αISMA) expression.)
Further,)even)under)TGFβ)conditions,)a)lack)of)MRTFA)resulted)in)decreased)
focal) adhesion) and) contractile) force) generation) (Crider) et) al.) 2011).)









higher) levels) in) SSc) fibroblasts) than) healthy) fibroblasts) indicating) a) higher)
baseline) levels) of) nuclear) accumulation) in) SSc,) explaining) the) elevated)αI
SMA.)Nuclear) translocation)of)MRTFA) in)healthy) fibroblasts)was)present)at)
very)low)levels)and)was)only)increased)upon)TGFβ)stimulation.)This)indicates)
that) SSc) fibroblasts) are) intrinsically) more) myofibroblastIlike) than) healthy)
fibroblasts.) Experiments) on) SSc) fibroblasts) showed) that) they) contract) in)








fibroblasts) with) the) inhibitor) stopped) gel) contraction.) On) the) other) hand,)
healthy)fibroblast)gel)contraction)was)not)affected)by)CCGI1423.))
"
Another) SSc) symptom) is) calcinosis.) The) abnormal) deposition) of)
hydroxylapatite)and)calcium)phosphate)bone)mineral)is)often)associated)with)
SSc) disease) severity) and) progression.) Studies) have) implicated) IL6) in)
calcinotic) pathology) and) mineralisation) since) MSC) treatment) with) IL6) in)
osteogenic) induction) media) showed) increased) osteogenic) differentiation)
(Fukuyo)et)al.)2014)."Often)the)presence)of)calcinotic)lesions)coincides)with)













7.3" Measuring" the" effect" of" matrix" stiffness" of" MSC" fibrogenic" RNA"
expression"
In) this) Chapter,) the) effect) of) tissue) stiffness) on) MSC) myofibroblast) and)
osteogenic)differentiation)is)discussed)where)healthy)normal)tissue)and)SSc)
















plates,) this)was)not)nearly)as)much)as) that) seen)on)stiff)plates) (stiff)mean)


































Myofibroblasts) are) known) to) express) CTGF,) releasing) it) into) the)
microenvironment) when) depositing) collagen) and) therefore,) if) MSCs) are)




in) MSCs) works) downstream) of) TGFβ) during) myofibroblast) differentiation.)





















































βIglycerophosphate) conducive) to) encouraging) osteogenic) differentiation.)




in)SSc) blister) fluid)was) responsible) for) osteogenic) differentiation) of)MSCs.)
Further,) to) test) the)effect)matrix)stiffness)has)on)differentiation,) the)MRTFA)
inhibitor) CCGI1423) was) used) to) inhibit) the) ability) of) MSCs) to) sense) the)
stiffness)of)the)matrix)and)react)accordingly.)Osteogenic)induction)media)was)
supplemented)with)TGFβ,) IL31,)CCGI1423)or)SSc)or)healthy)control)blister)
fluid.) Treatments) continued) for) 12) days) before) the) cells) were) stained)with)
Alizarin) Red) S) solution.) This) stain) is) absorbed) by) hydroxylapatite) crystals)
formed)by)differentiated)osteoblasts.))
 
Figure) 7.3) illustrates) the) effects) of) TGFβ,) IL31) and) CCGI1423) on) MSC)
osteogenic) differentiation.) It) is) worth) noting) that) the) collagen)matrix) of) the)
Softwell) plates) in) the) absence) of) cells) also) absorbed) the) red) stain) and)
produced)a)pink)or)purple)background)(Figure)7.5))and)as)such)calcification)









any) osteogenic) differentiation.) The) complete) opposite) was) seen) on) stiff)
matrices)where)IL31)treatment)of)MSCs)resulted)in)osteogenic)differentiation)
and) calcification) to) levels) similar) to) TGFβ.) Fitting) with) the) theory) that) the)
stiffness) is) enhancing) differentiation,) inhibition) of) nuclear) localisation) of)






gels) in)order) to)better)model) the)effect)of) the)disease)microenvironment)on)
differentiation) (Figure) 7.4).) The) induction) of) osteogenic) differentiation) in)
response)to)blister)fluid)was)less)obvious)than)that)in)response)to)TGFβ)and)
IL31)alone,)although)it)was)clear)that)SSc)blister)fluid)induced)more)osteogenic)
differentiation) of) MSC) than) healthy) control) blister) fluid.) There) was) not) an)





























































































the# adipose:derived# MSCs# were# pluripotent# enough# to# differentiate# into#
osteoblasts,#healthy#dermal#fibroblasts#were#cultured#alongside#the#MSCs#on#
































Firstly,# the# ability# of#MSCs# to# respond# to#mechanical# stress# in# surrounding#
extracellular# matrix# was# tested# using# myofibroblast# differentiation# as# the#
determinant#of#mechanosensing.#MSCs#cultured#on#stiff#matrices#respond#to#
TGFβ# by# significantly# upregulating# α:SMA# expression.# Since# α:SMA#
expression#is#an#important#myofibroblast#marker,#this#assay#not#only#confirmed#
that#MSCs#can#differentiate#into#α:SMA#expressing#myofibroblast:like#cells,#but#
that# they#are#encouraged# to#do#so# in#stiff#microenvironments.#The#effect#of#
TGFβ#on#α:SMA#expression#on#soft#substrates#was#much#lower.#On#the#other#
hand,# even# though#CTGF# is# expressed# by#myofibroblasts# the# difference# in#
stiffness# between# the# two# substrates# did# not# have# an# effect# on# CTGF#
expression.#Expression#of#both#pro:fibrotic#molecules#was#completely#inhibited#















This# theory# is#reinforced#by#the#observation#that#calcinosis# is#more#typically#
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$
seen# in# sites# of# mechanical# stress,# skin# tightening# and# dermal# collagen#
thickening.##
#
Not#only# is#TGFβ# a#potent# stimulator#of#pro:fibrotic#genes,# it# is#also#clearly#
involved# in# MSC# differentiation# on# stiff# substrates.# This# highlights# the#
heterogeneity#of#MSCs#where#the#same#signal#can#elicit#multiple#responses,#
context#dependent#on#tissue#and#soluble#microenvironment.#It#can,#therefore,#





IL31# has# potent# effects# on#MSC#osteogenic# differentiation# on# stiff#matrices#
similar#to#TGFβ.#This#pro:inflammatory#cytokine#therefore,#has#been#shown#to#






that# mechanosensing# by# MSCs# is# such# an# imperative# phenomenon# that#
inhibiting# it# may# be# able# to# override# stiffness# signals.# CCG:1423# should#
therefore,# be# of# interest# in# therapeutic# use# to# prevent# stiffness# induced#
myofibroblast# differentiation,# extracellular# matrix# escalation# and# MSC#
osteogenic#differentiation.##
#
This# thesis# has# established# IL31# as# an# important# part# of# the# SSc#
microenvironment#constitution.#To#date# IL31#has#not#been# investigated# in#a#










has#no# specific# curative# treatments#due# to#a# lack#of#well# defined# causative#
mechanisms.#For#the#most#part,#MSCs#are#considered#to#be#a#tool#that#can#be#
exploited#as#an#SSc#therapy,#rather#than#an#integral#part#of#the#pathology,#and#
only#recently,#have# there#been# investigations#regarding# the#role#of#MSCs# in#
SSc.#Even#in#these#studies,#the#main#factor#studied#is#the#pluripotency#of#MSCs#










to# become# pathogenic# within# the# context# of# SSc.# Such# contradictions# only#





Much# of# the# work# on# MSCs# in# SSc# has# been# investigating# these# cells# as#
therapeutic#agents.#Such#investigations#often#are#in'vitro#with#MSCs#treated#in#
tissue#culture.#Particularly#considering# the# fact# that# these#are#stem#cells,# in'
vitro#work# takes#a# reductionist#approach#being#somewhat#unrepresentative.#
This#is#because#MSCs#which#have#been#cultured#and#allowed#to#proliferate#in'
vitro,#will# inevitably# be# induced# to# change#phenotype#by# the#growth# factors#









they# are#mostly# quiescent# until# being# signalled# to# participate# in# adipogenic#
differentiation,# or# wound# healing.# MSCs# in' vivo# are# thought# to# have# a#
morphology# similar# to# fibroblasts,# with# a# thin,# elongated# body.# It# is#
hypothesised# however,# that# when# these# cells# are# activated,# they# adopt# a#




















surface,# and# using# partial# digestion# with# collagenase# to# expand# the#


















the#aberrant#synovial# fibroblasts#are# implicated# in#promoting#osteoclasts#via#
myostatin#and#RANKL#(Dankbar#et#al.#2015).# It# is#possible# that# the#disease#
fibroblasts#in#SSc#are#releasing#these#factors#to#induce#local#macrophages#to#








results# suggest# that# they# are# remaining# quiescent# in# the# subcutaneous# fat,#
whereas#the#presence#of#these#nuclei#in#disease#tissue#indicates#that#in#SSc,#
these# stem# cells# are# being# activated.# This# activation# results# in# their#
proliferation,#migration#and#division.#The#fact#that#these#nuclei#are#seen#in#the#
middle# and# bottom# layers# of# the# SSc# biopsy# also# highlights# their# probable#




refinement# to# this# method# would# be# to# use# antibodies# against# some#MSC#
markers# and# look# for# co:localisation# of# the# bell:shaped# nuclei# with# positive#
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$
staining.#Possible#makers# for#MSCs#could# include#Gli1.#Staining# for#α:SMA#
would# theoretically#co:localise#with#both#MSCs#and#fibroblasts,#and#staining#
for#RANK#or#calcitonin#would#confirm#the#bi:nucleated#cells#to#be#osteoclasts#





found# embedded# in# collagen# fibres,# the# question# arises# as# to# whether# the#
fibrotic#extracellular#matrix#of#SSc#attracts#and#recruits#MSCs#to#the#lesion#or#






from# their# role# in# healthy# skin.#The# results# supported# the# reasoning#behind#
elucidating#their#function#in#the#context#of#SSc#microenvironments.#To#fulfil#the#
aim# of# the# thesis,# investigating# the# interaction# between# MSCs# and# SSc#
microenvironment,#three#steps#were#conducted.#The#first#was,#to#confirm#the#
presence#of#dividing#activated#MSCs#in#SSc#tissue.#The#second#to#define#what#
the#SSc#microenvironment# is.#And# the# third#was# to# put# the# two# together# in#





components# of# the# patients’# blood,# particularly# looking# at# autoantibodies.#
Blood# offers# a# global# and# systemic# representation# of# bodily# processes# and#
therefore#does#not#draw#attention#to#red#flags#that#are#localised#and#specific#to#
certain#organs#or#areas.#Such# red# flags# include# increased# levels#of# soluble#
proteins#in#the#interstitial#fluid.#One#way#of#overcoming#the#issues#relating#to#




























of# the# IL6#superfamily,# its# levels# in#blister# fluid#were#measured#(Dillon#et#al.#
2004).# Ultimately,# the# goal# would# be# to# elucidate# all# factors# differentially#
expressed#in#SSc#blister#fluid#compared#with#healthy#blister#fluid,#and#assess#
their#downstream#functions,#before#creating#a#compound#designed#to#inhibit#or#
activate# a# factor# increased# or# decreased# in# SSc# blister# fluid# that# may# be#





Originally,# IL31# levels#were# found# to#be#significantly#elevated# in#both#blister#
fluid# and# plasma# of# SSc# patients.# The# only# limitation# of#measuring# IL31# in#
blister#fluid#in#this#way#is#that#an#ELISA,#is#not#directly#comparable#to#a#Luminex#
assay,#and#therefore,#the#conclusion#of#IL31#being#the#most#highly#increased#
of# all# factors#measured# in# SSc# blister# fluid,# cannot# be#made#with# absolute#




























dermal# IL31,# and#also# those# that# do#not# suffer# from#significant# pruritus.#As#
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$
such,# IL31#alone# is#not#sufficient# to#account# for#all# the#differences#between#
healthy# and# SSc# blister# fluid.# Raynaud’s# Phenomenon# is# an# even# more#
common#symptom#of#SSc#than#pruritus,#affecting#approximately#95%#of# the#
SSc#population.#This# symptom# is# caused#by#severe#vasoconstriction#of# the#








Raynaud’s# phenomenon# early# in# the# process,# allowing# for# more# effective#
treatment#before#avascularisation#results#in#necrotic#lesions,#often#leading#to#
amputation.# In# blister# fluid,# although# not# significant,# there# is# a# clear# trend#
towards# increased# lactate# in#SSc#samples#as#compared#to#healthy#samples#
and#with#a# larger#sample#size,# it#would#not#be#surprising# if#significance#was#
achieved.#Reassuringly,#results#in#literature#conclude#increased#lactate#to#be#
a#sign#of# increased#glycolysis# in#fibroblasts,#which#in#turn,# is#one#of#the#first#
steps#of#myofibroblast#differentiation.#This#glycolytic#reprogramming#was#found#
to# augment# lung# fibrosis,# and# further,# inhibition# of# the# glycolytic# response#
significantly#inhibited#fibroblast#to#myofibroblast#differentiation#(Xie#et#al.#2015).##





fluid# takes# a# localised# approach# to# the# microenvironment# of# the# site# of#
collection,#if#there#is#lactate#build#up#in#the#fingers,#the#blister#fluid#would#not#
necessarily# reflect# this,# whereas# a# Fingertip# Lacticemy# is# more# likely# to#












is# that# the# MSCs# in# SSc# patients# are# inherently# normal,# whereas# the#
microenvironment#is#pathological.#What#may#be#occurring#is#the#MSCs#residing#
in# such# an# abnormal# environment# become# primed# to# certain# soluble# and#
physical# factors,# in# turn,#altering# their#phenotype.#An# interesting#question# is#
whether# newly# “born”# MSCs# in# SSc,# i.e.# MSCs# that# have# not# had# prior#













fibrosis,# and# as# such,# the# use# of# adipose:derived# MSCs# rather# than# bone#
marrow:derived# MSCs# was# preferred.# # Furthermore,# adipose:derived# MSC#
populations#have#been#shown#to#contain#more#committed#progenitor#cells#than#














The# promiscuity# of# MSC# function# is# in# part# due# to# the# effects# of# the#
microenvironment.# This# poses# the# question# of# the# effects# of# the# SSc#
microenvironment#composition.#Perhaps#it# is#not#only#the#presence/absence#
of# a# particular# growth# factor# or# cytokine# in# the# microenvironment# that# is#
responsible# for# MSC# activation,# rather# it# may# be# the# overall# effect# of# all#
microenvironment#components#that,#only#when#together#in#a#certain#balance,#
do#they#induce#the#typically#quiescent#MSCs#to#become#activated.##This#thesis#
aimed# to# begin# unfolding# this# question# by# making# and# using# different#




in# stimulating# their# differentiation# into# myofibroblasts.# This# has# been#
documented# in# the# current# literature,# and# the# most# common# way# this# is#
measured#is#by#the#cells’#increased#expression#of#α:SMA.#This#protein#is#highly#
expressed# by# myofibroblasts,# and# is# mostly# polymerised# into# the# actin#
cytoskeleton# during# turnover,# giving# these# fibroblast:like# cells# a# myocyte#












that# pipetting# errors# were# more# likely,# and# the# short# treatment# time.#





α:SMA,# further# suggesting# that# if# the# MSCs# were# differentiating# into#
myofibroblasts,# this# had# not# fully# taken# place.# Overall# the# results# of# the#
Western#blots#were#particularly#encouraging#as#they#were#consistent#with#the#
results# observed# by# Boris# Hinz,# regarding# MSC# differentiation# into#






dilution,#and# in# fact# results#of#blister# fluid#on#MSCs,#cells#were# treated#with#
blister#fluid#of#different#concentrations.#A#dose#response#curve#was#generated,#
using# α:SMA# expression# as# a# measure# of# MSC# response# to# blister# fluid.#
Dilutions#ranged#from#1:5#through#1:125,#to#completely#serum#free#media#with#
no#blister#fluid.#Confirmative#of#the#Western#blot#analyses,#SSc#blister#fluid#was#
responsible# for# consistently# higher#α:SMA# expression# than# healthy# control#
blister# fluid# at# all# doses.# More# interestingly# was# the# apparent# lack# of# an#
optimum#dose,#where#higher#concentrations#at# lower#dilution#factors#did#not#












biopsy# histology# in# Chapter# 3,# where# these# parallel# collagen# fibres# were#
observed# in# SSc# skin.# As# such,# the# collagen# coated# glass# slides# were#
considered#to#be#a#valid#representation,#and#possibly#would#elucidate#whether#
collagen# configuration# has# an# effect# on#MSC#migration.# The#main# problem#
faced#with#the#used#of#these#slides#was#the#lack#of#adherence#of#the#cells#to#
the# collagen.# Human# integrins# are# thought# to# be# able# to# bind# to# bovine#
collagen,# as# advised# by# the# manufacturer# of# the# slides,# however,# in' vitro,#
fibroblasts# seeded#on# the# slides# at#many#different# densities,# to# account# for#
contact# inhibition,# were# unable# to# adhere.# For# this# reason,# other#migration#










through# both# the# PI3K# and# MAPK# pathways# induces# migration# of# both#









A# consideration# of# these# assays# was# the# extent# of# which# cell# proliferation#















and# to# incorporate# the# migration# assay# into# a# 3D# models,# gel# contraction#
assays#were#conducted.#On#plastic,#the#cells#most#likely#use#the#turnover#of#




fibres,#and#connect# to# the#collagen,# thereby#pulling#on# the#collagen#as# they#
move,#expelling#media#in#the#process,#resulting#in#smaller#gels.#The#formation#
of# these# contractile# fibres# rely# on# incorporation#of#α:SMA# into# polymerising#
actin# subunits.# This# is# a# more# accurate# representation# of# possible#
myofibroblast#differentiation#than#2D#migration#assays.#It#is#also#a#better#model#











treatments,# inhibitors# for# each# were# used# on# blister# fluid,# to# assess# their#
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function# in# blister# fluid,# and# as# food# for# thought# for# use# of# these# inhibitors#
therapeutically.# This# particularly# resonates# following# the# finding# that#





inducing# cell# migration.# Although# the# individual# effects# of# TGFβ,# IL31# and#





the# polymerised# collagen# gels.# This# theory#was# reinforced#when# the# same#
treatments#were#analysed#in#MSCs#cultured#in#monolayers,#and#analysed#for#
α:SMA# expression# rather# than# gel# contraction# as# measures# of# MSC#





















both# lactate# and# IL31# treatments# together# had# no# significant# effect# on# gel#
contraction#compared#with#their#individual#effects.#Of#note,#though#α:SMA#is#a#
good#readout#of#contractile#fibre#polymerisation,#it#is#worth#considering#the#fact#

















resemble# the#activation#state#of#MSCs# in# the#disease.#They#were#aimed#at#




As# such,# taking#a#broader#approach,# the# large#next# generation# sequencing#
assay#was#developed.#The#main#goal#of#this#assay#was#to#identify#all#the#genes#
differentially#expressed#in#MSCs#in#response#to#SSc#blister#fluid#and#compare#
them# to# those#expressed#by#healthy#control#blister# fluid#and# IL31.#This#was#
hoped# to# identify# key# pathways# initiated# by# SSc# blister# fluid# and# from# this,#




would# be# predicted.# Rather# than# assessing# the# individual# functions# of# all#
possible# elevated# factors,# the# approach# taken# by# the# next# generation#
sequencing#gave#much#more#comprehensive#results.#Combining#these#results#
with#Ingenuity#Pathway#Analysis,#the#differentially#expressed#genes#were#put#
into# biological# context.# Thus,# not# only# were# up/down:regulated# genes#
identified,#but#the#pathways#and#genetic#networks#these#genes#were#involved#












in# fibroblasts,# where# blister# fluid# induces# expression# of# some# pro:fibrotic#
proteins,# namely# α:SMA,# CTGF# and# collagen# type# I.# Therapeutically,#
therefore,#MSC#transplantation#as#an#SSc#treatment,#would#not#be#useful#with#













MSCs#may#be#expressing#such# factors,#which# result# in#short# term# localised#
alleviation# of# SSc# symptoms.#However,# as# observed# in#many#MSC# clinical#
trials# in# SSc,# the# beneficial# effects# wear# off,# and# even# sometimes# worsen#
symptoms# (Granel# et# al.# 2015).# Possible# explanations# of# this# may# be#




myofibroblast# differentiation.# Evidence# of# the# deleterious# effects# of# SSc#
microenvironments# is# highlighted# by# similar# reactions# of# both# MSCs# and#
fibroblasts#with#regards#to#α:SMA.#The#SSc#microenvironment#therefore,#has#
an#effect#on#both#MSCs#and#fibroblasts.#Since#normal#physiological#effects#of#





markers.# This# finding# supports# the# notion# that# MSCs# might# be# important#




effect# of#CTGF#and#TGFβ,# and# therefore,# its# direct# inhibition# has# not# been#
studied.#On#the#other#hand,#clinical#trials#of#drugs#inhibiting#the#TGFβ#pathway#
have# failed# to# result# in# successful# results,# with# cytotoxicity,# and# lack# of#













explaining#the# limited#effect#of# their# inhibition# in#clinical# trials.#Another#novel#
gene# is# CSRP2.# While# studies# exist# investigating# its# effect# in# fibrosis,# its#
specific#effect#in#SSc#is#largely#neglected#(Herrmann#et#al.#2004).#Furthermore,#















Some# of# the# most# useful# information# obtained# from# the# IPA# analysis# was#
regarding#the#function#of#MSCs#in#vasculogenesis.#The#cause#of#Raynaud’s#
phenomenon#in#SSc#is#often#put#down#to#hypoxia#and#ischemia#of#the#digits#
resulting# the#vascular#damage.#Although# the#primary#cause#of# this#vascular#
damage#is#still#up#for#debate,#IPA#analysis#of#blister#fluid#treated#MSCs#placed#
high# importance# on# how#well# the# expression# profile# of# these#MSCs# fit# into#
known# processes# in# vascular# damage.# Particularly# as# explanations# for# the#
differences# between# SSc# and# healthy# control# blister# fluid# treated# MSCs.#
Furthermore,# for# the# first# time,#a#significant# result#was# found#directly# linking#
SSc#treated#MSCs#to#fibrogenesis#(Table#6.1).#The#software#was#also#able#to#
pinpoint# the# specific# genes# responsible# for# categorising# the# MSCs# as#










fluid# treated# MSCs,# was# a# decrease# in# adipogenesis.# With# loss# of#
subcutaneous# fat,# a# common# SSc# symptom,# and# with# MSC# adipogenic#
potential,# the# adipogenic# differentiation# assay# in# Chapter# 5.8# aimed# at#





functions# in# response# to# SSc# blister# fluid# in# the# IPA# analysis.# In# the#
differentiation# assay,# this# balance# was# pushed# towards# adipogenesis# by#
culturing#MSCs#in#media,#conducive#for#adipogenic#encouragement.#In#spite#
of#this,#SSc#blister#fluid#was#better#than#healthy#control#blister#fluid#at#inhibiting#
this# differentiation.# Although# the# loss# of# subcutaneous# fat# in# SSc# is# not# a#
symptom# that# is# often# considered# as# needing# treatment,# with# it# not# having#
deleterious# effects# on# patient# well:being,# this# assay# implicated# the#
pathogenicity#of#MSCs#in#a#new#context.#As#such,#aside#from#MSCs#impairing#




In# summary,# comparing# SSc# and# healthy# blister# fluid,# pathway# analysis#
highlighted# a# potentially# important# mechanism# of# how# the# SSc# interstitial#
microenvironment#causes#vascular#damage.#Again#fibrosis#was#calculated#to#
be#an#important#function#of#SSc#blister#fluid#treated#MSCs.#This#analysis,#with#










The#majority# of# publications# investigating# MSCs,# often# focus# on# one# MSC#












Adding# to# the# already# convincing# evidence# that#MSCs#adopt# some# form#of#
myofibroblast:like#phenotype# in# response# to#SSc#microenvironments,# is# the#
qPCR#assay# for# the#expression#of#α:SMA#and#CTGF#by#MSCs#cultured#on#









cell# to# transduce# the# mechanosensing# signal# to# the# nucleus# by# MRTFA#




likely# that# soft# 4# kPa# matrices# are# sufficient# in# inducing# its# expression.$ In#
addition# to# investigating# the#effect#of#matrix#stiffness#on#MSC#expression#of#




osteogenic# differentiation# assay# firstly# confirmed# that# the# commercially#








resulting# in#relatively#strong#background#staining.#For#this#reason,# it# is# likely#
that#the#level#of#differentiation#may#have#been#underestimated.#In#this#assay,#













MSCs# are# cultured# seems# to# play# more# of# a# role# when# it# comes# to#
differentiation#than#it#does#in#α:SMA#and#CTGF#expression#since#inhibition#of#


















In# both# cases,# the# effect# of#matrix# stiffness# is# clearly# a#major# factor# in# the#
determination#of#MSC# function.#Therefore,# it# should#be#as# important#as# the#
soluble# microenvironment# when# considering# treatments,# since# theoretical#
inhibition#of#TGFβ,#as#a#pro:fibrotic#factor,#will#not#override#the#effects#of#the#
matrix#stiffness#of#SSc#on#MSC#fibrogenesis#and#calcinosis#for#example.#As#
such,# inhibition# of# mechanosensing# by# using# CCG:1423,# or# similar# more#
recently#developed#and#more#specific#derivatives,#is#a#valid#option#with#regards#

















In# order# to# develop# appropriate# and# effective# treatments# for# SSc,# robust#
elucidation#of#its#cause#is#needed.#And#in#turn,#before#this#can#be#determined,#















themselves# are# involved# in# SSc# pathogenicity# and# so# the# practice# of#
transplanting#MSCs# into#SSc#patients’# lesions# raises#questions.# In# the#case#






short# term# benefits.# The# theory# assumed# in# this# thesis,# is# that# the# MSCs#






This# thesis# presents# the# first# data# that# activated,# metakaryotically# dividing#
MSCs#are#present#in#abundance#in#SSc#skin,#while#being#completely#absent#in#
healthy# skin.# # To# date,# such# activation#was# only# documented# in# cancerous#
tumours,#and#during#embryonic#development#(Gostjeva#et#al.#2009).##
#
SSc#MSCs#are# theorised# to#be#physiologically#normal,# and# therefore,# there#
must#be#something#inducing#them#to#act#abnormally.#Based#on#the#findings#of#
this# thesis,# this# “something”# is# the# unique# constitution# of# the# SSc#
microenvironment#and#for#the#purpose#of#this#thesis,#is#represented#by#blister#




differentiation,# measured# by# increased# α:SMA# expression,# as# well# as#
migration# and# collagen# contraction.# # SSc# blister# fluid,# and# its# individual#
components,#induced#all#readout#measurements.#IL31#and#lactate#alone#were#
responsible# for# increased# α:SMA# expression# and# MSC# migration# both# on#
plastic#and# in#3D#collagen#matrices#but#SSc#blister# fluid#was# found# to#be#a#
better# inducer.#Three#pathways#predicted# to#be# involved# in#SSc#blister# fluid#
effects# were# inhibited,# the# TGFβ# pathway# with# 1D11,# PI3K# pathway# with#
Wortmmanin# and# MAPK# pathway# with# U0126.# Since# inhibition# of# all# three#
pathways# results# in# only# modest# inhibition# of# myofibroblast# differentiation#
readouts,# it# is# safe# to# conclude# other# factors# in#SSc# blister# fluid,# absent# in#
healthy#blister#fluid,#must#be#responsible.#This#unknown#factor(s)#might#even#










Whatever# the# factor,# it# is# likely# that# it# is# responsible# for# the#novel#pathways#
identified# by# the# RNAseq# next# generation# sequencing# assay.# This# assay#
proved# some# of# the# most# convincing# evidence# for# SSc# blister# fluid# being#
significantly#different#from#healthy#control#blister.#But#more#interestingly,#is#the#
stark# effect# it# has# on# MSCs# in# comparison# to# fibroblasts.# It# is# commonly#
believed# that# fibroblasts# are# the# main# pathological# cell# type# in# SSc,# being#
collagen#secretors,#fibrogenic#and#possible#myofibroblast#precursors.#As#such#





were#many# pathways# induced# by# SSc# blister# fluid# alone.# One# of# the#most#













MSC# pluripotency# was# not# overlooked# in# this# thesis.# Their# potential# for#
differentiation# is#often#neglected#when#being#considered# for# transplantation,#
likely#because#of#limited#engraftment#in#the#target#site#in'vivo.#For#this#reason,#
when# developing# MSCs# for# transplantation# trials,# their# immunomodulatory#
function#is#mainly#exploited.#In#SSc#however,#MSC#differentiation#is#implicated#
in# three# waysW# differentiation# into# myofibroblasts,# resulting# in# fibrosis,#





α:SMA# expression,# cell# migration# and# collagen# contraction.# Osteogenic#















































into' the' dermis'with' bell' shaped' nuclear'morphology.'Dermal' thickening' due' to' increased'
collagen' and' MSC' myofibroblast' differentiation.' Collagen' found' as' thick' fibrils' aligned' in'
parallel.' Vasculature' is' damaged' resulting' eventual' Raynaud’s' phenomenon.' MSC'
osteogenic'differentiation'resulting'in'calcinosis.'MSCs'react'to'increased'IL31,'lactate,'TGFβ,'








The# thesis# heavily# points# to# there# being# a# factor(s)# in# SSc# blister# fluid#
responsible# for# MSC# pathological# effects# in# SSc.# One# step# towards#
identification#of#this#factor#is#by#first#elucidating#its#nature.#It#would#be#useful#if#
SSc#blister#fluid#was#treated#in#such#a#way#to#produce#four#different#blister#fluid#
versions,#to# identify#the#bioactive#componentW#whole#blister# fluid,#blister# fluid#
lacking# proteins,# blister# fluid# lacking# immunoglobulins# and# blister# fluid# with#
miRNA#molecules#removed.#Similar#assays#to#those#described#in#the#studies#
of#this#thesis#would#be#conducted#and#theoretically#would#elucidate#whether#







in# the# Appendix# demonstrating# that# in' vivo# administration# of# IL31# into# the#




to# fibrosis,# immunomodulation,# calcinosis,# loss# of# subcutaneous# fat,# and#
wound#healing,#in#response#to#the#SSc#microenvironment.#These#processes#
cover# almost# all# pathological# aspects# of# the# disease# and# therefore,# these#
findings# not# only# raise# the# question# of# how# MSCs# are# considered# to# be#
beneficial#to#SSc,#nor#only#how#much#a#part#these#cells#play#in#SSc,#but#how#
likely#it#is#that#MSCs#are#responsible#for#much#of#SSc#pathogenicity.#This#thesis#
puts# forward# the# theory# that# MSCs,# through# their# pleiotropy,# are# highly#
influenced# by# the# SSc# microenvironment# and# possibly# very# early# in#
pathogenesis,# are# induced# into# becoming# pathogenic# themselves,#
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CI of diff. 
Significant? Adjusted 
P Value 
     
Top vs. Middle -0.8 -1.24 to -
0.3599 
Yes 0.0001 
Top vs. Bottom -0.7528 -1.205 to -
0.3007 
Yes 0.0004 
Middle vs. Bottom 0.04722 -0.4049 to 
0.4993 
No 0.9666 
     
Test details Mean 1 Mean 2 Mean Diff. SE of diff. 
     
Top vs. Middle 0.025 0.825 -0.8 0.1851 
Top vs. Bottom 0.025 0.7778 -0.7528 0.1901 
Middle vs. Bottom 0.825 0.7778 0.04722 0.1901 

























































































































































































































































Figure S3  IL-31 at 50ng/ml enhances healthy control dermal fibroblast migration across 
































































Treatment! 1! 2! 3! Average!
Serum$free$media$ 0.354$ 0.394$ 0.392$ 0.38$
TGFβ$ 0.158$ 0.154$ 0.159$ 0.157$
SScBF$ 0.14$ 0.139$ 0.128$ 0.136$
cBF$ 0.16$ 0.193$ 0.146$ 0.166$
SScBF$+$1D11$ 0.182$ 0.174$ 0.152$ 0.169$
cBF$+$1D11$ 0.162$ 0.194$ 0.161$ 0.172$
SScBF$ +$
Wortmannin$
0.153$ 0.149$ 0.16$ 0.154$
cBF$+$Wortmannin$ 0.166$ 0.196$ 0.162$ 0.175$
SScBF$+$U0126$ 0.152$ 0.149$ 0.148$ 0.15$
cBF$+$U0126$ 0.162$ 0.202$ 0.174$ 0.179$













     
serum free media vs. 
10% serum 
0.03667 0.009881 to 
0.06345 
Yes 0.0062 
serum free media vs. 
SScBF 
0.04233 0.01555 to 
0.06912 
Yes 0.002 
serum free media vs. 
cBF 
0.01867 -0.008119 to 
0.04545 
No 0.2505 
serum free media vs. 
IL31 
0.02 -0.006786 to 
0.04679 
No 0.1961 
serum free media vs. 
IL31+ Wortmannin 
-0.001 -0.02779 to 
0.02579 
No          
>0.9999 
10% serum vs. SScBF 0.005667 -0.02112 to 
0.03245 
No 0.977 
10% serum vs. cBF -0.018 -0.04479 to 
0.008786 
No 0.2818 
10% serum vs. IL31 -0.01667 -0.04345 to 
0.01012 
No 0.3528 
10% serum vs. IL31+ 
Wortmannin 
-0.03767 -0.06445 to -
0.01088 
Yes 0.0051 
SScBF vs. cBF -0.02367 -0.05045 to 
0.003119 
No 0.0954 
SScBF vs. IL31 -0.02233 -0.04912 to 
0.004452 
No 0.1248 
SScBF vs. IL31+ 
Wortmannin 
-0.04333 -0.07012 to -
0.01655 
Yes 0.0016 
cBF vs. IL31 0.001333 -0.02545 to 
0.02812 
No          
>0.9999 
cBF vs. IL31+ 
Wortmannin 
-0.01967 -0.04645 to 
0.007119 
No 0.2087 
IL31 vs. IL31+ 
Wortmannin 

















































Treatment! 1!(g)! 2!(g)! 3!(g)! Average!
weight!of!gel!
(g)!
Serum$free$media$ 0.354$ 0.394$ 0.392$ 0.38$
TGFβ# $ 0.158$ 0.154$ 0.159$ 0.157$
SScBF$ 0.14$ 0.139$ 0.128$ 0.136$
cBF$ 0.16$ 0.193$ 0.146$ 0.166$
SScBF$+$1D11$ 0.182$ 0.174$ 0.152$ 0.169$
cBF$+$1D11$ 0.162$ 0.194$ 0.161$ 0.172$
SScBF$+$
Wortmannin$
0.153$ 0.149$ 0.16$ 0.154$
cBF$+$Wortmannin$ 0.166$ 0.196$ 0.162$ 0.175$
SScBF$+$U0126$ 0.152$ 0.149$ 0.148$ 0.15$
cBF$+$U0126$ 0.162$ 0.202$ 0.174$ 0.179$
260$
$
Tukey's multiple comparisons test adjusted 
p-value  
serum free vs. TGFb < 0.0001 
serum free vs. SScBF < 0.0001 
serum free vs. cBF < 0.0001 
serum free vs. SScBF+1D11 < 0.0001 
serum free vs. cBF+1D11 < 0.0001 
serum free vs. SScBF+ Wortmannin < 0.0001 
serum free vs. cBF+ Wortmannin < 0.0001 
serum free vs. SScBF+ U0126 < 0.0001 
serum free vs. cBF+U0126 < 0.0001 
serum free vs. IL31+Wortmannin < 0.0001 
TGFb vs. SScBF 0.7793 
TGFb vs. cBF 0.9991 
TGFb vs. SScBF+1D11 0.9917 
TGFb vs. cBF+1D11 0.9625 
TGFb vs. SScBF+ Wortmannin > 0.9999 
TGFb vs. cBF+ Wortmannin 0.9128 
TGFb vs. SScBF+ U0126 0.9999 
TGFb vs. cBF+U0126 0.7332 
TGFb vs. IL31+Wortmannin < 0.0001 
SScBF vs. cBF 0.3316 
SScBF vs. SScBF+1D11 0.2243 
SScBF vs. cBF+1D11 0.1456 
SScBF vs. SScBF+ Wortmannin 0.8934 
SScBF vs. cBF+ Wortmannin 0.1017 
SScBF vs. SScBF+ U0126 0.9794 
SScBF vs. cBF+U0126 0.0473 
SScBF vs. IL31+Wortmannin < 0.0001 
cBF vs. SScBF+1D11 > 0.9999 
cBF vs. cBF+1D11 > 0.9999 
cBF vs. SScBF+ Wortmannin 0.9917 
cBF vs. cBF+ Wortmannin 0.9997 
cBF vs. SScBF+ U0126 0.9375 
cBF vs. cBF+U0126 0.9878 
cBF vs. IL31+Wortmannin < 0.0001 
SScBF+1D11 vs. cBF+1D11 > 0.9999 
SScBF+1D11 vs. SScBF+ Wortmannin 0.9625 
SScBF+1D11 vs. cBF+ Wortmannin > 0.9999 
SScBF+1D11 vs. SScBF+ U0126 0.8478 
SScBF+1D11 vs. cBF+U0126 0.9984 
SScBF+1D11 vs. IL31+Wortmannin < 0.0001 
cBF+1D11 vs. SScBF+ Wortmannin 0.8934 
cBF+1D11 vs. cBF+ Wortmannin > 0.9999 
cBF+1D11 vs. SScBF+ U0126 0.7172 
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cBF+1D11 vs. cBF+U0126 > 0.9999 
cBF+1D11 vs. IL31+Wortmannin < 0.0001 
SScBF+ Wortmannin vs. cBF+ Wortmannin 0.8081 
SScBF+ Wortmannin vs. SScBF+ U0126 > 0.9999 
SScBF+ Wortmannin vs. cBF+U0126 0.583 
SScBF+ Wortmannin vs. IL31+Wortmannin < 0.0001 
cBF+ Wortmannin vs. SScBF+ U0126 0.6 
cBF+ Wortmannin vs. cBF+U0126 > 0.9999 
cBF+ Wortmannin vs. IL31+Wortmannin < 0.0001 
SScBF+ U0126 vs. cBF+U0126 0.3737 
SScBF+ U0126 vs. IL31+Wortmannin < 0.0001 




























































































































































































































serum free media vs. SScBF -12.53 -19.46 to -
5.603 
Yes 0.0004 
serum free media vs. cBF -5.557 -12.48 to 1.37 No 0.1667 
serum free media vs. SScBF + 
1D11 
6.491 -0.4363 to 
13.42 
No 0.074 
serum free media vs. cBF + 
1D11 
-1.998 -8.925 to 4.93 No 0.9846 
serum free media vs. SScBF + 
Wortmannin 
5.56 -1.367 to 
12.49 
No 0.1664 
serum free media vs. cBF + 
Wortmannin 
-6.409 -13.34 to 
0.5178 
No 0.0796 
serum free media vs. SScBF + 
U0126 
5.067 -1.86 to 11.99 No 0.2487 
serum free media vs. cBF + 
U0126 
0.817 -6.11 to 7.744 No >0.999
9 
serum free media vs. SScBF + 
x3 
4.836 -2.091 to 
11.76 
No 0.2972 
serum free media vs. cBF + x3 -3.21 -10.14 to 
3.717 
No 0.7728 
TGFβ vs. SScBF 5.337 -1.59 to 12.26 No 0.2002 
TGFβ vs. cBF 12.31 5.382 to 
19.24 
Yes 0.0005 




TGFβ vs. cBF + 1D11 15.87 8.942 to 22.8 Yes <0.000
1 
TGFβ vs. SScBF + 
Wortmannin 
23.43 16.5 to 30.35 Yes <0.000
1 
TGFβ vs. cBF + Wortmannin 11.46 4.53 to 18.38 Yes 0.001 
















SScBF vs. cBF 6.972 0.04525 to 
13.9 
Yes 0.048 




SScBF vs. cBF + 1D11 10.53 3.605 to 
17.46 
Yes 0.0021 
SScBF vs. SScBF + 
Wortmannin 






SScBF vs. cBF + Wortmannin 6.12 -0.8067 to 
13.05 
No 0.1027 




SScBF vs. cBF + U0126 13.35 6.42 to 20.27 Yes 0.0002 




SScBF vs. cBF + x3 9.32 2.393 to 
16.25 
Yes 0.0058 
cBF vs. SScBF + 1D11 12.05 5.121 to 
18.98 
Yes 0.0006 
cBF vs. cBF + 1D11 3.56 -3.367 to 
10.49 
No 0.6653 
cBF vs. SScBF + Wortmannin 11.12 4.19 to 18.04 Yes 0.0013 




cBF vs. SScBF + U0126 10.62 3.697 to 
17.55 
Yes 0.0019 
cBF vs. cBF + U0126 6.374 -0.5528 to 
13.3 
No 0.0821 
cBF vs. SScBF + x3 10.39 3.466 to 
17.32 
Yes 0.0023 
cBF vs. cBF + x3 2.348 -4.58 to 9.275 No 0.9548 
SScBF + 1D11 vs. cBF + 1D11 -8.488 -15.42 to -
1.561 
Yes 0.0122 
SScBF + 1D11 vs. SScBF + 
Wortmannin 




SScBF + 1D11 vs. cBF + 
Wortmannin 
-12.9 -19.83 to -
5.973 
Yes 0.0003 
SScBF + 1D11 vs. SScBF + 
U0126 
-1.424 -8.351 to 
5.503 
No 0.999 
SScBF + 1D11 vs. cBF + 
U0126 
-5.674 -12.6 to 1.253 No 0.1511 
SScBF + 1D11 vs. SScBF + x3 -1.655 -8.582 to 
5.272 
No 0.9963 
SScBF + 1D11 vs. cBF + x3 -9.701 -16.63 to -
2.774 
Yes 0.0042 
cBF + 1D11 vs. SScBF + 
Wortmannin 
7.557 0.63 to 14.48 Yes 0.0282 
cBF + 1D11 vs. cBF + 
Wortmannin 
-4.412 -11.34 to 
2.515 
No 0.4033 
cBF + 1D11 vs. SScBF + 
U0126 
7.064 0.137 to 
13.99 
Yes 0.0442 
cBF + 1D11 vs. cBF + U0126 2.814 -4.113 to 
9.742 
No 0.875 
cBF + 1D11 vs. SScBF + x3 6.833 -0.09392 to 
13.76 
No 0.0544 





SScBF + Wortmannin vs. cBF 
+ Wortmannin 
-11.97 -18.9 to -
5.042 
Yes 0.0006 
SScBF + Wortmannin vs. 
SScBF + U0126 
-0.493 -7.42 to 6.434 No >0.999
9 
SScBF + Wortmannin vs. cBF 
+ U0126 
-4.743 -11.67 to 
2.184 
No 0.3186 
SScBF + Wortmannin vs. 
SScBF + x3 




SScBF + Wortmannin vs. cBF 
+ x3 
-8.769 -15.7 to -
1.842 
Yes 0.0095 
cBF + Wortmannin vs. SScBF 
+ U0126 
11.48 4.549 to 18.4 Yes 0.001 
cBF + Wortmannin vs. cBF + 
U0126 
7.226 0.2992 to 
14.15 
Yes 0.0381 
cBF + Wortmannin vs. SScBF 
+ x3 
11.24 4.318 to 
18.17 
Yes 0.0011 
cBF + Wortmannin vs. cBF + 
x3 
3.199 -3.728 to 
10.13 
No 0.7758 
SScBF + U0126 vs. cBF + 
U0126 
-4.25 -11.18 to 
2.677 
No 0.4494 
SScBF + U0126 vs. SScBF + 
x3 




SScBF + U0126 vs. cBF + x3 -8.276 -15.2 to -
1.349 
Yes 0.0147 
cBF + U0126 vs. SScBF + x3 4.019 -2.908 to 
10.95 
No 0.5192 
cBF + U0126 vs. cBF + x3 -4.027 -10.95 to 2.9 No 0.5166 



























Condition 1 (g) 2 (g) Average weight of 
gel (g) 
serum free media 0.102 0.153 0.1275 
10% serum 0.06 0.052 0.056 
lactate 0.089 0.126 0.1075 
lactate + aCHCA 0.174 0.179 0.1765 
SScBF 0.086 0.073 0.0795 
cBF 0.1625 0.166 0.16425 
SScBF + aCHCA 0.072 0.112 0.092 













































































Tukey's multiple comparisons test Significant? P Value 
serum free media vs. 10% serum No 0.0757 
serum free media vs. lactate  No 0.9587 
serum free media vs. lactate + aCHCA  No 0.3157 
serum free media vs. SScBF No 0.3347 
serum free media vs. cBF No 0.6014 
serum free media vs. SScBF + aCHCA No 0.6349 
serum free media vs. cBF + aCHCA No 0.9976 
10% serum vs. lactate  No 0.2718 
10% serum vs. lactate + aCHCA  Yes 0.0040 
10% serum vs. SScBF No 0.9132 
10% serum vs. cBF Yes 0.0078 
10% serum vs. SScBF + aCHCA No 0.6215 
10% serum vs. cBF + aCHCA No 0.1648 
lactate vs. lactate + aCHCA  No 0.0891 
lactate vs. SScBF No 0.8259 
lactate vs. cBF No 0.1963 
lactate vs. SScBF + aCHCA No 0.9891 
lactate vs. cBF + aCHCA No 0.9998 
lactate + aCHCA vs. SScBF Yes 0.0152 
lactate + aCHCA vs. cBF No 0.9973 
lactate + aCHCA vs. SScBF + aCHCA Yes 0.0328 
lactate + aCHCA vs. cBF + aCHCA No 0.1496 
SScBF vs. cBF Yes 0.0323 
SScBF vs. SScBF + aCHCA No 0.9969 
SScBF vs. cBF + aCHCA No 0.6215 
cBF vs. SScBF + aCHCA No 0.0721 
cBF vs. cBF + aCHCA No 0.3204 







TBP$Ct$ ΔCT$ 2^5ΔCT$ Average$




serum$free$ 19.16$ 24.79$ 55.63$ 49.5220797
9$
$
serum$free$ 19.86$ 24.87$ 55.01$ 32.2225776$ $




10%$ 18.83$ 24.79$ 55.96$ 62.2499166
3$
$
10%$ 18.84$ 24.42$ 55.58$ 47.8351759
6$
$
10%$ 18.64$ 25.18$ 56.54$ 93.0542411
1$
$




Lactate$ 20.63$ 25.95$ 55.32$ 39.9465775
6$
$
Lactate$ 20.26$ 26.27$ 56.01$ 64.4451552$ $
Lactate$ 20.18$ 26.33$ 56.15$ 71.0124462
1$
$




Lactate$+$aCHCA$ 22.78$ 25.66$ 52.88$ 7.36150120
5$
$
Lactate$+$aCHCA$ 21.81$ 24.79$ 52.98$ 7.88986163
6$
$
Lactate$+$aCHCA$ 21.27$ 24.89$ 53.62$ 12.2950014
5$
$




SScBF$ 18.87$ 24.66$ 55.79$ 55.3303828$ $
SScBF$ 18.87$ 24.79$ 55.92$ 60.5476893
9$
$
SScBF$ 18.88$ 24.41$ 55.53$ 46.2057342
6$
$
cBF$ 20.18$ 25.24$ 55.06$ 33.3589043
5$
27.9094825$
cBF$ 20$ 25.44$ 55.44$ 43.4113384
8$
$
cBF$ 20.59$ 24.9$ 54.31$ 19.8353232$ $









SScBF$+$aCHCA$ 22.06$ 25.38$ 53.32$ 9.98664439
1$
$
SScBF$+$aCHCA$ 22.79$ 26.3$ 53.51$ 11.3924015
6$
$
SScBF$+$aCHCA$ 21.58$ 26.46$ 54.88$ 29.4460048
2$
$




cBF$+$aCHCA$ 19.57$ 25.35$ 55.78$ 54.9481879
3$
$

































































Tukey's#multiple#comparisons#test# Significant?# Adjusted# P#
Value#

































Condition! 1!(g)! 2!(g)! 3!(g)! Average!weight!of!gel(g)!
serum#free#
media#
0.106# 0.107# # 0.1065$
10%#serum# 0.042# 0.045# # 0.0435$
lactate# 0.102# 0.089# 0.091# 0.094$
IL31# 0.109# 0.101# 0.082# 0.097333333$
































































Media    Average  corrected for 
blank  
fold difference  
serum 
only 












0.259 0.252 0.239 0.25 0.121666667 4.397590361  
blank 0.13 0.12 0.135 0.128333333 0   
Tukey's#multiple#comparisons#test# Significant?# Adjusted#P#
Value#
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Abstract 
In scleroderma, an autoimmune process leads to progressive fibrosis of the skin 
and internal organs, which is resistant to therapy.  Cytokines released by 
infiltrating T cells may provide a mechanistic link between the autoimmunity and 
the persistent fibroblast activation seen.  We investigated the role of IL-31, a Th2 
cytokine, implicated in other pruritic skin conditions. IL-31 was present at high 
levels in plasma and skin lesions of scleroderma patients, and the receptor, IL-
31RA, overexpressed by downstream effector cells relevant to the disease process, 
including skin and lung fibroblasts, epidermal cells and fat derived mesenchymal 
stem cells (MSCs).  Treatment of skin fibroblasts with IL-31 induced gene 
expression profiles linked to integrin signalling, growth, actin polymerisation, 
motility, plus Wnt and TGFβ signalling, and induced phenotypic changes 
including migration and collagen protein release, resembling the activation state 
in the disease.  MSCs derived from subcutaneous fat were induced to migrate and 
differentiate by IL-31.  In mice, IL-31 caused skin fibrosis more than the pro-
fibrotic growth factor TGFβ, and led to increased cytokine and growth factor 
levels in a scleroderma-like pattern.   IL-31 appears to act as a central mediator 
in scleroderma skin fibrosis and is confirmed as a target for specific therapies.  
Introduction$
In scleroderma (also called systemic sclerosis, SSc), progressive fibrosis of the skin 
and internal organs resistant to current therapy remains a significant clinical problem 
linked to severe disability and increased mortality (1, 2).  Whereas progress has been 
made in the treatment of pulmonary hypertension, renal crisis and peripheral 
ischaemia, current treatments for fibrosis have limited efficacy and are associated with 
toxicity.  Immunosuppressive regimens, such as methotrexate or cyclophosphamide, 
have a modest effect against skin fibrosis and may cause sepsis or myelosuppression 
276$
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(3, 4).  Autologous haematopoietic stem cell therapy following high intensity 
immunosupression, has shown long term clinical benefit but is associated with up to 
10% increase in mortality in the first year (5). Improved understanding of underlying 
biomechanisms might lead to a more selective and effective anti-fibrotic treatment.    
The mechanisms underlying SSc pathogenesis are, however, complex and 
incompletely understood. Large systematically designed genomic studies have 
implicated immunogenetic and immunoregulatory factors in the disease, at least in 
subsets (6). Gene polymorphism associated with SSc include HLA DR subtypes, 
IRF5, STAT4, CD247, TNIP, IRF8, IL12RB2, CSK, KIAA0319L, PXK, JAZF1, 
BLK, ITGAM, TNRFAIP3(7, 8). In particular, the role of Th cell dependent 
mechanisms in SSc is supported by a number of observations, including the genetic 
associations with HLA-DR alleles,  infiltration of involved tissues by Th cells as well 
as macrophages in approximately 50% of patients, restricted T cell receptor repertoire 
in involved tissue and downstream antigen-specific B cell responses (reviewed in (9)).  
More specifically, Th2 cells are capable of stimulating fibroblasts directly through 
cytokine production or indirectly through polarisation of macrophages to the 
alternatively activated (“M2”) subtype (10-13).    
The heterogeneity of SSc makes therapeutic trials challenging, as beneficial effects 
may only be seen in certain subgroups. Gene expression profiling of lesional RNA 
from SSc patients, has indicated patient-specific inflammatory, fibroproliferative, 
limited, and normal-like patterns (14). Response to therapy might also be predictable 
on the basis of these classifications (15). Recent attempts at therapy have focused on 
clinically defined subsets such as those patients with raised C-reactive protein, in 
whom the use of anti-IL6 receptor antibody trended towards clinical benefit (16). For 
this reason, biological definition of subgroups may further benefit clinical trial design 
in SSc, especially for more targeted therapies.  
Of the clinical features of SSc, severe and intractable itch or pruritus poses a 
significant problem in a sub-population of patients, which may be resistant to 
conventional treatment. The severity of itch varies in intensity from a mild discomfort 
to a disabling symptom associated with a significant psychosocial burden, impacting 
negatively on quality of life. Razykov et al. estimated the prevalence of pruritus at 
43%, in one epidemiological study of 959 scleroderma patients. Although prevalence 
did not change with disease duration (46% at 1.0 – 4.9 years vs. 41% ≥ 5.0 years since 
onset of disease from first non-Raynaud’s symptom), pruritus was independently 
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associated with greater skin and gastro-intestinal involvement(17).  Patients with 
scleroderma who reported higher pain and itch severity were also more likely to have 
more severe depressive symptoms, overall disability, and sleep and fatigue problems, 
even when demographic measures were controlled for (18).   
Pruritus is also a prominent feature of other chronic skin conditions, including atopic 
eczema, nodular prurigo, and T cell lymphoma. Mast cell recruitment, histamine 
release and inflammatory cytokine production are the mechanisms which have been 
implicated in pruritus (reviewed in (19)).  One particular cytokine, Interleukin-31 (IL-
31), which was recently identified as a member of the four-helix bundle structure IL-
6 family of cytokines, is now considered an important itch-inducing factor (20). IL-31 
is predominantly Th2 secreted and signals via a heterodimeric receptor, composed of 
the oncostatin M receptor (OSMR) and interleukin 31 receptor alpha (IL-31RA). It 
has been shown to be strongly associated with pruritic skin conditions including atopic 
dermatitis and cutaneous T-cell lymphoma, and induces itching behaviour in mouse 
models (20-23). IL-31 is known to signal through the JAK-STAT, RAS/ERK and 
PI3K/AKT pathways (24, 25).   
Since Th2 responses have been implicated in SSc, we studied the levels of IL-31 in 
tissue fluid and plasma and sought correlation with itch severity. In addition we 
assayed levels of the IL-31 receptor IL-31RA in target cells from patients and 
investigated whether recombinant IL-31 induced gene expression and phenotypic 
changes linked to the SSc disease process.   The fibrogenic potential of IL-31 has not 
been previously evaluated and we investigated the capacity of recombinant IL-31 to 
induce skin fibrosis in mice.  
Results 
IL-31in plasma and skin of scleroderma patients  IL-31 concentrations were 
measured in plasma and blister fluid of 43 SSc patients and 27 healthy controls.  
Plasma IL-31 was elevated in SSc (HC range 0-792, mean 196, SEM 48, SSc range 0-
17764, mean 1370, SEM 567, p<0.048).  BF IL-31 trended towards elevation in SSc 
but did not reach significance (HC 0-2777, mean 196, SEM 139, SSc 0-38222, 
mean1203, SEM 872 pg/ml, pNS) (Figure 1). IL-31 was present in BF at over 
1000pg/ml in a subgroup of 5 SSc patients (Table 1).  These patients were from both 
limited and diffuse scleroderma subgroups, but had high itch scores (median 5D score 
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Table 1 Clinical and laboratory characteristics of scleroderma patients with dermal blister fluid 
IL-31 >1000 pg/ml.  A subgroup of patients was identified with high blister fluid IL-31. These patients 
were from both diffuse and limited cutaneous subsets and early and late disease, but had in common 
very high 5D itch scores.  In general marked systemic inflammatory features such as high CRP, anaemia 
or high platelet count, associated with a high IL-6 phenotype, were not seen. (Scl70=anti-
topoisomerase, ANA=antinuclear antibody, ACA=anti-centromere, RNA PolIII=anti-RNA polymerase 






Figure 1 Elevated IL-31 in plasma and skin lesions of scleroderma patients.  (A, B) IL-31 was 
assayed by ELISA of plasma and synchronous dermal blister fluid (BF) of SSc patients and healthy 
controls (SSc N=43 HC N=27).   IL-31 was significantly elevated in plasma of SSc patients and BF IL-
31 trended towards elevation in SSc but did not reach significance. (C) Involved forearm skin biopsy 
material from SSc patients and biopsies from the normal forearm skin of healthy controls were frozen 
in OCT and cut as frozen sections, and then immunostained with anti-IL-31.  No positive staining was 
identified in healthy control sections, or with control mouse polyclonal IgG.  However, in the SSc 
lesions strong perivascular and epidermal positive staining was identified.  Human spleen tissue was 
used as positive control.  
!
!
IL31 is present in SSc skin To ascertain whether increased IL-31 levels were present 
in SSc skin, biopsies taken from patients with recent onset diffuse SSc experiencing 
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severe pruritus, were stained for IL-31 (Figure 1C). IL-31 expression was mainly 
localised to the epidermis in SSc skin and around blood vessels. IL-31 expression in 
healthy skin was not seen. The specific upregulation and localisation to the epidermis 
may account for the severe pruritus experienced by the SSc patients. 
IL131%Receptor%expression%in%downstream%effector%cells!!In$order$to$more$fully$explore$the$







Figure! 2! Expression! levels! of! ILA31RA! by! target! cells! and! tissue.$ (A)$ Potential$ effector$ cells$










IL531$ might$ be$ involved$ in$ pathologic$ changes$ in$ addition$ to$ its$ known$ pruritogenic$
properties,$and$we$went$on$to$study$the$effect$of$recombinant$human$IL531$on$target$cells$
































31$ (50$ ng/ml)$ enhanced$ osteogenic$ polarisation$ identified$ by$ Alluzarin$ red$ stain$ on$ stiff$ 50kPa$
substrates$but$not$4$kPa$ substrates,$appearance$at$day$12$ shown.$ $The$ stiff$ substrates$model$ the$
stiffness$of$lesional$fibrotic$skin$in$SSc.$$CCG51423$10µM,$an$inhibitor$of$the$mechano5sensing$MRTF5
A$ pathway,$ blocked$ the$ osteogenic$ differentiation$ induced$ by$ IL531.$ $ *$ P<0.05$ versus$ control,$ **$
P<0.05$vs$IL531$treatment$
%
IL31% induces% osteogenic% differentiation% of% MSCs% IL6$ is$ known$ to$ affect$ MSC$ osteogenic$
















Next$ generation$ sequencing$ using$ Illumina$ TruSeq$ highlighted$ specific$ RNA$ molecules$
expressed$by$healthy$control$dermal$ fibroblasts$ in$response$to$ IL31.$ Interleukin533$ (IL33),$













The$ positive$ effect$ seen$ on$ the$ PI3K$ pathway$ in$ response$ to$ IL31$ is$ notable,$
highlighting$ this$pathway’s$ importance$ in$ the$downstream$effects$of$ this$cytokine$
and$ supporting$ the$ use$ of$Wortmannin$ as$ an$ IL31$ inhibitor$ is$ the$migration$ and$
protein$ expression$ experiments.$ Furthermore,$ PTEN,$ an$ inhibitor$ of$ the$ PI3K$





Figure 5 Next generation sequencing analysis of IL-31 treated fibroblasts. (A) Healthy control dermal fibroblasts were treated with IL-31 (50 ng/m) for 16 hours 
and then lysed for RNA extraction followed by NGS.  Key responsive genes are shown. IL33, ANXA1, and CXCL5 were significantly increased in IL-31 treated 
cells (p= 0.043, p= 0.02, p= 0.005) and MMP10 expression was also higher in response to IL31 than serum free controls, although not significantly so (p= 0.26.). (B) 
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Significantly altered canonical pathways in response to IL-31 treatment are shown. The significance threshold was set at p< 0.05. Blue bars indicate pathway positively 
upregulated by IL31 and the orange, the pathways negatively regulated. The transparency of the bars indicate the Z-score with more opaque bars showing pathways 
with higher z-scores. (C) IPA pathway analysis identified a non-directional gene interaction map network with a score of 33 and 26 focus molecules. These proteins 
have been identified as being involved in cellular movement, cell-to-cell signalling and interaction, and cellular development. Of note are the fibrillary collagens I 
and III, as major constituents of the extracellular matrix, as well as the ERK1/2 signalling pathway implicated in myofibroblast activation in SSc. (D) IPA pathway 
analysis identified a non-directional gene interaction map network with a score of 16 and 16 focus molecules. These proteins have been identified as being involved 
in the inflammatory response, cell-to-cell signalling and interaction, haematological system development and function. IL-6 , known to implicated in SSc 
pathogenesis, features as a central node in the network. Green symbols indicate activated by IL31, and the red indicate inactivated by IL31.   
 
Canonical pathway x-log(p-
value) Z-score  ratio of overlap  Genes 
PCP pathway 5.5 1.889822 0.159 ROCK1,ROR2,SDC2,EFNB1,CTHRC1,JUND,SDC3,FZD2,FZD7,HSPB1 
Colorectal Cancer Metastasis 
Signalling 3.8 0.27735 0.0688 LRP5,AKT2,GNAS,NRAS,BAD,RHOJ,GNG10,GNG11,MSH2,TGFB1,FZD2,MMP1,RALGDS,GNG12,FZD7,ATM,MMP19 
Hypoxia Signaling in the 
Cardiovascular System 2.27 1 0.0923 BIRC6,ATF4,LDHA,UBE2D1,ATM,PTEN 
Integrin Signalling 2.06 -0.33333 0.0548 ROCK1,TSPAN3,AKT2,NRAS,ITGA11,ITGA2,ARPC3,RHOJ,GSN,NEDD9,ATM,PTEN 
fMLP Signalling in Neutrophils 1.97 -1.63299 0.0661 NRAS,GNAS,GNG11,NFAT5,ARPC3,GNG12,GNG10,ATM 
PI3K/AKT Signalling 1.91 -1.41421 0.0645 AKT2,RHEB,NRAS,YWHAG,BAD,ITGA2,MAPK8IP1,PTEN 
Actin Nucleation by ARP-WASP 
Complex 1.9 -1.34164 0.0893 ROCK1,NRAS,ITGA2,ARPC3,RHOJ 
Wnt/Ca+ pathway 1.87 1.341641 0.0877 NFAT5,PDIA3,ATF4,FZD2,FZD7 
Phospholipase C Signalling 1.81 -0.37796 0.0506 MARCKS,NRAS,GNAS,GNG11,NFAT5,ITGA2,HDAC7,ATF4,RHOJ,GNG12,RALGDS,GNG10 
TGF-β Signalling 1.68 -0.44721 0.069 NRAS,BMP4,TGFB1,BMPR1B,ACVR2A,PMEPA1 
G Beta Gamma Signalling 1.65 -0.8165 0.0682 AKT2,NRAS,GNAS,GNG11,GNG12,GNG10 
CXCR4 Signalling 1.65 -0.37796 0.0545 ROCK1,AKT2,NRAS,GNAS,GNG11,RHOJ,GNG12,GNG10,ATM 
IL-8 Signalling 1.59 -0.70711 0.0508 ROCK1,AKT2,NRAS,GNAS,GNG11,CXCL1,RHOJ,GNG12,GNG10,ATM 
Regulation of Actin-based 
Motility by Rho 1.59 -0.44721 0.0659 ROCK1,PIP5K1C,ITGA2,ARPC3,RHOJ,GSN 
PTEN Signalling 1.54 0.377964 0.0588 AKT2,NRAS,BAD,ITGA2,BMPR1B,FGFRL1,PTEN 
Thrombin Signalling 1.51 0.377964 0.0493 ROCK1,AKT2,NRAS,GNAS,GNG11,PDIA3,RHOJ,GNG12,GNG10,ATM 
Cardiac Hypertrophy Signalling 1.48 0.333333 0.0468 ROCK1,NRAS,GNAS,GNG11,TGFB1,PDIA3,RHOJ,GNG12,GNG10,ATM,HSPB1 
 
Table 2 Canonical pathway analysis of IL-31 treated dermal fibroblasts assayed by RNAseq. 4 control dermal fibroblast lines were treated with IL-31 (50ng/ml) 
over 16 hours and then lysed for RNA extraction and subject to next generation sequencing.  IPA software was used with IPA Knowledge Base as its reference to 
identify signalling pathways induced in the target fibroblasts, based on the profile of induced gene expression. Pathways ranked by p values, those highlighted orange 
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are inactivated by IL31 and those in blue are activated by IL31. The –log(p-value) indicates significance. The p-value significance threshold was set at p<0.05 and 
as such –log(0.05)= 1.3. all pathways with –log(p-values) of more than 1.3 are shown in the table. The z-score is the predicted directionality of the pathway. Negative 







Categories Functions Diseases or Functions Annotation p-Value Z-score number of molecules involved/561 
Carbohydrate Metabolism, Small Molecule Biochemistry production production of lactic acid 0.00368 -2.021 5 
Cellular Growth and Proliferation proliferation proliferation of cells 4.5E-13 -1.589 200 
Cell Morphology mineralization mineralization of connective tissue cells 0.000473 -1.358 5 
Cell Death and Survival apoptosis apoptosis of fibroblast cell lines 0.000175 -1.219 23 
Cell Death and Survival, Organismal Injury and Abnormalities cell death cell death of endothelial cells 0.00612 -0.904 11 
Cellular Development, Connective Tissue Development and Function differentiation differentiation of fibroblast cell lines 0.00419 -0.73 12 
Cell Death and Survival apoptosis apoptosis of fibroblasts 0.000117 -0.694 17 
Cardiovascular System Development and Function, Organismal 
Development angiogenesis angiogenesis 6.71E-05 0.085 52 
Cardiovascular System Development and Function development development of vasculature 6.12E-06 0.106 62 
Cardiovascular System Development and Function, Organismal 











In addition to canonical pathways affected by IL-31, the software can also predict 
functionality of the genes expressed in relation to whole system physiology and the 
number of genes out of those differentially expressed by IL-31 that fit into the known 
genes involved in the annotated functions (Table 3). Consistent with a role for IL-31 
in SSc pathophysiology was the reduction in “development of vasculature” function, 
of relevance to the microvascular injury and failure of neoangiogenesis considered to 
be a ubiquitous finding in SSc patients. Also of note IL-31 enhanced gene expression 
patterns linked to apoptosis and lactic acid production possibly relevant to the 
ischaemic microenvironment. 
The IPA software was also able to group molecules predicted to work together, based 
on existing literature and published experimental data, into networks. Biological 
function and molecular relationship is represented as a line between two molecules 
and any grey molecules are those filled in by the Knowledge Base software. The 
differently shaped focus molecules denote enzymes, kinases, receptors, cytokines and 
growth factors. Figures 5C and 5D depict the most significantly and highly scored 
networks illustrating functions in cell movement and inflammatory process 
respectively.  
IL-31 induces fibrosis in mice A widely used mouse model of SSc fibrosis consists 
of daily subcutaneous  injections of the clastogen bleomycin over 3 or more weeks to 
induce tissue injury, leading to dermal fibrosis and inflammation. Marked macrophage 
infiltration is seen by day 3, and progressive fibrosis is apparent by day 14.  On day 
21 histologic changes showing epidermal hypertrophy, dermal fibrosis, and an 
accumulation of myofibroblasts, collagen and dense extracellular matrix material, and 
adipose atrophy are seen, thus resembling SSc skin pathology. Biopsy of lesional skin 
shows upregulated TGFβ1, and increased nuclear phosphorylated SMAD2/3 in 
fibroblasts (27), and upregulated CTGF (28). However, the initiating tissue damage in 
this model is non-specific and unrelated to SSc and the bleomycin model responds to 
anti-inflammatory therapies that are less effective in the human disease.  We developed 
a mouse model whereby IL-31 was delivered continuously for 14 days into the 
subcutaneous tissues by an implanted minpump. Comparison was made with the 
effects of treatment with the known pro-fibrotic TGFβ, and possible synergy was 
investigated by giving both agents together. Dermal thickening was seen following IL-
31 treatment, and piscosirius red (PSR) staining for collagen revealed increased 
dermal collagen cross linking.  No change in lung histology was seen.  In general 
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TGFβ failed to induce fibrotic changes and did not synergise with IL-31 treatment 
(Figure 6 A,B). Treatment with IL-31 led to a significant increase in plasma IL-6 and 







subcutaneous$ mini$ pump$ in$ wild$ type$ Balb/c$ mice$ (N=6)7$ per$ group)$ for$ 14$ days,$ which$ were$
euthanised$at$21$days.$$Skin$and$lung$biopsy$material$obtained$at$21$days$are$shown.$$Lung$histology$
was$ not$ affected.$ $ (B)$ Treatment$ with$ IL)31$ led$ to$ significantly$ increased$ dermal$ thickness$ plus$










Treating progressive skin and organ based fibrosis in SSc remains a significant unmet 
need.  It is possible that the complex pathology developing in SSc fibrotic lesions is 
irreversible because of the chaotic cellular and cytokine environment, plus the severe 
mechanical stress-related changes that evolve.  However, other complex rheumatic 
disorders have turned out to be treatable and reversible through specific treatments 
inhibiting key pathogenic cytokines or cell populations, and both of these approaches 
have shown promise against SSc (16, 29).  In this paper we present data implicating 
the IL-31/IL-31RA axis in multiple pathogenic steps in this disease, including 
fibroblast activation via multiple pathways, enhancement of migratory behaviour by 
fibroblasts and fibroblast precursors, osteogenic differentiation of these cells of 
relevance to the calcinosis, and stimulation of collagen release independent of gene 
expression.  Since cytokines may be involved in T cell-fibroblast cross talk in this 
disease IL-31 was evaluated further as a pathogenic factor.  These studies reveal that 
the receptor was present on multiple candidate cells relevant to the disease 
process.     Epidermal tissues, fat derived MSCs, as well as dermal and lung derived 
fibroblasts were found to express the IL-31 receptor. It is possible that elevated IL-31 
is promoting known pathogenic mechanisms including activation of the epidermis 
(30), mobilisation and activation of subcutaneous fat derived precursor cells (31), as 
well as having a direct effect on tissue fibroblasts.  Interestingly IL-31 triggered 
collagen I protein release without altering mRNA levels, although the non-
transcriptional regulation of collagen I is a well-known phenomenon (32).  
Furthermore, we showed that in dermal fibroblasts IL-31 induced multiple fibrosis 
relevant pathways including Wnt, PI3K, and TGFβ itself, well established as central 
to the pro-fibrotic phenotype (33, 34).  IL-31 induced patterns of gene expression 
associated with apoptosis of endothelial cells and suppression of angiogenesis, also 
relevant to the disease (35).  Based on these findings it is proposed that IL-31 is a key 
central cytokine involved in persistent skin and lung fibrosis in a disease subgroup. 
   
 
Limitations of our study include the relatively small number of tissue fluid samples 
analysed and the cross sectional but non longitudinal nature of the data, which could 
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be extended.  However, the seminal work implicating IL-31 in atopic dermatitis has 
led to specific clinical trials of the monoclonal against IL-31RA (20, 36).  A single 
dose of anti-IL31RA monoclonal was shown to have a lasting benefit extending up to 
12 weeks.  This treatment could be assessed in patients with SSc and high itch scores 
or those with high blister fluid IL-31, adding a single infusion of the anti-IL31Ra to a 
standard treatment, and would be the clearest experiment to fully establish the role of 
this factor in SSc pathogenesis.  Blister fluid sampling before and after therapy could 
provide useful biomarker data.  It is possible that IL-31 is a key central pathogenic 
cytokine in this disease and this idea is favoured by the very high blister fluid levels 
seen, which greatly exceed those of other cytokines including IL-6, as assayed by us 
previously (37) , and the multiple pathogenic effects described.  Reservations would 
include the absence of a clear IL-31/IL-31RA signal in previous gene arrays studies, 
although there is some support for an OSMR increase in disease cells (14, 38, 39).   
 
When first identified as a pathogenic cytokine, it was shown that IL-31 induces 
inflammation and itching behaviour relevant to atopic dermatitis(20).  However, the 
fibrogenic activity of IL-31 was not evaluated in these studies.  Since SSc is both 
pruritic and fibrotic we thought that IL-31 could be promoting multiple aspects of the 
disease, and we have modelled this, delivering IL-31 subcutaneously in wild type mice 
with or without additional TGFβ.   This method has led to a fibrotic change in the 
mouse dermis, where increased dermal thickness and enhanced mature cross linked 
collagen was observed.  Furthermore, an SSc-like pattern of cytokine induction was 
seen, with high levels of plasma IL-6.  However, fibrosis in the deep fascia was 
observed and loss of subcutaneous fat absent, in contrast to the typical changes of SSc.  
However, this may reflect the route of administration of the drug which is 
preferentially into the subcutaneous tissue, whereas the SSc pathology is initiated in 
perivascular regions in the dermis and at the dermo-epidermal junction.  Other 
competing models for SSc skin fibrosis include the bleomycin induced model which 
recapitulates dermal fibrosis and inflammation, but is initiated by a non-specific 
clastogenic stimulus, as well as hypochlorite induced skin fibrosis, which has been 
shown to induce scleroderma-like auto-antibody reactions(40).  Possible merits of the 
current IL-31 induced model include disease-specific cytokine induction, the 
relatively non-invasive method which involves a single subcutaneous implantation 
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under anaesthesia, and clearly reproducible results in terms of the plasma IL-6 
induction and dermal thickening.  
Th2 responses have evolved as critical in host defence mechanisms against parasitic 
infections, promoting specific immune-allergic reactions as well as pro-fibrotic 
responses downstream that are essentially required for containment of focal invasion 
in the skin, gut, liver and elsewhere.  We believe that IL-31 could have a similar role, 
inducing itching as a danger signal in the skin and also inducing fibroblasts and 
mobilising MSCs, in order to wall off invasion from pathogens.  
It may be possible to target the IL-31 pathway in scleroderma patients, and therapeutic 
blockade with a neutralizing anti-IL-31RA or other specific approaches may treat 
severe pruritus and attenuate fibroblast activation in a subset of patients, possibly 
identified by severe pruritus and high dermal IL-31. The anti-IL-31 RA antibody 
nemolizumab has recently been shown to benefit itch and extent of skin involvement 
in atopic dermatitis (36).  We propose to study this or similar therapy in patients with 
SSc-related pruritus using itch severity as well as biomarkers of skin fibrosis as 
endpoints.  In addition we have previously shown that the dermal blister fluid method 
can be used to assay protein biomarkers, which now include IL-31 (37). 
 
Methods 
Patients studied All donors who provided peripheral blood, skin biopsy or dermal 
blister fluid samples did so with written informed consent to a study approved by the 
NHS Health Research Authority, NRES Committee London-Hampstead, HRA, 
reference number 6398. All samples were collected at the Royal Free Hospital Centre 
for Rheumatology and Connective Tissue Disease. Scleroderma patients met 
internationally agreed criteria for diagnosis.  Clinical itch severity was assessed using 
a standardised 5D Pruritus questionnaire (41).  In total plasma was sampled from 43 
scleroderma patients and 27 healthy controls, and blister fluid from 44 scleroderma 

































Sample Collection:  Interstitial fluid samples from the forearm skin of patients with 
scleroderma and healthy controls were collected using the dermal suction blister 
method as previously described (42). This involved using dermal suction machine with 
an 8mm orifice adhering to sterilised forearm skin. The machine was attached to a 
vacuum line, and left for 3.5 hours with suction pressure of 280-310 mmHg. Interstitial 
fluid was removed from the blister using a 23 gauge needle and syringe, before being 
stored in aliquots at -80°C. At the end of the procedure the epidermal tissue roof of 
the blister was dissected from the skin with a scalpel and stored in RNA later prior to 
RNA extraction by Qiagen miniRNA kit.  In total 44 SSc and 27 healthy control 
samples were analysed. Plasma samples were obtained synchronous to the time of 
blister sampling.  Plasma was aliquoted and frozen for later analysis at -80°C. 
Clinical details on the patients were collected, including type of disease, gender, age, 
duration of disease onset, antibody status, current treatment, prior treatment, organ 
involvement, most recent FVC and FEV1, recent creatinine, recent estimated 
pulmonary artery pressure on echocardiogram, and recent NT-BNP results. 
Assay of IL-31 and IL-31RA  ELISA was employed to determine the concentration 
of IL -31 in plasma and blister fluid samples (R&D systems). RNA from 4 SSc and 
healthy control skin and lung fibroblast cell lines was extracted, along with RNA from 
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2 lines of adipose derived MSCs, and assayed for IL31 receptor expression using 
qPCR. Primers for the receptor were designed using NCBI q bank. Qiagen Quantifast 
SYBR Green kit was used for the assay, with TBP expression used as a control 
housekeeping gene to normalise IL31 receptor expression. Rotogene6000 series 
software 1.7 was used to analyse the results and Graphpad prism 7 was used to conduct 
ANOVA statistical analysis.  
Protein assays for CTGF and Collagen I in IL31 treated fibroblasts  Dermal 
fibroblasts were cultured from 4mm skin biopsies taken from the involved forearm 
skin of SSc patients and healthy controls and the fibroblast outgrowth was used at 
early passage number 3-4 as described previously (43).  Fibroblasts were cultured 
initially in DMEM supplemented with 10% FCS plus penicillin/streptomycin, and 
then switched to serum free DMEM overnight prior to treatment with IL-31 at 
increasing concentrations (1/2.5/5/10/50/100 ng/ml).  TGFβ (4ng/ml) was used as 
positive control alone and together with IL31. Collagen and CTGF induction were 
assayed by Western blot of cell lysates using a standard method (43), as well as by 
qPCR.  Nitrocellulose blots were probed with anti-collagen I (Abcam ab34710), anti-
CTGF (Santa Cruz sc14939) and anti-GAPDH (Abcam ab8245) polyclonals.   
IL31 in SSc Skin 4mm punch biopsies from healthy volunteer and SSc patients were 
taken from the anterior forearm before freezing and sectioning. Mouse anti-human 
IL31 primary antibody (1:50) and horse anti-mouse secondary antibody (1:200) were 
used. Sections were immersed in xylene and mounted before imaging. 
IL31 mouse model  To determine whether IL31 induces multiple pro-fibrotic 
pathways that are distinct from the effects of TGFβ in inducing fibrosis, IL31 was 
pumped into mouse skin over 21 days. A mini ALZA osmotic pump embedded into 
the skin of 6-8 week old male Balb/c mice (Charles River Laboratories, CA) delivered 
0.2 µg IL31 (Peprotech #210-31-10) per day over 24 hours (0.008 µg/hour) (n=7). 
Mice were also treated with 800 ng TGFβ per day  (Prosec #cyt-8585b) (n=6). Mice 
either received IL31 or TGFβ treatments alone or together (n=6) and compared to 
saline control treated mice (n=7). Treatments were every day for 14 days before 
removing the pumps and allowing 1 week recovering before euthanisation on day 21. 
Paraffin embedded sections were prepared of the skin and lung tissue for analysis of 
collagen content, loss of subcutaneous fat, PSR staining for increased dermal thickness 
and Masson’s Trichrome.  
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IL31 migration assay Fibroblast migration was studied using a scratch migration 
assay(44).  1 healthy control (NF25) and 2 SSc (SScF1 and SScF2) cell lines were 
cultured in three 24 well plates. All cells were at passage 4. Once confluent, cells were 
serum starved overnight before making a scratch of the diameter of each well using a 
p200 pipette tip. Cells were treated as follows with 4 replicates of each treatment: 
0.2% serum, 10% serum, 50ng/ml IL31 in 0.2% serum, 50ng/ml IL31 plus 
Wortmannin 100 nM(PI3K inhibitor) or U0126 10µM (ERK pathway inhibitor) (45, 
46).    Migration was quantified by imaging the cells at 0, 3, 6, 20 and 24 hours using 
Axioscope light microscope at 2.5x magnification and The same protocol was used 
for one MSC cell line treated as follows in replicates of 3: 0.2% serum, 10% serum, 
50 ng/ml IL31 in 0.2% serum, 50 ng/ml IL31 plus Wortmannin 100nM. Wells were 
imaged at 0, 8 and 24 hours in the same way as the fibroblasts. The area of the scratch 
was measured using NIH ImageJ software followed by ANOVA with Tukey’s post 
hoc statistical analysis using SPSS software.  
Next generation sequencing Healthy dermal fibroblast and fat derived MSCs were 
cultured in 24 well plastic plates until fully confluent. After overnight serum 
starvation, both cell lines were treated in replicates of 4 as follows; 0.2% serum , SSc 
or healthy control blister fluid (1:125), or IL31 (50 ng/ml). Blister fluid and IL31 were 
added to 0.2% serum conditions. A different sample of blister fluid was used for each 
replicate for both cell lines. Cells were treated for 16 hours and lysed for RNA 
extraction using Qiagen RNeasy extraction kit and protocol. In collaboration with 
UCL Genomics, RNA extractions were assayed using Illumina TrueSeq standards 
library with 15 million reads per sample. Quality control of the samples was performed 
using the High Sensitivity Tapestation kit and 43 paired end sequencing.  
 
Transcriptome analysis Paired end reads were mapped to the Ensembl human 
transcriptome reference sequence (latest version available during analysis: GRCh38 
(47). Mapping and generation of read counts per transcript were done using Kallisto 
(doi:10.1038/nbt.3519), based on the novel idea of pseudoalignment. R/Bioconductor 
package tximport was used to import the mapped counts data and summarise the 
transcripts-level data into gene level as described in this paper Further analyses were 
run using DESeq2 package (48)https://doi.org/10.1371/journal.pone.0157022). Some 
advantages of this method includes (i) correction for potential changes in gene length 
across samples (i.e. from differential isoform usage), (ii) Kallisto is faster and require 
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less memory and disk usage compared to alignment-based method. Normalization and 
differential analysis are carried out according to the DESeq2 model by use of negative 
binomial generalized linear model. The estimates of dispersion and logarithmic fold 
changes incorporate data-driven prior distributions.  Using this method, we compared 
the two conditions for each experiment and we extracted a result table with log2fold 
changes, Wald test p values and adjusted p values (according to false discovery rate). 
Mapped reads for each sample ranged between 12 and 21 million. Principal component 
analysis was used as a quality control assessment.  
Functional classification of genes’ list was performed using Ingenuity Pathway 
analysis (IPA, https://www.qiagenbioinformatics.com/). The “core analysis” function 
was used to interpret the data in the context of biological processes, pathways and 
networks. Both up and down regulated identifiers were defined as value parameters 
for the analysis. Significance of the biofunctions and the canonical pathways were 
tested by the Fisher Exact test p-value. The more interconnected the network is, the 
more likely it represents a significant physiological process or function. The network 
is constructed using the focus molecules from the dataset obtained from the NGS and 
the database used by the IPA software, Knowledge Base, fills in areas lacking 
connectivity with predicted non-focus molecules.  
The networks were then scored based on an algorithm which ranks different networks 
by function based on significance of connectivity and relatively to focus molecules 
from the dataset. The score is based on the number of focus molecules and the overall 
size of the network for a specific function compared with how close the network is to 
the focus genes of the original dataset. Countplots of differentially expressed genes 
were produced using Graphpad prism 7.0. 
Osteogenic differentiation study  In order to induce osteogenic differentiation, 
adipose derived MSCs were cultured in osteogenic induction media (OIM) containing 
50 mM ascorbic acid, 10 mM b-glycerophosphoric acid and 0.1 mM dexamethasone 
(Life technologies; Paisley) with or without TGF-β1 (4ng/ml) or IL-31  (50 ng/ml) 
(R&D systems; Minneapolis, USA). Cells were cultured on either soft (4 KPa) or stiff 
(50 KPa) collagen matrices mimicking healthy or SSc skin respectively. Calcification 
was examined using Alizarin Red S (ARS) staining (Sigma-Aldrich; Missouri, USA). 
The culture media was changed and replaced with the new addition of TGF-β1 and 
IL-31 as above, every three  days, over nine days. Photographs were made using a 
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light microscope and Axiovision Rel 4.5, on day 9 to confirm that cells were present 
prior to the mineralisation assay. On day 9 of culture, which is a known intermediate 
time-point of osteogenic differentiation, Briefly, cells were fixed with 4% 
formaldehyde (CellPath; Newtown, UK) for 20 minutes and rinsed with deionised 
water before adding 4 pipette droplets of 1% ARS solution (pH 4.1) per well. 
Following incubation at room temperature for 15 minutes, the cells were washed 
thoroughly with deionised water to remove all non-specific staining. Differentiation 
was visualised by the identification of red dots.   
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